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Abstract 
Oligodendrocyte damage and myelin loss are cardinal features of Multiple 
Sclerosis (MS). Intrinsic myelin repair occurs in MS, mediated by quiescent 
oligodendrocyte progenitors that divide and migrate into demyelinated lesions. 
Experimental remyelination suggests that this repair restores function and can 
protect axons from subsequent degeneration. However this repair is limited, 
and disability supervenes. Designing treatments that augment myelin repair is 
both feasible and attractive. 
Much is known about the rodent oligodendrocyte lineage, but significant 
species differences exist and extrapolation to humans requires direct 
experimental support. Human oligodendrocyte progenitors are hard to grow in 
vitro, and supplies of source tissue and cellular yield are both limited. This 
problem is exacerbated by the failure of rodent mitogens to induce equivalent 
growth expansion of human progenitors. Several possible methods could be 
employed to circumvent these difficulties:-
A conditionally immortalised human progenitor cell line transfected with a 
temperature sensitive oncogene has been reported. However, it was 
demonstrated that all stocks of this cell line have been irredeemably 
contaminated with rodent cells. 
It has been suggested that rodent progenitors can dedifferentiate into a more 
proliferative, multipotent phenotype. If dedifferentiation was a feasible method 
of inducing committed progenitors to a more proliferative state, it might be 
exoected that this property would be widespread amongst similar cells. The 
rodent progenitor cell line CG4 did not dedifferentiate in these circumstances, 
although the original experiment was not repeated. This exemplifies the 
problems of assessing lineage commitment using cell lines, while attesting to 
the stability of CG4. 
Primary cultures of glia from surgical specimens can yield small numbers of 
oligodendrocyte progenitors. Identifying these cells traditionally relies on the 
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morphology and the expression of A285 antigens. Some studies have used 
NG2, an established marker of developing rodent progenitors but there is little 
experimental evidence to support its use in adult humans. It was shown that 
this antibody binds human endothelial cells, fibroblasts and certain types of 
astrocytes and thus lacks specificity for the oligodendrocyte lineage in vitro, 
although the proportion of cells staining with these markers requires further 
study. A population of bipolar and clawed cells, unidentified by traditional 
markers, appears to label with NG2. 
Purification of oligodendrocyte lineage cells using magnetic beads was 
optimised and there was preliminary evidence that the resulting cells 
proliferate in vitro. They gave rise to a population of small bipolar cells that 
were did not express A285 antigens but stained for NG2. We believe these to 
be of the oligodendrocyte lineage and further investigation of these cells is 
required. 
The emergent reports of stem cells in the adult mammalian brain were 
supported by studies using adult human tissue. These cells grow in aggregate 
cultures and can be induced to express oligodendrocyte markers. The 
feasibility of this approach as a source of oligodendrocyte lineage cells will rely 
on further work to ensure that their progeny remain faithful to native 
oligodendrocytes. 
Finally, rodent cells were used to establish that two key determinants of 
myelinating cell efficiency, migration and proliferation, are resistant to the 
effects anti-inflammatory drugs used in MS. It is anticipated that this type of 
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Chapter 1. General Introduction 
Multiple Sclerosis 
Multiple Sclerosis (MS) is the commonest progressive neurological condition 
affecting young people in Britain. It affects some 55,000 people in this country alone. 
It has devastating consequences to the patients, and far-reaching social and economic 
sequelae. Despite much publicity, the treatments available are disappointing, 
expensive and ultimately fail to reverse or halt the disease. 
The disease is typified by episodes of discrete neurological deficits progressing over 
days and resolving, often completely, over weeks. They characteristically affect 
different parts of the central nervous system (CNS) at different times, but certain 
regions appear particularly susceptible. Common manifestations include unilateral 
visual loss from optic neuritis, ataxia and diplopia from brainstem lesions and 
sensorimotor symptoms from spinal cord involvement. These neurological episodes 
are irregular, but typically occur slightly less than once a year (Compston & McAlpine 
1998) (relapsing-remitting phase). 
However, with time, previously dramatic recovery from attacks becomes less 
complete, and disability accumulates (secondary progressive phase). Relapses may 
become less frequent or cease altogether. Spasticity, disabling ataxia and sphincter 
disturbance are common accompaniments of chronic disease. A proportion of patients 
(300/0) develop progressive disease from the outset, and one-third of these never 
manifest acute relapses (Weinshenker et al. 1989) (primary progressive mUltiple 
sclerosis). 
The majority of research into MS has been aimed, directly or indirectly, at finding 
ways of controlling disease activity, and hence preventing progression. Though self-
evidently wholly necessary, this approach ignores the disability already suffered by 
many. 
Aetiology and pathology 
Despite a century and a hairs interest and enomlOUS investment in ~1S research. no 
causal hypothesis has been universally accepted. Controversies abound, as is amply 
demonstrated by the extraordinarily diverse hypotheses and counter-hypotheses 
currently proposed (Behan et al. 2002;Compston & McAlpine 1998J1awkes 2002). 
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While many aspects of the disease do remain frustratingly elusive, painstaking 
research has provided a broadly coherent picture of disease pathogenesis, which 
requires a brief summary. 
Important evidence comes from epidemiological studies. These reveal a complex 
interplay between genetic susceptibility and environmental triggers. The genetic 
contribution has been systematically explored; some 5-7 regions of the human genome 
are consistently identified, but none of these appear to carry alleles that are either 
sufficient or necessary for development of the disease (Compston 1999). However, 
consistent associations with the regions encoding the HLA complex and cytokine 
(TNFa) genes are important evidence for an immunological component to disease 
aetiology. The unusual epidemiology of the disease, and in particular the marked 
geographical variation and existence of restricted outbreaks (eg Faeroe Islands), 
implicate environmental agents, of which viruses have always been prime contenders. 
However, while a clear relationship between relapse and viral infection has been 
established (Sibley et al. 1985), and many viruses have been proposed as contenders, 
no viral agent has ever been convincingly demonstrated as a cause for the disease. 
Further important clues come from detailed pathological studies. Charcot described 
the essential pathological features of MS in the nineteenth century (Charcot 1868), and 
his observations have been confirmed and extended several times since. The classical 
pathological hallmarks of the disease are of areas of inflammation (plaques), often 
localised around blood vessels, in the brain and spinal cord. These contain prominent 
myelin destruction and oligodendrocyte death, with relative, but not absolute, 
preservation ofaxons. More recently it has been recognised that there are widespread 
abnormalities, including diffuse inflammation, small foci of demyelination (Allen & 
McKeown 1979) and axonal changes (Trapp et al. 1998) in macroscopically normal 
appearing white and grey matter as well. 
While these three cardinal features of MS; inflammation, myelin loss, and relative 
axonal sparing, are present in all patients, there are sufficient differences between 
individuals to suggest that the pathogenic mechanisms may not be entirely uniform 
between MS patients. A study of actiyc demyelinating lesions in a large series of \1S 
patients found evidence for four di tTcrcnt pattenls of pathological findings that were 
conserved within lesions from the same patient. The most conunon pattern (designated 
pattern II). found in just oyer half of these patients. suggested myelin dalllage 
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consequent on both T cell mediated destruction and antibody deposition. A related, but 
rarer pattern (1) was similar but lacked notable antibody mediated destruction. In both 
of these, myelin loss was centred on veins, providing further support for an 
inflammatory cause for the myelin loss. These patterns are very similar to those seen 
in experimental allergic encephalomyelitis (EAE) which has been widely used as a 
model for MS. However the second commonest pattern of pathology (lIn, seen in 
about 30% of the patients, was unlike that seen in any of the EAE models. The most 
notable feature in biopsies and autopsies from these patients was premature loss of 
myelin associated glycoprotein (MAG) immunoreactivity. MAG is expressed by the 
periaxonal, inner myelin lamellae and it is consequently at the furthest (and most 
metabolically vulnerable) extremity of the oligodendrocyte. Thus early loss of this 
protein implies selective damage to this metabolically vulnerable region, and hence 
suggests primary damage to the oligodendrocyte itself. The demonstration of apoptotic 
oligodendrocytes and prominent loss of oligodendrocyte numbers in the demyelinated 
plaque centre supports this. While inflammatory changes were seen in these lesions, 
the peri axonal part of the myelin sheath is relatively protected from immune attack, 
and the demonstration of relative myelin preservation around venules also tends to 
exonerate inflammation as the primary mechanism of myelin injury in these patients. 
This pattern of pathology is also seen in diseases where oligodendrocyte damage is 
caused by viruses or toxins. The rarest pattern (IV), found only in primary progressive 
MS patients, also showed prominent oligodendrocyte loss but without premature loss 
of MAG or evidence for apoptosis within the lesions (Lucchinetti et al. 2000). 
These variations may have a number of origins. Variability in the effecter mechanisms 
of an immune response between individuals with a different genetic background is 
seen in EAE, but pattern III is particularly difficult to explain with a pure immune 
hypothesis. The authors of the report suggest that this variability might reflect 
different stages in the disease or even fundarnental difference in the pathogenesis 
between different patients. There are insufficient data presently available to 
differentiate between these possibilities with any certainty. This study does, however, 
re-emphasise the limitations of EAE as a model for MS a whole. 
The sequence of en~nts that lead to this triad of inflammation. myelin loss and axonal 
drunage remain to be fully elucidated. Disruption of the blood brain barrier has 
traditionally been one of the earliest identi fied pathological events in lesion fonnation 
(Compston & ~lc:\lpine 1998) and the first e\"idence of the inflammatory phase. This 
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can be demonstrated by gadolinium enhancement on ~1RI, often mirroring the 
development of clinical symptoms (Miller & Thompson 1999). In that the blood-brain 
barrier usually restricts the exposure of intrinsic brain antigens to systemic immune 
surveillance, damage to this is thought to lead to antigen recognition and hence to an 
escalating immune response. Activation of infiltrating macrophages and resident 
microglia, release of pro-inflammatory cytokines and chemokines, up-regulation of 
their receptors, increased expression of adhesion molecules, MHC antigens and a 
range of co-stimulatory molecules (Lassmann 1999) have all been demonstrated. 
These findings all appear to support a primarily immune hypothesis of MS 
pathogenesis, similar to that seen in EAE, and consistent with the pathology in 
patterns I and II. 
During the period of active inflammation, a process of myelin destruction occurs, but 
there are several pointers to suggest that these processes may be separate. It is notable 
that many of the inflammatory features of MS are seen in other CNS diseases, but the 
degree of demyelination is unique to MS (Lassmann 1999). A major demyelinating 
mechanism in many patients appears to be antibody deposition and subsequent 
complement activation on myelin sheaths (pattern II), which is demonstrable at the site 
of active myelin destruction (Storch et al. 1998). This has similarities with a widely 
used EAE model; myelin oligodendrocyte glycoprotein (MOG)-induced EAE in Lewis 
rats. In this particular model, inflammatory lesions can be induced by transfer of 
nlyelin basic protein (MBP)-reactive T -cells, but little demyelination occurs unless 
antibodies directed against MOG are injected at the same time as the T -cells. Antibody 
and complement deposition is not a universal finding in MS (Lucchinetti et a1. 2000) 
and although many patients (but not all) have antibodies to MOG detectable in their 
CSF, these can also be found in patients with other eNS inflammation (Reindl et a1. 
1999) and so cannot be sufficient for demyelination alone. 
Other mechanisms for demyelination may co-exist, or dominate the pathology in some 
patients. The oligodendrocyte itself, rather than the myelin sheath, may be the primary 
target of attack (patterns III & IV). The high metabolic load required to maintain the 
myelin sheath makes the oligodendrocyte very vulnerable to injury, and direct 
oligodendrocyte cytotoxicity from a range of agents has been demonstrated, many of 
which have been shown to occur in \lS lesions. These include nitric oxide and its 
highly reacti\'c metabolite peroxynitrite, perforins and the cytokines TNFu and IF:\y 
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(Benn et al. 2001). The presence of apoptosis and the up-regulation of molecules 
involved in death-related signalling have also been demonstrated in \lS lesions, but 
the significance of these remain open to debate (Rodriguez & Lucchinetti 1999). 
Recent insights from more advanced MRl sequences have challenged the traditional 
view that myelin and axonal damage follow damage to the blood brain barrier. 
Magnetisation transfer ratios, which are particularly sensitive to pathological changes 
in myelin and axons, decrease focally months or even years before lesions become 
visible with T 2-weighted (Goodkin et al. 1998;Pike et al. 2000) or gadolinium 
enhanced (Filippi et al. 1998) images. The causes for these early changes are unclear, 
but they have important implications for our understanding of lesion development and 
challenge the rational of some current therapies. These findings raise the intriguing 
possibility that inflammation and plaque formation may be the culmination of a 
longstanding pathological process, rather than its inception. If confirmed, the role of 
inflammation as the prime mechanism of damage is in doubt, indeed it may playa 
much more benign role (discussed further in Chapter 6). 
The final component of the triad, axonal damage, was reported in the earliest 
descriptions of MS, but it is the recent attempts to quantify it that have fuelled a 
resurgence of interest in this component of the disease. It is worth re-emphasising that 
axons are relatively spared, particularly in comparison with the widespread myelin 
loss. However, the traditional histopathological features of axonal swellings and axon 
bulb formation proximal to the site of axon damage and fragmentation were described 
in 1936 (Greenfield & King 1936). These are specific for axonal damage - they occur 
in axonal dystrophies, be they primary or secondary, but not in neurodegenerative 
conditions where the neuronal soma is primarily targeted. However they lack 
sensitivity, which limited these few early attempts to quantify axonal damage in MS 
(Greenfield & King 1936). Recent studies have been assisted by newer and more 
sensitive techniques. One of these includes the immunohistochemical demonstration of 
p aIllyloid precursor protein (APP). This is normally carried down the axon by fast 
axonal transport, but it accumulates immediately proximal to foci of axonal injury 
where it can be demonstrated by immunohistochemical methods. The proliferation of 
new techniques of magnetic resonance based imaging has allowed estimation of axon 
loss in li\'ing patients. and this has enabled longitudinal clinical studies to be 
pcrfonned. These studies use quantitati\~ \lR spectroscopy to determine le\'els of ~-
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acetyl-aspartate (NAA). Since this substance is mostly expressed in axons (Bjartn1ar et 
al. 2002) (although some rodent studies suggest that oligodendrocyte progenitors may 
also express it (Bhakoo & Pearce 2000»), reduction of the NAA peak has been used as 
a surrogate for axonal damage. These suggest that chronic disability itself cannot be 
fully explained on the basis of demyelination alone, and furthennore that there is an 
important correlation between chronic disability and axonal loss. 
Axon loss is unlikely to have a single cause. There is strong evidence that axon loss 
occurs in the acute MS lesions, but it is rather less likely to have a pathophysiological 
impact. The reversible nature of acute relapses is more easily explained by the 
resolution of oedema and of inflammation, and by spontaneous remyelination 
(discussed later); it is less consistent with functionally significant axon fragmentation 
(Bjartmar & Trapp 2001 ;Scolding & Franklin 1998;Smith & McDonald 1999). indeed 
some studies suggest 85-95% ofaxons need to be damaged for significant loss of 
function (Sabel 1997). However, axon loss in chronic MS is widespread, and one 
might postulate that this could impair functional reserve, and so cause symptoms at a 
more modest level than certain studies predict (Sabel 1997). Axon loss may start early, 
but it may need to accumulate for several years before making a substantial 
contribution to disability (Figure 1-1). 
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Figure 1-1 Diagram to illustrate the hypothesis of axon 10 s as a ub trate for 
accumulating disability in progressi eM. Axon loss may start earl and continue for e 
before reaching a clinical threshold whereupon it starts contributing to di ability . 
.--
-.-
Secondary Progressive Phase 
Clinical threshold 
Years of Disease Activity 
The dominant cause for accumulating axonal damage is of great importance. Two 
major mechanisms have been proposed, and both have considerable experimental 
support. The first is that inflanunation per se causes the bulk of axon damage, the 
second is that axon loss accumulates as a consequence of persistent demyelination . 
The NAA peak, a putative marker of axonal integrity, is rapidly lost in acute MS 
lesions, but recovery, albeit incomplete, is similarly quick. It seems unlikely that this 
mirrors axonal transection, though may reflect reversible axonal damage. This degre 
ofNAA loss is not seen in central pontine myelinolysis where demyelination occur 
without marked inflaIl1Dlation (Da ie et al. 1999). Undoubtedly some axon trans ti on 
and loss occurs in acute lesions alongsid an inflanmlatory infiltrate (Bitsch et al. 
20 O' Kom k t al. 2000) and th inflanunation almost c rtainl contribut to a ut 
axona l fragm ntation Bjartmar t al. _OO l 'F rguson et al. 1 7'Trapp t aI . 1 
H w r th ria tin hip b t \ n th t\ 0 h not b n. APP 
and b inti r n lin than in ti n 
K m k t n t m upp rti n th 
intlammati n 1 u ti v . H \ \' r th m 1t1 fth iftlr nt 
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processes in acute lesions have already been underlined and myelin loss is a major 
component that cannot easily be ignored. 
The second possibility, that persistent demyelination causes the bulk of axon loss, 
might occur by several possible mechanisms. This could occur directly, through the 
loss of oligodendrocyte-derived trophic support (Bjartmar & Trapp 2001 ;Meyer-
Franke et al. 1995;Scolding & Franklin 1998) or dependence on contact with their 
myelin sheaths (Griffiths et al. 1998), or by sustained demyelination-induced 
conduction block or electrical silence (Lipton 1986), or indirectly through increased 
vulnerability of the exposed axon to injurious agents (Raine & Cross 1989). 
Furthermore, the adaptations that occur to the demyelinated axolemma to restore 
impulse conduction may themselves predispose to later damage. Sodium channels 
diffuse along the internodal membrane from their aggregations at the original nodes of 
Ranvier, and may facilitate sodium leakage into the axoplasm. This in tum may impair 
outward calcium transport, leading to calcium mediated axon damage (Kapoor et al. 
2003). 
While both these processes probably contribute to axon damage, is it transient (albeit 
perhaps repeated) inflammation or chronic demyelination that is dominant, and thus 
should be the focus of therapeutic intervention? Axon loss does not correlate with 
either inflammatory cell infiltrate, tumour necrosis factor expression, nitric oxide 
expression, or demyelinating activity, but is related to the overall extent of myelin loss 
(Bitsch et al. 2000;Kornek et al. 2000). Furthermore it is seen in lesions which are 
demyelinated even when they exhibit sparse or no inflammation, but is rare in 
remyelinated lesions (Kornek et al. 2000). In that accumulating axon loss appears to 
be a major determinant of chronic disease, and that the course of this appears to be 
closely influenced neither by early inflammatory disease activity (Bitsch et al. 
2000;Confavreux et al. 2000;Kornek et al. 2000) nor by even the most profound 
immune suppressant treatments, it seems unlikely that inflammation is wholly 
responsible. These arguments would favour demyelination as the dominant cause, and 
the key observation of axonal preservation in remyelinated lesions gives an important 
direction for therapeutic efforts. 
Ihe Pathophysiology of Relapse, Rccu\'('ry' and Progression 
A characteristic feature of early ~lS is the remarkable spontaneous recovery in the 
aftennath of acutdy disabling symptoms. It is worth re-emphasising that this is 
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unlikely to reflect axonal fragmentatio~ but fits much more closely with the 
pathophysiology of demyelination and inflammation (Smith & McDonald 1999). 
While certain axons are never myelinated yet are able to support slow, but secure 
action potentials, acutely demyelinated axons cannot. The sodium channels of denuded 
axons remain clustered at the nodes of Ranvier after the myelin is lost. The intervening 
axolemma remains bare, and without these channels, it is unable to support an action 
potential. Even axons with short demyelinated segments, or where the nodes have 
been widened by myelin damage, may fail to propagate an impulse. High cytokine 
concentrations also contribute to this block, either directly or through their induction 
of nitric oxide production. Individually these obstacles present only a relative 
impediment to the propagation of action potentials, but act in co-operation to block 
conduction (Smith & McDonald 1999). 
The return of transmission could reflect the resolution of any of these factors. The 
characteristically rapid clinical recovery has been shown to mirror the regression of 
MRI determined inflammation and it is therefore likely that falling cytokine levels are 
important in the initial resolution of symptoms. Sodium channels also start to diffuse 
along the denuded axon over a few days, allowing the return of slow impulse 
propagation. 
Unfortunately these reparative processes remain tenuous, and conduction block can 
return to persistently demyelinated axons with relatively minor physical changes or 
rises in systemic cytokine levels (Smith & McDonald 1999). Symptoms occurring 
with physical stress (Lhermitte's) or rising temperature (Uhtorrs phenomenon) both 
indicate that demyelination rather than axon loss is the major cause of disability in the 
early phase of the disease. The fact that these symptoms can also occur in chronic 
disease emphasises that persistent demyelination remains as important cause of 
symptoms even in chronic disease. It is only with repair of the myelin sheath that 
robust and secure saltatory conduction can return (Smith et al. 1979). 
Remyelination in Multiple Sclerosis 
The occurrence of spontaneous myelin repair was first demonstrated in MS in 1965 
with the advent of electron microscopy (perier & Gregoire 1965), only a few years 
after the first demonstration of experimental spontaneous CNS remyelination (Bunge 
et al. 1961). This phenomenon has been much studied by contemporary pathologists 
(Lassmann et al. 1997;Prineas & Connell 1979;Raine & Wu 1993) who have revealed 
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some interesting historical perspecti es. Firstly, the classicall des rib d .. h ow 
plaque" (Markschattenherde), originall felt to represent a oung and ti 'e or 
incompletely demyelinated lesion (Dawson 1916) in fact represents su 
of myelin across whole plaques (Figure 1-2). 
ful r p Ir 
Figure 1-2 Section of cerebral hemi pheTes of a patient who died with M ho\ ' ng b th 
persistently demyelinated plaques (green arrows) and remyelinated "hado -plaque ". M lin 
labelled with Luxol fast blue. Reproduced from (Franklin 2002). 
These areas are particularly e ident in acute cases, are common accompaniments of 
immune mediated myelin damage (patterns I & II), and compris areas of pal - t mmg 
myelin either on the edg of a plaque or in normal unaffected whit matt r. Th 
contain larg nwnbers of uni form I thin m lin sheaths which tog th r \i ith h rt 
int rn d ar charact ri ti hallmark f r m lination . econdl bin ki 
du d illu trati n f m lin pha in multipl i unwittin I 
illu lrat Wl UI a l m lin r p Ir 1- ). 
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Figure 1-3 Joseph Babinski s original illustration (1 85) of myelin phago 0 1 m 
multiple sclerosis also demonstrates the characteri stic thin myelin sheath and hort int mod 
of spontaneous myelin repair to the right of the axon. 
Quiescent oligodendrocyte progenitor cells (OPC) or even more immature cells ait-
Oumesmar et al. 1999), rather than surviving mature oligodendrocytes, are generally 
considered responsible for the majority of spontaneous remyelination (Gensert & 
Goldman 1997; Carroll & Jenrungs 1994;Duncan et al. 1997;Wolswijk 2000). Large 
populations of immature oligodendrocytes can be found in fresh MS lesions (Raine et 
al. 1981), including significant numbers of cells with the phenotypic markers of 
oligodendrocyte precursors (Chang et al. 2000a;Maeda et al. 2001 ;Scolding et al. 
1998;Wolswijk 1998). Additionally (and particularly in the spinal cord), Schwann 
cells also contribute to endogenous myelin repair (Itoyama et al. 1983;Ludwin 
1988;Ogata & Feigin 1975). 
Recent studies have probed the origin, nature and limitations of spontaneous myelin 
repair. That it commences while demyelination is still occurring, as unwittingly shown 
by Babinski, has been confirmed (Prineas et al. 1993a;Raine & Wu 1993). In the early 
inflammatory phase of multiple sclerosis some 40% of plaques may contain areas of 
remyelination occupying 100/0 or more of plaque volume (Ozawa et al. 1994;Prinea et 
al. 1993a). This figure appears to fall as the disease progresses (Ozawa et al. 1994), 
with the majority of chronic plaques ha ing either no new myelin or a thin p riph ral 
rim (Lassmann 1983). Histological r pair does not equate with functional r co r 
but there is con incing e idenc th t entral remyelination is accompani d by th 
r storation of cur altator condu tion ( mith t. al. 1 7 . Thi pro of r p 1r, 
h w r f~ ti ,1 limit d and ultim t I f il to pr nt th umul ti n f 
di a ilit 
nurnb r fp ibl ' pl anati n f r th fai lur f r p ir hav b n pr p d. 
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proposed as a possible mechanism (Carroll et a1. I 998;Duncan et al. 1997;Keirstead et 
a1. 1998;Rosenbluth 1996;Scolding & Franklin 1999). Indeed there is much to favour 
this as a hypothesis although recent evidence suggests that progenitor depletion may 
not be a universal consequence of repeated demyelination (Penderis et a1. 2003). The 
limited migratory capacity of endogenous progenitors may contribute (Franklin et a1. 
1997) and/or oligodendrocyte progenitors may be directly targeted by disease 
processes (Niehaus et a1. 2000). However, changes in chronically demyelinated axons. 
rendering them less amenable to remyelinating cells, are also likely factors (Charles et 
a1. 2000). 
In addition, the progression of the astrocytic scar, obstructing the dispersal of myelin-
forming glia within areas of demyelination, also might impede remyelination (Fawcett 
& Asher 1999). The influence of astrocytes is complex, however. In experimental 
studies, extensive myelination by implanted oligodendrogliallineage cells or by 
Schwarm cells occurred unimpeded by host or purified transplanted astrocytes (Archer 
et a1. 1997;Duncan & Hoffman 1997;Franklin et a1. 1991). Others have described 
cohabiting astrocytes and Schwarm cells in lesions which exhibit "peripheral" myelin 
repair (Itoyama et a1. 1983;Ogata & Feigin 1975). Paradoxical roles for astrocytes are 
increasingly appreciated in oligodendrocyte remyelination: chronic astrocytic scars 
may obstruct myelin repair by oligodendrocyte progenitors, while acutely reactive 
astrocytes synthesise and release pro-migratory and proliferative growth factors for 
oligodendrocyte progenitors. A final possibility, eloquently argued in a recent review 
(Franklin 2002), is that dysregulation of a finely co-ordinated process, rather than 
failure of anyone component of this, is ultimately responsible. 
Whatever the mechanism of failure, persistently demyelinated axons dominate the 
pathology of chronic MS. If, as we have argued, chronic demyelination rather than 
active inflammation is mostly responsible for the progressive axonal loss of chronic 
disease, and axonal loss is confirmed as a major substrate of progressive disability 
along with demyelination-induced conduction block, then myelin repair must be a 
major therapeutic priority. The challenge is to augment successful, but limited, 
spontaneous myelin repair in time to pre\'ent axon loss. 
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Strategies for repair 
Myelin damage and oligodendrocyte loss, while occurring in the context of other 
processes, dominate the pathology, broadly explain the clinical phenomena, and may 
be ultimately responsible for the relentless progression of MS. They thus become 
enonnously attractive targets for therapeutic intervention. 
The aims of a remyelinating therapy are both to restore function and to protect axonal 
tracts from subsequent degeneration. The increasingly recognised importance of 
axonal loss as a pathophysiological substrate of accumulating disability by no means 
excludes a significant or substantial contribution by persistent demyelination per se to 
chronic disability (Scolding & Franklin 1998;Smith & McDonald 1999). Thus it 
should be feasible to reverse certain types of persistent disability in patients with 
multiple sclerosis. The relative preservation ofaxons even in chronic lesions offers 
pathological reasons for believing remyelination to have a prospect of functional 
value, while the transient deterioration in chronic symptoms with fever - Uhtoff's 
phenomenon - provides strong pathophysiological evidence for demyelination as an 
important substrate for impaired function. 
The occurrence of spontaneous remyelination has profound conceptual implications 
for myelin repair therapies. The aim of such treatments ceases to be that of creating a 
repair phenomenon de novo, and becomes one of enhancing or supplementing a 
spontaneous process. How this might be done must self-evidently depend on 
understanding what may be termed the clinical biology of the disease. The reasons 
why endogenous repair is not even more successful, and whether the limitations can be 
overcome can only emerge from a fuller appreciation of the biology of myelinating 
glial cells. 
Myelinating Glia in the Central Nervous System 
Oligodendrocytes were first discovered only 80 years ago by del Rio Hortega; he also 
described their principal function, the synthesis of myelin in the CNS. It is now known 
that they develop from a progenitor cell whose properties have been much studied 
since culture techniques offered new opportunities for cell biological investigations 
(Raff et ale 1983;Skoff 1996). Furthermore, the origins of these can be traced back to 
cells of the developing embryo, and insights from these studies have informed our 
understanding of cellular specification, fate and potential. It is valuable therefore to 
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summarise some of this work as it can provide important clues as to how 
remyelination may be augmented. 
Develoomental Neurobiology In Vivo 
Cells of the oligodendrocyte lineage are originally derived from the neural plate. an 
area of ectoderm that invaginates to form the neural tube in the developing embryo. 
Neuroectodermal cells around the primitive ventricle (ventricular zone) proliferate and 
migrate away from it to produce the surrounding sub-ventricular zone, developing in 
humans by gestational week six. Both zones contain pluripotential stem cells that 
divide asymmetrically to produce more lineage-restricted progenitors that populate the 
developing CNS parenchyma. 
During development a series of waves of neuronal and glial subtypes exit the cell 
cycle and migrate laterally into the mantle zone where neural circuitry and glial 
interactions mature. The processes of cell cycle exit and lineage determination are 
orchestrated by the interplay of extracellular signalling molecules and nuclear 
transcription factors. These have been most fully understood in the spinal cord of 
experimental animals. A series of spatially and temporally determined gradients 
interact to allow the development of specific regions from which separate lineages 
arise. Orchestrating these processes, and of established pertinence to the production of 
oligodendrocytes, is sonic hedgehog (Shh), a signalling molecule secreted by cells of 
the notochord and overlying floor-plate. Various homeodomain transcription factors 
(eg Pax, Dbx & Irx proteins) are suppressed at distinct concentrations ofShh, while 
others are induced (e.g Nkx). Co-repression of pairs of transcription factors sharpens 
the boundaries, leading to a ladder-like series of zones with unique transcription factor 
Inilieus (Figure 1-4). These give rise to distinct neural progenitors destined to form 
di fferent subclasses of mature neurones and glia (Marquardt & Pfaff 200 1 ). 
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Figure 1-4 Transcriptional control of fate determination in the de elopin spinal 
Adapted/rom (Marquardt & Pfaff2001) r . 
class/ ~ 
""" 
N <.C , kbs ~ ~ ~ ('l') ~ c. 0 ~ c. 
- Elements under 
ca [ 1 -+ 0 dorsal influences 
o[ T-
Co I -+ vO Intemeurons 
<.[ 
-+ v1 Intemeurons 
<;i [ I 
-+ v2 Interneurons 
I [---r - N Motomeurons , ~ 
-+ MNs i5 then opes 
'a [ --r-- T T -+ v3 Visceral Motomeurons 
class" C'- """ """ ~ ~~ . . 
kkHs <.C <.C N NN ~ ~ ~ ~~ 
z z z zz 
However, both motor neurones and oligodendrocytes arise from the same zone (PMN) 
in the ventral neural tube at different times. During motor neurone production, the 
bHLH factor Olig2 is induced by the co-expression of two homeodomain proteins, the 
Shh-activated Nkx6.1 and Shh-suppressed Pax6, where they overlap. The Olig2 
expressing region is further linlited by repression ventrally from Nkx2.2 and dorsally 
from lrx3. This combination in the Olig2 expressing region leads to the de elopment 
of motor neurones, in part through Neurogenin 2 (Ngn2) a pan-neuronal determinant. 
Lat ral inhibition ofNgn through Notch-Delta signalling lea es undifferentiat d 
progenitors remaining in this region for subsequent glial production. 
Lat r in de lopment and perhap result of increased Shh secretion th bound 
Oli 2 and Nkx2.2 pr in r gions br aks down with the latt r r gl n 
111 rl ap with lie) ' Th pre si n of both Oli 2 and 2.2 m 
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in the precise sequence of these events, and to date these have not been clarified in 
humans. 
Generation of oligodendrocytes in the central nervous system is less comprehensively 
understood but there appear to be a number of similarities to the process described 
above. Oligodendrogenesis appears in focal regions of the ventral forebrain, and at 
least some of the oligodendrocytes appear to develop form migratory cells in a Sbh-
dependant process (Richardson 2001). Some of this knowledge arises from the 
regional expression of early myelin genes and putative oligodendroglial markers. 
However different markers label different popUlations, raising the possibility of 
different lineages within the developing forebrain. 
Oligodendrocyte progenitors generated by mechanisms such as these migrate into the 
developing grey and white matter regions. Unlike the essentially post-mitotic 
neurones, these oligodendrocyte progenitors remain mitotically active and undergo 
substantial further proliferation in the developing parenchyma (Marquardt & Pfaff 
2001). 
Proliferation and Population Control of Oligodendrocytes 
As has been noted, oligodendrocyte progenitors migrate out of the subventricular zone 
as mitotically competent cells. These cells continue to divide in the developing grey 
and white matter tracts under the influence of both soluble growth factors and 
extracellular matrix ligands. PDGF-AA, acting through the PDGFa receptor plays an 
important role in both proliferation and survival of oligodendrocyte progenitors (Noble 
et ale 1988). Secreted by neurons and astrocytes, this molecule appears to be present in 
limiting concentrations (Calver et ale 1998): PDGF-A knockout mice have profoundly 
reduced numbers of progenitors (Fruttiger et ale 1999) and augmented production 
during development causes a substantial increase in progenitor numbers (Fruttiger et 
ale 2000). Excess numbers then die through apoptosis (Calver et ale 1998). 
Recent insights into the mechanism of action of PDGF AA, obtained through in vitro 
work, suggest that at physiological concentrations, its response depends on 
downstream signalling between cell surface integrins and specific extracellular matrix 
ligands. When PDGF binds to its receptor on the surface of oligodendrocyte 
progenitors, in-out signalling mechanisms prime avp 1 integrins to recognise 
vitronectin. Only in the presence of appropriate binding will subsequent intracellular 
signalling cascades lead to cellular proliferation. However as progenitors mature, 
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developmental switching of the ~-subunit occurs leading to the expression of a\.~s. 
which has both a different extracellular ligand (merosin, a laminin sUbtype expressed 
in axonal tracts) and a different associated intracellular signalling cascade. The same 
signal that promotes cell division and inhibits differentiation then promotes survival 
and maturation (Baron et al. 2002). 
Following the proliferative phase, the majority of oligodendrocyte progenitors that fail 
to associate with axons die by apoptosis. This is particularly evident in models where 
over-expression ofPDGF has lead to a significant excess of these cells (Fruttiger et al. 
2000). Widespread cell death in these animals leads to a similar numbers of mature 
oligodendrocytes as is seen in wild-type controls. Integrin signalling may go some 
way to providing mechanisms for this type of population control (vide supra). 
However, oligodendrocyte progenitors persist in the adult rodent, and undergo slow 
turnover (Alonso 2000;Horner et al. 2000). Why these cells remain in the 
undifferentiated state in the adult nervous system is unclear. Their prime role may be 
oligodendrocyte replacement and to facilitate remyelination following injury but there 
is growing evidence of additional physiological roles for oligodendrocyte progenitors. 
Oligodendrocyte progenitors in the rodent hippocampus receive substantial numbers 
of synapses directly from neurons (Bergles et al. 2000), and may themselves modulate 
inter-neural signalling (Levine et al. 2001). The reasons for these interactions remain 
broadly speCUlative. 
A possible mechanism for how these cells maintain this quiescent state arises from the 
observation that mature central nervous system myelin arrests maturation of 
oligodendrocyte progenitors (Miller 1999). It seems possible that these cells, following 
migration into the eNS parenchyma, arrive after the formation of significant quantities 
of myelin, and so are held in the undifferentiated state. The influence of the integrin-
mediated interactions with axons and extracellular matrix on cytokine response, 
discussed earlier, may also playa role (Baron et al. 2002). 
The Oli godendrocyte Lineage 
The exact genealogy of glia, often studied using cell culture and transplantation, has 
been much harder to determine. There may be fundamental reasons for this difficulty. 
Traditional dogma suggests that cells progress in an orderly sequence from the 
totipotential cells of the early blastomere. through progressively restricted stem cells 
of the n:ntricular and sub-ventricular zone and then via transient amplifying cells to 
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the final maturation pathway of the post-mitotic oligodendrocyte. ~umerous 
antigenically distinct glial progenitors have been described in vi\'o and in vitro, and the 
apparent differentiation potential of many of them has been well documented (for 
review see (Lee et al. 2000). However, a number of recent findings haye challenged 
the traditional model. The unexpected potential of apparently tissue-restricted stem 
cells (Alison et al. 2000;Bjornson et al. 1999;Clarke et al. 2000b) and reports 
suggesting de-differentiation of lineage-restricted progenitor cells (Kondo & Raff 
2000a) have suggested that, at the very least, there may be exceptions to this "rule", 
The significance not only of a cell's history, but also of its niche, influential not only 
to its differentiation pathway but also to the maintenance of a stem cell's phenotype, is 
becoming appreciated (Temple 2001). Furthennore the importance (and difficulty) of 
distinguishing between a cell's fate in vivo and potential in vitro is increasingly 
apparent; the degree to which cellular plasticity is mirrored in physiological or 
pathological conditions in vivo is unclear. 
In spite of these important caveats, and the large number of apparently different 
classes of glial progenitors described, a broadly coherent path of rodent glial 
differentiation can be traced from neural stem cell through to mature myelinating 
oligodendrocyte. Significantly less infonnation is available from human work, but 
some investigators, appreciating the hazards of ignoring the species barrier, have 
attempted to redress this (Ostenfeld et al. 2002). 
Stem Cells 
Before discussing the glial lineage, it is worthwhile clarifying some general points 
about stem cells. Stem cells are defined as clone fonning, self-renewing progenitor 
cells that can generate one or more specialised cell types. There are several different 
types that can be divided into those that are active during development and those that 
have a primarily regenerative role. These cells often express DNA repair enzymes 
such as telomerase, which help to defer cellular senescence and possess unusual 
growth characteristics, including the ability to divide asymmetrically, although 
sYlllmetric di\'ision can also be seen during development (Temple 2001). 
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Embryonic Stem Cells 
This group includes the only truly totipotent cells (able to give rise to all cell types 
including those of the trophoblast) which are the fertilised egg and the cells of the 
early developmental blastomere, and they are merely mentioned for completeness. 
Pluripotent cells (able to give rise to all cell types of the developing embryo and 
adult), which are found in the inner cell mass of the developing embryo, were first 
isolated in 1981 (Evans & Kaufman 1981). This followed on from work on 
teratocarcinomas, tumours which contain elements derived from all three embryonic 
layers; ectoderm, mesoderm and endoderm. These cells are highly proliferative and 
pluripotent, but carry with them the risk of teratoma formation following 
transplantation. Much of the initial work on these cells was performed in rodents, but 
they have subsequently been isolated from human embryos, grown in culture 
(Thomson et al. 1998) and can be enriched for neuronal lineages using a combination 
of growth factors and mitogens (Carpenter et al. 2001). Similar cells migrate widely 
when placed in the developing rat brain, and differentiate appropriately without the 
development of teratomas (Zhang et al. 2001). Other investigators have demonstrated 
that embryonic germ cell lines obtained from aborted human fetuses carry a similar 
potential to pluripotential embronic stem cells (Shamblott et al. 1998). 
Neural Stem Cells 
As development progresses, embryonic stem cells give rise to a second group of cells 
which retain the essential characteristics of stem cells, but whose progeny develop into 
cells of one particular organ or tissue (organ-specific stem cells). These cells are still 
multipotent (able to give rise to more than one cell type) and highly proliferative, and 
can be isolated from many different tissues. 
Cells have been isolated from embryonic rodent brain, expanded with epidermal 
growth factor, subjected to clonal and population analysis and shown to possess the 
key attributes of a stem cells (Reynolds & Weiss 1996). Interestingly, subsequent 
work suggests that more primitive rodent neuroepithelial stem cells initially do not 
express EGF receptors (Kalyani et al. 1999) but may develop them in response to FGF 
stimulation (Temple 2001). There may also be differences in the default pathway of 
differentiation at different stages of development; embryonic stem cells favour 
neuronal progeny_ whi k later in development astrocytes appear to be the default 
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pathway (Zhu et al. 1999). This exemplifies the difficulties inherent in interpreting 
studies where different SUb-popUlations may exist in close proximity. 
Embryonic neural stem cells have unusual growth characteristics in that they start to 
proliferate in an anchorage-independent fashion and continue to proliferate as 
colonies. Cultures of these cells, with appropriate mitogens develop free-floating 
aggregates termed "neurospheres". This growth pattern is mirrored by other stem cells 
and has facilitated their isolation and identification, particularly in that most other 
neural cell types grow only as adherent cultures. Aggregate culture systems are 
believed to exploit cell-cell, and possibly cell-matrix interactions, which are as yet 
imperfectly understood. Daughter cells derived from these spheres have a tendency to 
start differentiation after plating down (Reynolds & Weiss 1996). Important mitogens 
for these cells include FGF2 & EGF (Reynolds & Weiss 1996), either separately or in 
combination, although autologous secretion of FGF complicates attempts to dissect the 
exact growth requirements of these cells. They characteristically express nestin, an 
intermediate filament protein originally identified as a marker of neuroepithelial 
precursors (Frederiksen & McKay 1988). 
These cells have also been identified in the developing human brain and proliferate in 
response to EGF & FGF2 alone (Vescovi et al. 1999), or in combination with 
leukaemia inhibitory factor (LIF) (Carpenter et al. 1999;Uchida et al. 2000). More 
recently these cells have been demonstrated from all regions of the developing rodent 
and human brain, but they do not appear to be entirely homogeneous. Furthermore, 
important interspecies differences have again been demonstrated (Ostenfeld et al. 
2002). 
Adult Stem Cells 
The presence of stem cells in adult mammals was surmised in organs such as skin and 
blood where cell turnover continues at a high rate throughout adult life. They were 
first identified, and perhaps most comprehensively characterised in the haemopoetic 
system, and this knowledge continues to inform our understanding of stem cell 
biology. Adult stenl cells playa very different role from their developmental 
counterparts, but the characteristics of self-renewaL clone formation and multiple 
lineage potential remain. They act as a source of cells lost during normal cell turnover, 
as epitomised by the hacmopoetic system. but they are also able to orchestrate 
regenerative repair following trauma or disease. Perhaps the most dramatic example of 
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this is seen in certain amphibians that retain the ability to regrow entire limbs. This 
ability is attributed to small numbers of cells that proliferate and differentiate rapidly 
from the stump following trauma. The best examples of regenerative repair in hwnans 
occur in the skin and liver, although even in these organs the cues that orchestrate 
repair are poorly understood. 
Adult stem cells are a numerically small group of cells and they possess unusual 
qualities that set them aside from other cells of the mature organ. The ability to divide 
asymmetrically; that is to produce an identical copy of themselves as well as a more 
committed daughter cell, is one of these. Furthermore, they possess a phenomenal 
replicative potential that enables them to repopulate large areas of damage, and to do 
this may activate DNA repair enzymes, such as telomerase, which defer senescence. 
Adult stem cells appear to be relatively robust, a necessity in a cell whose vocation it 
is to survive disaster and repopulate. This is exemplified by their capacity to survive 
both enzymatic dissociation protocols and protracted post-mortem intervals (Laywell 
et al. 1999). This may be a consequence of relative metabolic inactivity as they often 
reside in a quiescent state, yet they are able to respond rapidly and dramatically to the 
challenge of repopulating damaged tissue. 
These cells have been identified in diverse organs such as bone marrow, skin, liver and 
muscle where regeneration is prominent. However regenerative repair is rare in the 
central nervous system, remyelination being a crucial exception to this, so their 
isolation from the adult rodent brain was of particular note (Gritti et al. 1996;Rietze et 
al. 2001; Weiss et aI. 1996). In fact neurogenesis also continues throughout adulthood, 
with cells destined for the hippocampus and rostral migratory stream. However 
demonstration of these adult neural stem cells has fuelled increased interest in the 
possibility of more widespread eNS regeneration in response to injury or disease. 
Adult Human Stem Cells 
More recently the isolation of stem cells and their growth in vitro from adult human 
brain has also been reported (Arsenijevic et al. 2001 ;Johansson et al. 1999;Kukekov et 
al. 1999;Palm et al. 2000) although rigorous demonstration of clonogenicity and of 
functional progeny from separate neural lineages, or prolonged expansion in vitro is 
not always presented. 
These cells have similar characteristics to their fetal counterparts, expressing nestin 
and Musashi-l (Palm et al. 2000). They grow into spherical bodies in free-floating 
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cultures, under the influence of EGF and FGF2, and differentiate into cells bearing 
markers of astrocytes, neurons and oligodendrocytes. Interestingly, though 
multipotent, oligodendroglia are poorly represented among progeny - typically 1-50/0 
of all daughter cells express GalC (Palm et al. 2000). However there are some notable 
differences between adult and fetal human stem cells, notably the former's ability to 
differentiate even in the presence of mitogens (Arsenijevic et al. 2001). If confirmed, 
the isolation of human stem cells form adults has far-reaching implications. 
The Generalised Potential of "Organ-Restricted" Stem Cells 
As our knowledge has extended, traditional assumptions as to organ restriction have 
been challenged. The first reports of trans differentiation emerged with the discovery of 
donor-derived myocytes occurring in the recipient following bone marrow transplants 
(Ferrari et al. 1998). This observation lead to a several experiments into the lineage 
potential of diverse stem cells. These have uncovered many such example of 
transdifferentiation (Alison et al. 2000;Azizi et al. 1998;Bjornson et al. 1999;Galli et 
al. 2000), including the extraordinary generalised potential of adult neural stem cells 
when implanted into blastocysts, where they can generate cells from all three germ 
layers (Clarke et al. 2000a). Of particular note is the discovery of the neural potential 
of bone marrow derived cells (Mezey et al. 2000a), mesenchymal stem cells 
(Woodbury et al. 2000) and possibly their haemopoetic counterparts (Bonilla et al. 
2002), discussed later. 
Glial-Restricted Progenitors and Oligodendrocyte Pre-Progenitors in Rodents 
From the early neural stem cell, it is likely that progeny go through a stage of 
restriction to a glial fate before further commitment to oligodendrocyte differentiation, 
although this hypothesis remains unconfirmed in humans. Cells able to produce both 
astrocytes and oligodendrocytes, but without evidence of neuronal differentiation have 
been described from rodent embryonic spinal cord (Rao et al. 1998;Rao & Mayer-
Proschel 1997). These cells express nestin (Gallo & Amlstrong 1995}and appear to 
gain PDGFaR expression as they mature (Lee et al. 2000). Other researchers, also 
attempting to clarify whether oligodendrocytes and astrocytes emerge from a common 
progenitor, have described a cell population with a slightly different antigenic 
phenotype and response to growth factors that again seems restricted to glial progeny 
(Ben Hur ct al. 1998). 
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Pre-progenitors, originally defined as the immediate precursors of the "0-2A" stage 
(vide infra) express PSA-NCAM, nestin and both POGFaR and FGF receptors. These 
cells appear to be able to fonn spheres with FGF2, while both FGF2 and tri-
iodothyronine are important survival factors. Withdrawal of these mitogens leads to 
the production of astrocytes and oligodendrocytes (Ben Hur et al. 1998). To what 
extent these cells could represent stem cells that have not manifested their neural 
potential because of culture conditions is unclear, but stem cells much more readily 
produce neurons than oligodendrocytes (palm et a1. 2000). 
A direct human equivalent to this cell has yet to be identified. However, studies of 
human oligodendroglial production from fetus-derived sphere forming cells have been 
perfonned and followed through to myelin basic protein-expressing oligodendrocytes 
(Zhang et a1. 2000). 
Rodent Oligodendrocyte Progenitors - the "O-2A" Stage 
One of the most studied cells of the oligodendrocyte lineage is the rodent "O-2A" 
progenitor - so called because of its potential for differentiation into oligodendrocytes 
or a type of astrocyte (designated ''type 2") in vitro. It was first identified in tissue 
culture from neonatal rodent optic nerve (Raff et a1. 1983) and subsequently from 
other parts of the postnatal CNS. These cells differentiate constitutively into 
oligodendrocytes on mitogen withdrawal, but can be induced to produce ''type 2" 
astrocytes by certain environmental cues. "Type 2" astrocytes express certain 
ganglioside antigens (including A2B5 epitopes) not expressed by astrocytes in vivo 
and lack Ran2 epitopes (Lee et al. 2000). They seem not to be fonned in nonnal 
maturation, and transplantation of the 0-2A cells into developing rodents sees the cells 
differentiate exclusively into oligodendrocytes, and participate in myelination (Groves 
et aI. 1993). However, there is some evidence that the type 2 astrocyte pathway can be 
induced in vivo in certain pathological situations (Matthews et a1. 1995). 
0-2A cells are highly motile with two long processes when seen under phase contrast. 
They carry a characteristic immuno-phenotype, with surface molecules (subsequently 
shown to be gangliosides) recognised by the A2B5 and anti-G03 antibodies. They 
have also be identified by the presence of the POGFa receptor (Pringle et aI. 1992;Yu 
et aI. 1994), or the related surface component chondroitin sulphate proteoglycan 
(Stallcup & Beasley 1987), or by their characteristic glutamate channel properties 
(Fulton et aI. 1992) (discussed further in Chapter 4). 0-2A cells have not been thought 
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to generate neurons or type 1 astrocytes except under exceptional circumstances 
(Kondo & Raff 2000b). 
Rodent neonatal "O-2A" progentiors are influenced by a number of different 
mitogens. Fibroblast growth factor 2 (FGF2) (also known as basic FGF) is a member 
of a structurally related family of 14 polypeptides. Present in developing and adult 
brain it has a broad range of mesodermal and neuroectodermal cell targets. Four high 
affinity FGF receptors and some variants have so far been identified along with a class 
of low affinity, high capacity cell surface receptors, heparan sulfate proteoglycans, 
which are essential for signalling. A number of cell adhesion molecules can also 
interact with interact with these receptors (eg Ll, NCAM, N-Cadherin) (Bansal & 
Pfeiffer 1997). 
FGF2 plays a prominent role in oligodendrocyte development. It up-regulates PDGFa-
receptor expression on early progenitors, and in combination with PDGF AA supports 
long term proliferation and migration (Bogler et al. 1990;McKinnon et al. 1990;Milner 
et al. 1997;Osterhout et al. 1997). FGF2 is mitogenic for late progenitors and 
reversibly blocks their terminal differentiation (Bansal & Pfeiffer 1994;Gard & 
Pfeiffer 1993;McKinnon et al. 1990). During lineage progression, oligodendrocytes 
regulate the expression of their FGF receptors. Progenitors express FGF-receptors 
1,2&3, and upregulate FGF-R3, heparan sulfate proteoglycan 
coreceptors(S yndecan 1,2,3&4) and glypican during terminal differentiation (Bansal & 
Pfeiffer 1997). 
The second major mitogen acting on rodent progenitors is platelet derived growth 
factor PDGFAA. This polypeptide induces proliferation of glial precursors (Calver et 
al. 1998;Engel & Wolswijk 1996) acting on the PDGFareceptor, which is expressed at 
pre-progenitor stage (vide supra). It maintains oligodendrocyte progenitor cells in a 
proliferative phenotype and promotes cell division and motility (Engel & Wolswijk 
1996). 
Several other mitogens, hormones and second messengers have a role in glial 
development. Neurotrophin-3 (NT-3) promotes neonatal rodent oligodendrocyte 
progenitor survival, and synergises with the mitogenic effect of PDGFAA. Leukaemia 
inhibitory factor (LIF) and ciliary neurotrophic factor (CNTF) induces 02A cells to 




Oligodendrocyte progenitors express the chemokine receptor CXCRl and its ligand. 
Gron enhances 02A proliferation in the presence of PDGF.A.A (Nguyen & Stangel 
2001). Neuregulins may be required for proliferation and survival of later 
oligodendrocyte progenitors and pro-oligodendrocytes (Canoll et al. 1996). Tri-
iodothyronine and retinoic acid promote oligodendrocyte differentiation and inhibit 
proliferation (Barres et al. 1994;Billon et al. 2001), and increased intracellular 
cyc1icAMP accelerates oligodendrocyte precursor differentiation (McKinnon et al. 
1990;Raible & McMorris 1989). 
Finally, an intriguing hypothesis based on a final common pathway of intracellular 
redox state has been proposed in rodent progenitors; the more reduced a cell, the more 
likely it is to proliferate. Thus mitogens which promote proliferation induce a reduced 
intracellular environment while those promoting differentiation promote a more 
oxidised state (Smith et al. 2000). 
The growth characteristics of perinatal rodent 0-2As are complex. Mathematical 
analysis suggests that they undergo both symmetric and asymmetric division at 
different times, perhaps requiring a critical period of symmetric division to attain 
asymmetrical division-competence (Whittemore et al. 1994). Thyroid hormone and the 
bHLH gene Id4 appear to play important roles in this regard, both in the clock 
mechanism and the subsequent differentiation into oligodendrocytes (Kondo & Raff 
2000). As this process continues the development of an adult type progenitor emerges 
[vide infra] with distinct biological properties. 
Fetal Human Oligodendrocyte Progenitors 
Equivalents to this cell have been isolated from fetal human brain (Kennedy & Fok-
Seang 1986) but interestingly attempts to grow these or related cells with the rodent 
mitogens PDGF and/or FGF2 have shown little response (Aloisi et al. 1992). Sphere-
derived human embryonic progenitors differentiate nlore slowly than their rodent 
counterparts and divide more rapidly in contact with astrocytes or neurons, but follow 
the sanle pathway (Zhang et al. 2000). 
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Figure 1-5 A Comparison between the adult rodent and human oligodendro yte linea e 
reveals broad similarities, but important interspecies differences. Much of the rodent \! or ha 
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Adult Rodent Oligodendrocyte Progenitors 
A cell with similar potential also persists in the adult rodent nervous system, although 
this cell is intrinsically different from its perinatal equivalen~ with subtle but 
important differences in antigenic phenotype and mitogenic response (Shi et al. 
1998;Wolswijk & Noble 1989). The neonatal cells can be discriminated by the 
intermediate filament protein vimentin, which is absent from the adult form (W olswijk 
et a1. 1991b). The latter also divide much more slowly, are less migratory and usually 
unipolar, although they can be induced to revert to neonatal phenotype (W olswijk & 
Noble 1992). Both the neonatal and the adult forms of the rodent cell have mitotic 
potential, proliferating markedly under the influence of POGF and FGF2 as well as 
other mitogens (Bogler et a1. 1990). 
Adult Human Oligodendrocyte Progenitors 
Following a substantial number of studies identifying adult oligodendrocyte 
progenitors in rodents, the existence of an equivalent cell in the adult human was first 
suggested by the isolation of a bipotential oligodendrocyte progenitor from adult 
human white matter (Scolding et a1. 1995) and confirmed later by tissue print 
experiments (Scolding et a1. 1999). These studies indicate that this oligodendrocyte 
progenitor is a small bipolar cell and labels with A2B5. Furthermore, it develops into 
an oligodendrocyte in low serum conditions, and into a ''type 2" astrocyte at higher 
serum concentrations. This cell does proliferate modestly on an astrocyte monolayer; 
cells incorporating bromodeoxy-uridine (BrOU) and hence passing through S-phase 
were identified, but no proliferation was seen with POGF, FGF or NT-3 alone or in 
combination, mitogens known to stimulate adult rodent progenitor proliferation. 
Since then cells with similar characteristics have been further studied by selecting out 
fluorescent cells from adult human primary glial cultures transfected with a gene 
encoding for green fluorescence protein, driven by an early promoter for an 
oligodendrocyte specific protein. These cells also stained with A2B5, but no evidence 
for subsequent proliferation in vitro was presented (Roy et al. 1999). 
This stage of the oligodendrocyte lineage is of particular interest. As discussed earlier, 
intrinsic remyelination is widely accepted as being mediated by oligodendrocyte 
progenitors at the "O-2A" stage (referred to simply as "oligodendrocyte progenitors" 
in the following chapters) that proliferate and migrate into lesions. The process of 
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myelin fonnation has to start while the cell is still dividing (Compston et al. 
1997;Keirstead & Blakemore 1997) and subsequent stages in humans appear not to 
divide (vide infra). Furthennore, the most efficient myelinating popUlation in rodents 
appears to be comprised ofO-2A progenitors (Keirstead et al. 1999;Warrington et al. 
1993;Zhang et al. 1998a), with little or no myelination occurring with transplantation 
of human GalC positive immature oligodendrocytes or later (Targett et al. 1996). More 
primitive cells may need to be committed to the oligodendrocyte lineage prior to 
transplantation (Smith & Blakemore 2000). 
In stark contrast to the wealth of investigations that have used rodent cells, very few 
have studied adult human oligodendrocyte progenitors, and those that have 
demonstrate differences that highlight the species barrier (Armstrong et al. 
1992;Prabhakar et al. 1995;Scolding et al. 1995). Further information about these 
important human cells is urgently required. 
Rodent and Human Oligodendrocyte Differentiation and Maturation. 
The next identifiable stage of the differentiation pathway in rodents is termed the pro-
oligodendrocyte. These cells develop a more complex morphology with multiple 
branched processes and start expressing epitopes, such as those on sulfatide, 
recognised by the 04 antigen (Gard & Pfeiffer 1993). This cell remains modestly 
proliferative, although its migratory potential is more limited, presumably reflected in 
its altered morphology. 
The identification of antigenically similar cells in adult human brain was an early 
indicator that oligodendrocytes might arise in the mature brain parenchyma 
(Armstrong et al. 1992) and that sources of myelin other than mature oligodendrocytes 
might be responsible for intrinsic remyelination in humans. However this cells does 
not proliferate in culture, and was termed the pre-oligodendrocyte to differentiate it 
from its proliferative rodent counterpart. 
As cells mature beyond this point they become essentially post-mitotic and start 
expressing galactocerebroside (GaIC). Both 04 and GalC are considered reliable 
markers of oligodendrocyte lineage cells both in vivo and in vitro (Ranscht et al. 
1982), although occasional cells with both GF AP and Gale staining have been 
reported (Raff et al. 1983;Scolding et al. 1999). 
Post-mitotic rodent oligodendrocytes cells then follow an orderly sequence of myelin 
gene expression to the fully di tTerentiated oligodendrocyte (Compston et al. 1997). a 
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sequence that appears to be broadly similar in humans (Zhang et a1. 2000). If exposed 
to appropriate conditions early enough in this development the cells will make contact, 
engage and produce myelin membranes which ensheath and finally compact to form 
mature functional myelin segments. This is a complex interaction requiring the 
presence of a combination of physical factors, including the presence of appropriately 
sized axons, cell-cell and cell-matrix interactions and soluble ligands (Compston et aI. 
1997;Zajicek & Compston 1994). 
Investigative Strategies 
Remyelinating therapies have enormous potential in the treatment of MS, but rely on a 
detailed understanding of the clinical biology of the disease in general, and the human 
oligodendrocyte progenitor in particular. This is broadly lacking. An enormous 
amount is known about the rodent oligodendrocyte lineage but significant differences 
exist between these species. We have argued strongly that information from work with 
rodent cells cannot be reliably extrapolated to humans without direct experimental 
support using human cells. Such studies require a large number of cells. Furthermore, 
there are good reasons for believing that the adult human oligodendrocyte progenitor 
is the best candidate for any transplantation strategy in MS. If this potential is to be 
realised, then even larger numbers of cells will be required. 
The predominant obstacle to the investigation of the human oligodendrocyte lineage is 
the limited number of cells available for experimentation. Various sources of human 
glia exist - and some of them have been used experimentally. Many experiments have 
used tissue derived from aborted fetuses, an approach that carries significant ethical 
problems. Tissue from spontaneous abortions, while more ethically acceptable, 
involves its own complex issues of consent. 
The major sources of adult cells are surgical specimens from patients undergoing 
treatment for refractory epilepsy. These samples typically contain less than lcm3 in 
volume (own observations) from which of the order of 2000 oligodendrocyte 
progenitors can be harvested (Roy et al. 1999). Other tissue such as that resected 
during emergency frontal and temporal lobectomies for life-threatening cerebral 
oedema has also been used, but most investigators have been careful to avoid 
specimens from tumour surgery because of the risks of confusing resident glia with 
neoplastic cells. The use of adult post-mortem tissue, while providing sizeable starting 
volumes, is limited by marked reductions in cell viability, although there are 
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suggestions that some of the more immature precursors may survive for long periods 
post-mortem (Laywell et at. 1999;Palmer et at. 2001;Roisen et at. 2001). 
The absence of techniques to expand the limited starting numbers confounds this 
problem. Occasional human oligodendrocyte progenitors cells divide on astrocyte 
monolayers, but these cells have not been expanded significantly in vitro. Thus one of 
the foremost issues for which human tissue is so necessary, understanding their 
mitogen requirements, provides the very obstacle to its investigation. 
It is this particular problem that the following series of experiments addresses. Four 
approaches have been explored to overcome this hurdle. Chapter 2 describes the 
investigation of primary human glial progenitors previously transformed using viral 
oncogenes to enable controlled proliferation. Chapter 3 describes the strategy of 
dedifferentiating "committed" progenitors to a more proliferative state. Chapter 4 
describes the study of primary adult human oligodendrocyte progenitors and their 
expansion in cell culture using mitogens and Chapter 5 describes the isolation and 
expansion of adult neural stem cells and strategies to induce differentiation along the 
oligodendrocyte lineage. 
Chapter 6 addresses a specific question of relevance to our understanding of the 
clinical biology of MS, and the role of inflammation in remyelination. It also 
illustrates the need for substantial numbers of cells, and exemplifies the type of study 
required to understand this debilitating disease. 
Hypothesis 
The starting hypothesis for these experiments can be summarised as follows: Human 
oligodendrocyte progenitors and neural stem cells are present in, and can be isolated 
from adult human brain. They can be grown in vitro and can be expanded, either using 
genetic manipulation or with mitogens predicted from studies using other mammalian 
glia. They can provide a source of substantial numbers of oligodendrocyte progenitors 
for studying oligodendrocyte biology. In addition they may represent a practical 
source of cells for transplantation studies, and ultimately could provide a source of 
cells for therapeutic transplantation. 
Aim 
-
The goal of these experiments was to help develop remyelination therapies by 
providing insights into the biology of the adult human oligodendrocyte progenitor. The 
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major hurdle was thus to find a source of substantial numbers of purified human 




Chapter 2. An Investigation of the Human Oligodendrocyte 
Progenitor Cell Line HWI 
Introduction 
Directed transformation of a human oligodendrocyte progenitor to form an 
immortalised cell line is an attractive solution to the problem of cell numbers. This 
approach has been used successfully with other myelinating glia (Barnett et al. 1993). 
The use of conditional oncogenes such as the temperature sensitive mutant of SV 40 
large T antigen incurs added benefits. With the oncogene active, the normal controls to 
cell proliferation are bypassed, allowing large numbers of cells to be grown with 
relative ease. By switching off the oncogene, the cell can revert to its original 
phenotype, rewarding the researcher with vast numbers of genetically and 
phenotypically identical cells. 
Producing cell lines using SV 40 antigens is a valuable and frequently used procedure 
and the mechanism with which these cells overcome blocks in the cell cycle have been 
a subject of much scrutiny (Bryan & Reddel1994;Jha et a1. 1998). These mechanisms 
are not uniform, varying significantly between lines derived from different cell types 
and possibly even between lines from the same source cell. It appears likely that in 
most cells, immortalisation is a multi-stage phenomenon, some stages of which may 
be stochastic or only indirectly related to the action of the oncogene product. The most 
common pattern seen with large T antigen is for the gene product to cause a limited 
delay of cell senescence, after which the population passes through a "crisis". During 
this, the majority of cells apoptose, while a much smaller sub-population survives to 
become truly immortal. Presumably this involves a further genetic event, such as the 
loss of a further tumour suppresser gene. However, the proportion of cells surviving 
crisis varies considerably, and some cell lines (Bartek et a1. 1991), including those 
created with the temperature sensitive double mutant used here(Barnett, S. personal 
communication) show no evidence of passing through crisis. 
A previous investigator, Dr H Wilson, created the original human oligodendrocyte 
progenitor cell line used in this investigation. This cell line, which will be referred to 
as HW 1, was created by infecting a primary human glial culture with a retroviral 
vector carrying the temperature-sensitive double mutant of SV 40 large T antigen. The 
resulting cell was characterised and reported at a recent conference. 
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In brief, it was shown to possess an immunophenotype comparable to that of early 
oligodendrocyte lineage cells. When grown at 33°C (the permissive temperature), the 
cells stained positively with A2B5 and 04 antibodies, and with antibodies directed 
against NG2 chondroitin sulphate. Immunofluorescence using antibodies directed 
against astrocytes (GFAP), more mature oligodendroglia (GalC, MOG, MBP), more 
immature stem/progenitor cells (nestin, vimentin) and neurons (~III tubulin, MAP2 & 
neurofilament) were negative, as were antibodies identifying other cell types including 
fibroblasts (Thyl), microglia (CDllb), Schwann cells (SlOO, NGF receptor) and 
endothelial cells (von Willebrand factor). 
Surprisingly, immunocytochemistry for PDGFa. receptor was negative. However, 
SDS-PAGE and Western blotting, using monoclonal anti-PDGF receptor antibody as 
the probe, demonstrated that it was present in low quantities. 
When cultured at a temperature sufficient to inactivate the oncogene (39°C), cell 
division was reduced and some cells demonstrated morphological evidence of 
differentiation and expressed the later lineage marker GalC (Figure 2-1). 
This cell line was frozen in a standard manner in Cambridge, stored in liquid nitrogen, 
and then transferred to the cryostorage facility in the Glial Cell Biology Laboratory 
(either directly, or via the cryostore at the pathology department). 
Plan of Investigation of HWI 
Further Characterisation of the Cell Line 
The growth properties and antigenic profile of HWI needed repeating to confirm its 
integrity as an oligodendrocyte progenitor. Its stability, and the cessation of oncogene 
activity, also needed further clarification, as preliminary evidence indicated that only a 
limited proportion of cells left the cell cycle and commenced terminal differentiation 
at the non-permissive temperature (H. Wilson, personal communication). 
Directed Experiments Using the Cell in its Untransformed State 
Experiments were planned to investigate the cell following inactivation of the 
oncogene by growth at 39°. These aimed to investigate stimuli and inhibitors of cell 
division and differentiation, migratory potential at different stages of differentiation 
and on different substrates, chemokinesis, and finally myelin formation. Two 
approaches were anticipated, the former approach would test the hypothesis that 
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rodent and human cells behave similarly. The second would be to probe for growth 
factor receptor expression using immunocytochemistry and molecular biological 
techniques, and then to use this data to identify potential mitogens. 
Co-culture Experiments 
The simultaneous growth of HW 1 and neuronal cell lines would be used to determine 
the biological interactions involved in myelination. 
Transplantation Studies 
It would be anticipated that success in the above experiments would lead to the use of 
HWI cells, perhaps after further in vitro manipUlation, to investigate myelination in 
vivo. The animal work itself would be performed by collaborators in Cambridge using 
a rodent model of demyelination (Woodruff & Franklin 1999), although any prior 
manipulation of the cell line would be performed by the author. 
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Materials and Methods 
Media Recipes - 10% FBS in DMEM 
Dulbecco's Modifies Eagle Medium 
Foetal Bovine Serum -heat inactivated 
Penicillin / Streptomycin / Fungizone 







10% Fetal Bovine Serum (FBS) in Dulbecco's modified Eagle Medium (DMEM) and 
a separate aliquot of FBS were wanned to 37°C in a water-bath. A 50% FBS solution 
was made by adding 4.5ml FBS to 5.5ml 10% FBS in DMEM in a sterile universal. 
The cryovial was removed from liquid nitrogen, defrosted in the waterbath and the 
contents transferred to a fresh 15ml centrifuge tube with a glass Pasteur pipette. 1 ml of 
50% FBS was added drop-wise to the 15 ml tube containing the cell suspension (to 
minimise sudden osmotic shifts). This was agitated gently, the remaining 9ml of 50% 
FBS was then added slowly and the resulting mixture centrifuged at 1500 rpm for 5 
minutes. The supernatant was then removed, the cells were resuspended, and 5ml of 
fresh 10% FBS added. The cells were transferred to a T25 tissue culture flask (Nunc) 
and placed in the incubator with 5% CO2 at the 33° or 39°C. 
Passaging Cells 
Phosphate buffered saline (PBS), 100/0 FBS in DMEM with 10/0 
penicillinistreptomyciniFungizone®(Amphotericin B) (PSF) and trypsin Ix (Sigma) 
solution were warmed in a 37°C waterbath. A T25 flask of sub-confluent cells was 
removed from the incubator, wiped with 70% alcohol and residual medium was 
aspirated off under the laminar flow hood. The cells were then rinsed with IOmI PBS 
before 50J.11 trypsin in 1 ml fresh PBS was added to free the cells from the surface. The 
flask was incubated at 37°C until the cells rounded up and came off the plastic, and 
then tapped gently to facilitate dislodgement. 10 ml fresh 10% FBS was added to 
neutralise the trypsin and the resultant mixture was poured into a 15ml Falcon tube 
and centrifuged at 1200rpm (200g) for 5 min. The supernatant was removed, the cells 
resuspended, and lOmI fresh 100/0 FBS was added. 
The cells were counted in a Neubauer haemocytometer with trypan blue exclusion. 
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Iml of the cell mixture was then added to 5ml fresh medium in a new T25 flask (1:5 
split) and returned to the incubator 
Cryopreserving Cells 
Phosphate Buffered Saline, 10% FBS in DMEM with 1% PSF, Trypsin Ix solution 
and a separate aliquot of FBS were warmed in a 37°C waterbath. Freezing medium 
was then prepared by mixing 4ml FBS and 1 ml dimethylsulphoxide (DMSO) in a 
sterile Bijou tube. Cells were prepared as for passaging (see above) but resuspended in 
only 0.75 mll0% FBS, triturated with Iml Gilson pipette and split into two cryovials. 
375, . .11 pre-prepared freezing medium was added to each cryovial to make a final 
concentration of 50% FBS, 10% DMSO and 40% DMEM with 0.4% PSF. Cells were 
frozen in a "Mr Frosty" cryopreservation container, which was placed in a -70°C 
freezer overnight. The vials were transferred to the liquid nitrogen storage facility the 
next day. 
Immunofluorescence 
Cells in 100J.lI medium were seeded onto poly-lysine coated coverslips, for a final 
density when stained of about 5x 1 03 -5x 1 04cells per coverslip. The wells were flooded 
with medium after 1-24 hours and incubation continued until ready to stain. The 
coverslip was then removed from the well, washed once in culture medium containing 
10% FBS and placed on a staining platform (humidified). (Cells that had been 
incubated in medium with less than 5% FBS required a blocking step using 5-10% 
FBS or Normal Goat Serum (NGS) for 1 hour to reduce background staining.) Test 
coverslips were then incubated with antibodies directed at surface antigens for 20 min 
at 37°C together with control slides that were processed identically but with the 
primary antibody omitted. They were washed twice in 10% FBS and incubated with 
appropriate secondary antibodies conjugated to fluorescent molecules for 20 min at 
37°C. They were washed twice in 10% FBS again and fixed for 5 min in 4% 
paraformaldehyde. A further step involving permeabilization in ice-cold methanol (-
20°C for 10 min) or 0.05% NP40 in PBS or 0.1 % Triton X-I 00 in PBS for 5 min was 
added for intracellular antigens only. These cells were washed again and incubated 
with antibodies (to intracellular antigens) at 4°C overnight - or at 37°C for 20 min, 
followed by a wash and further incubation with appropriate secondaries (20min at 
37°C). All slides were then washed a final time in 10% FBS, mounted in Vectasheild 
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(Vector laboratories) and sealed with nail varnish. Immunofluorescence was observed 
using an Olympus IX40 inverted microscope. 
Bromodeoxvuridine Assav 
Bromodeoxyuridine (BrDU) is incorporated into cellular DNA during the S-phase of 
the cell cycle, and thus labels cells which have been dividing while exposed. Cells 
harvested as above were plated out onto polylysine coated covers lips at low density 
(between 103 and 5xl04 cells per well- depending on the proliferative capacity of the 
cells, and the proposed incubation period) in IOOfll culture medium and incubated 
overnight. The wells were then flooded with 400 fll culture medium and any required 
mitogens, and incubation continued in the appropriate experimental conditions. When 
ready to label, 0.5 fll stock BrDU solution (lOmM - kept in aliquots at -20°C) was 
added and incubation continued for 1-24 hours (dependent on the estimated 
proliferative rate). BrDU incorporation was terminated by fixing cells with 2% PFA 
for 10 minutes at room temperature in the wells. This was aspirated afterwards. Cells 
were permeabilised with ice-cold methanol for 10 min at -20°C and then rehydrated 
with 10% FBS. DNA was denatured with 2N HCI for 30min at 37°C followed by two 
neutralisation steps using 0.1 M borate buffer for 5 min at room temperature. The 
covers lips were then removed from the well, rinsed in DMEM(or PBS) with 10% FBS 
(or NGS) and placed on staining platform. They were incubated for 20 minutes with 
6J.lglml anti BrDU in 10% FBSIDMEM, washed twice in DMEMlI0% FBS and then 
incubated with fresh anti mslgG1-FITC 1:100 and Hoechst 33258 (1:1000). Following 
a further wash step, they were mounted in Vectashield and sealed with nail varnish. 
They were viewed under the IX40 inverted immunofluorescence microscope with a 
high power objective lens. The number of cell nuclei staining for BrDU (green) was 
compared with those staining with Hoechst (blue) to give the BrDU index. 
Methylthiazoletetrazolium Assay. 
Methylthiazoletetrazolium (MIT) is reduced to a visible tetrazolium salt by sub-
cellular organelles dependant on mitochondrial respiration. This reaction is 
proportional to viable cell mass, and can be used to measure cell numbers, cytotoxicity 
or proliferation (Mosmann 1983). A stock solution ofMTT was made up in a culture 
hood to a final concentration of 5mglml. lOOmg of MTT from a fresh bottle was added 
to 20ml of PBS (O.OIM made with milli Q ultra pure water) then filtered through a 
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0.2J,1M filter. MIT is light sensitive, therefore the tube was covered with foil and 
o 
stored at 4 C until required. 20J,11 of MIT was added to each well on the plate to be 
assayed using a multi-channel pipette and the plate incubated at 3tC for 1 hour. Using 
an aspirator and a 25 gauge needle, the media and MIT were carefully removed from 
each well. In a fume cupboard, 100JlI of isopropanol was added to each well of the 
plate. The isopropanol dissolves the tetrazolium salt synthesised in the cells thus 
allowing a comparative reading to be made. The plate was left until the colour was 
dissolved (30 minutes). The plate reader was switched on and allowed to warm up for 
30 minutes. The results were read on an Ascend plate reader with a measuring filter of 
540nm, and a refractive filter of 62Onm. Accompanying computer software was used 
to subtract the second value from the first, and subtract the chemical blank mean from 
the resultant means. Further calculations were performed using Microsoft Excel. 




Five vials ofHWl were originally transferred from the laboratory in Cambridge to a 
liquid nitrogen freezer at Bristol. They were defrosted according to the protocol 
recorded in the methods section. 
The first two cryovials were defrosted without any viable cells. Several possible 
explanations were considered. These included technical error, so minor modifications 
to the protocol were tried, based on suggestions from investigators in other 
departments. On the third occasion a very small number of cells (less than 0.1 % of the 
total population), from a sample described as passage 8, survived to adhere to the 
tissue culture plastic. These cells survived the extremely low initial surface density 
and were expanded and subcultured to a working population. The very low yield from 
the frozen cells remained a concern. Had there been more cryovials available, this 
yield would not have been accepted and the cells would have been discarded. 
Further expansion allowed cells to be stored for later work. Viability from these 
samples, when defrosted after a week in liquid nitrogen, was in excess of 80%, 
although the protocol used (see methods) was apparently identical to that used to 
cryopreserve the original line. The reason for this discrepancy was not immediately 
apparent. After repeated enquiries, it finally transpired (some months later) that these 
cells had spent a considerable time at -80°C prior to transfer, a temperature not 
conducive to efficient cryopreservation. 
Initial Characterisation 
Momhology and Growth at Different Temperatures 
Two flasks (approximately 10% confluent) from the same passage were placed 
simultaneously at 33 or 39°C and observed at 3 and 5 days. 
Morphology 
The cells assumed an elongated, slightly flattened appearance somewhat akin to 
fibroblasts (Figure 2-1). They had up to four short "processes", although it was 
unusual for these to be more than just extensions of the soma (NB these did not fulfil 
the description of processes as defined in Chapter 4). Secondary arborisations were 
almost never seen. The nuclei were large with prominent nucleoli. At 39°C the cells 
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remained similar in appearance at low surface densities (Figure 2-2), and never 
assumed the mUltiple ramified processes of oligodendrocytes or their later precursors. 
There was a tendency to adhere better to the uncoated tissue culture plastic at 39°, and 
this gave the cells a more flattened polygonal appearance(Figure 2-5). This became 
more obvious as the cells approached confluence, with progressive pavementing of the 
cells at 39°C, whereas their sister cells at the lower temperature retained the elongated 
shape and tended to grow over each other if left. Occasional cells at either temperature 
became very large and flat with a large nucleus. This was initially thought to be a 
transient stage, perhaps associated with cell division but these cells appeared to persist 
and no mitotic figures were visible. 
Growth Characteristics 
After the problems of the initial low cellular density following defrosting had been 
overcome, the cells grew rapidly at 33°C, with a 1:10 passage reaching confluence 
after about six days (estimated division time 24x6 / Lo~ 1 0 = 43 hours). Contrary to 
expectation, cells at 39°C continued to divide and became confluent slightly faster 
than at the lower temperature (on average at about 4-5 days). However, exact cell 
numbers were difficult to count near confluence, and the possibility remained that this 
was an artefact from their more flattened morphology occupying a larger surface area 
per cell. 
This experiment was repeated several times with consistent results. 
This suggested that the cell line was not behaving in the temperature sensitive manner 
originally described. Various possible explanations for this were considered:-
I) The experimental conditions were different 
The cells were being exposed to a lower temperature that was allowing the 
oncogene to remain active, either because the incubator was not be maintaining its 
temperature or because the oncogene was being reactivated by the lower temperature 
when the cells were being examined. 
2) The cell line had changed from its original description. 
There had been a progressive alteration in the milieu of transcription factors 
and hence gene expression with a resultant change in the cellular phenotype and 
behaviour. (e.g. an intrinsic timer now signalled apoptosis upon oncogene inactivation, 
rather than maturation). 
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It had accumulated further copies of the oncogene, acquired unrelated 
mutations or had undergone a chromosomal rearrangement (aneuploidy). 
3) The cells grown were not those of the original cell line described. 
The cells had been contaminated with another cell line. 
There had been an error in transit. 
Many of these possibilities could apply merely to a subpopulation, or perhaps lead to a 
quantitative not qualitative alteration in response (e.g. the oncogene might require 
longer to switch off than originally described). Any subpopulation that matured or 
apoptosed amongst a rapidly growing popUlation would be quickly swamped. 
Similarly any cell that acquired a survival advantage through genetic or epigenetic 
means could quickly dominate the culture. 
The incubator temperature was carefully and repeatedly checked but was found to be 
accurately controlled. 
The original experiments were repeated with the flasks left in the incubator throughout 
the experiment. This caused some problems, as the medium could not be changed. 
However there was still no evidence of growth arrest, or significant slowing at 39°, 
and the morphological features did not suggest differentiation. During all subsequent 
experiments, the design incorporated mechanisms for ensuring that removal from the 
incubator was eliminated or kept to a minimum, and that any medium added was 
warmed to the incubator temperature first. 
The original investigator (who was now in New York) and Cambridge laboratory 
technical staff were contacted, and details about the experimental procedure discussed 
further. The possibility of a clerical error leading to the wrong cells being transported 
was also examined but rejected (all flasks were clearly labelled and dates tallied with 
that recorded in logbooks). However, this enquiry did uncover the error in 
transportation that had lead to the cells being exposed to -80°C. Further cells from the 
original liquid nitrogen store were defrosted and an acceptable yield (>600/0) of viable 
cells was achieved from a cryoviallabelled as passage 3. This was thought to be the 
earliest passage stored. However repeated experiments confirmed that these cells 
behaved indistinguishably from the first batch and failed to stop proliferating or show 




Cells immortalised with a temperature sensitive oncogene have been described which 
subsequently escape from this temperature restriction. Some of these continue to 
proliferate at both temperatures while still retaining characteristics of the original 
parent cell and maintaining the ability to differentiate at the non-permissive 
temperature (Conejero et al. 1999). In spite of the absence of any morphological 
evidence of differentiation, it was decided to characterise the immunophenotype of 
these cells to identify what features had changed from when previously described. 
This work was started on cells from the first sample, but the experiments were 
repeated and continued on the earlier passage cells. 
The experiments used A2B5, NG2 (Chondroitin Sulphate), 04, GalC (both Ranscht 
mAb & 01), GFAP (both poly and monoclonal) separately and in combination. 
Staining remained uniformly negative for all markers used. This was surprising. The 
original cell line was clearly positive for A2B5, NG2 and 04 even when growing at 
33°C (Figure 2-4). The staining protocol appeared to be identical to that used in 
Cambridge. Repeated attempts were made with alternative protocols used by other 
investigators, but the cells were consistently negative. It was thought that technical 
inexperience was the most probable explanation for the failure to stain. Minor 
problems caused by lipid artefact and difficulties with live staining because of toxic 
preservatives in the antibody preparations were possible contributors. At this time, 
there were no opportunities for positive controls, as there were no other cell lines with 
these antigens available, and the primary glial work was still awaiting ethical approval. 
Two approaches to this problem were pursued. Firstly the original researcher 
requested access to the cell line and some samples (passaged and frozen at Bristol) 
were sent to New York, where they were grown up and stained. It was reported that 
the cells no longer stained for A2B5 or 04. Secondly, this researcher went to 
Cambridge to compare staining profiles using Cambridge reagents in parallel with 
reagents brought up from Bristol. The staining was done both by an experienced 
technician from Cambridge and this researcher, working in parallel. The Cambridge 
reagents demonstrated equivocal :\2B5 staining, a result that was not seen USlI1g the 
Bristol reagents. None of the other antigens wcrc detected. 
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Antimitotics 
One further possibility that was pursued was that some of the cells did differentiate, 
but that these were rapidly overgrown by proliferative cells. To investigate this, cells 
were grown in the presence of anti-mitotic agents. 
Firstly, the optimum dose to arrest cell growth was determined by plating out a fixed 
starting density (104 cells per well) in a 24 well plate, and making doubling dilutions 
of antimitotic agents, above and below the recommended dose. These were then 
incubated at 39°C. The dose and agent used permitted a significant number of cells to 
remain viable at one week, but inhibited proliferation. Cytosine Arabinofuranoside 
(AraC) at a dose of 1.25J.1M in isolation or a combination ofO.6J.1M 5-Fluorodeoxy 
Uri dine (5-FU), 0.6f.1M AraC and 0.5f.1M Uridine (Antel 2003) both appeared to 
achieve the desired result. It was observed however that, if left, the majority of cells 
eventually died at any concentration of antimitotic agent sufficient to prevent them 
from reaching confluence. Since the agents used are incorporated into and disrupt the 
DNA of dividing cells - the implication was that the whole population remained 
mitotically active at 39°C. 
Notwithstanding this conclusion, the experiment was continued and fresh cells were 
plated onto PLL coated coverslips, and left overnight to plate down. The wells were 
then flooded with medium containing the appropriate concentration of antimitotic 
agents and incubated at 33° or 39°C for 5 days without further manipUlation. They 
were then photographed in situ, and immediately removed and stained for A2B5, 
GaIC, GF AP, 01 and 04. The staining was negative for all antigens, but there was 
significant morphological change - most marked at 39°. The cells developed multiple 
extended processes, often with secondary, though rarely tertiary, arborisations. 
Although these were significantly different from their usual appearance, they bore 
little resemblance to oligodendrocytes or their precursors. 
The possibility that inactivation of the oncogene leads to cell death was also 
considered. There is some support in the literature for this explanation (Jha et al. 
1998). Human fibroblasts incorporating large T can replicate for some 20-30 
generations more than their normal life span, but after this either senesce or die. Large 
T antigen appears to depend for its action on its inactivation of two tumour suppresser 
gene products - p53 and pRB. Inactivation of large T will lead to the cell reverting to 
its previous phenotype, and if it is beyond its natural life span, senescing or dying 
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(Hubbard-Smith et al. 1992). A very small proportion (10-5 - 10-8) of fibroblasts 
incorporating large T do not senesce with the other cells, and those that survive this 
crisis progress to become truly immortalised. These cells presumably acquire an 
additional (genetic) event, which may involve stabilisation of telomere length. Even 
these cells depend on large T for continued proliferation (Radna et al. 1989; Wright et 
al. 1989). 
Cells were grown at 33° or 39° in high or low serum in the presence or absence of 
antimitotic agents. After a week they were stained with a combination of Acridine 
Orange and Ethidium Bromide, which enables the identification of early and late 
apoptotic cells, and differentiates these from viable and necrotic cells (Leite et al. 
1999). A few dying cells (both apoptotic and necrotic) were seen at both temperature 
in 10% FBS, but this figure was <2% for the cells grown at 39°C. These figures were 
similar in 1 % FBS suggesting that this proportion of serum is sufficient for survival, 
but the proportion of dead or dying cells increased dramatically in the presence of the 
anti-mitotic agent AraC (Figure 2-4). 
Proliferation 
Three methods were employed to investigate the proliferative potential of these cells, 
and these studies were commenced at the point where faster proliferation at 39°C was 
first suspected. 
The first method involved measuring the time taken for a flask passaged 1: 10 to reach 
confluence. This was 6 (±2) days, but was unduly influenced by subtle differences in 
the protocol used. Cells at 39° reached confluence after 4-5 days; consistently earlier 
than those at 33°. However this technique suffered from several problems: It took no 
account of the time taken for the cells to settle and attach and calculations assumed 
logarithmic growth ab initio. Cells needed at least one medium change during this 
time, and it was very difficult to ensure that there was no drop in temperature during 
this time. The end point was hard to quantify, particularly because the cells at 39° 
pavemented quickly, whereas gaps remained between those at 33° until they were 
nearly peeling off. In addition subtle differences in starting density lead to certain 
areas reaching confluence before others, making the determination of a clear endpoint 
problematic. 
The second method used BrDU, a synthetic nucleotide analogue, which is 
incorporated into cellular DNA during S-phase of the cell cycle. Any cell that is 
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passing through the S phase during BrDU exposure can then be labelled with an 
antibody directed against BrDU, which can then be visualised with a fluorescent 
secondary. The BrDU index can then be ascertained by the proportion of labelled cells 
divided by total cells) to be obtained. In practice, this procedure was rather variable. 
Cells at 39° stained very strongly, and it was very easy to distinguish labelled cells 
from unlabelled cells, and thus to obtain an index. At 33° however, cells did stain, but 
much less brightly, and the difference between labelled and unlabelled cells was less 
distinct, increasing the potential for error. In addition, the Hoechst stain appeared to 
interfere with the anti-BrDU (Hoechst binds to double stranded DNA, anti-BrDU will 
only label partially denatured (single stranded) DNA (Molecular Probes 2001», so 
nuclei had to be counted under phase contrast. This was acceptable at low starting 
densities, but became problematic as the cells reached confluence. No reliable 
qualitative comparison was possible but in excess of95% ofHWl cells incorporated 
BrDU at 39°C after a 36-hour pulse (Figure 2-5). 
The third, and most reproducible method, relies on the property of viable cells to 
reduce MTT to a dark blue formazan dye. Even recently killed cells fail to change the 
dye - enabling it to be used as a measure of cell number (Mosmann 1983). This 
reaction was originally presumed to occur in mitochondria, but recent work suggests 
that the reaction itself takes place in other organelles (Morgan 1998) fuelled by 
mitochondrially derived NADH. Prior to using this assay, the linearity of the assay 
was confirmed by comparing doubling dilutions of a cell numbers with the MIT 
readout after allowing the cells to adhere for 2 hours (Figure 2-6). 
Three experiments using the MTT assay were performed. These looked at proliferation 
against starting cell number, temperature (Figure 2-9), serum concentration (Figure 
2-9) and a selection of proliferative cytokines implicated in glial growth and 
maturation (Figure 2-10). The cells showed a characteristic growth curve - "lag", 
"log" and "plateau" phases were all identified. The previous observations were 
confirmed - HWI cells grow faster at 39°C as measured by the gradient of the growth 
curves, and there was no evidence of slowing except as the cells reached confluence. 
Interestingly, the cells appeared to stop growing at a lower final surface density 
(maximum MIT value) when grown at 39°C compared with cells at 33°C (Figure 2-7 
&Figure 2-8). This is in keeping with the previous observation that the cells at 39°C 
are more flattened, adhere better and become confluent without overlapping. Cells 
grew faster in 10% serum than in 1 %, an effect that could not be restored by the 
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addition of EGF, FGF, PDGF or both F &PDGF to the lower serum concentration, 
although there was a modest increase in MTT value after the addition of both FGF &: 
PDGF (Figure 2-10). 
The key observation in all these experiments was that growth was persistently Jaster at 
39° than at 33°. This was not dependent on cell density, although there was evidence 
that the effects of contact inhibition at 39° caused growth arrest earlier than at 33°. 
There was also little evidence of growth enhancement by any of the growth factors 
used. Growth appeared to be maximal at low density, although below a certain 




HWI was originally designed to facilitate investigation of the human oligodendrocyte 
lineage. The key attributes (both intended and reported) were that it was 
phenotypically similar to the human oligodendrocyte progenitor when grown at 33°C, 
a temperature at which the transforming oncogene was active, and was able to 
proliferate rapidly under these conditions. When grown at the non-permissive 
temperature it was reported to stop proliferating and start expressing antigens 
suggestive of progressive glial differentiation. Furthermore at the non-permissive 
temperature it was reported to be bipotential, able to differentiate along the 
oligodendrocyte lineage in low serum conditions, or to express markers of type 2 
astrocytes when grown in 15% FBS or above, a characteristic of the rodent 
oligodendrocyte progenitor. 
The following conclusions were made from the experiments described above:-
The cell line does not have the same immunophenotype as originally described at 
33°C. 
It does not appear to express demonstrable amounts of any of the glial progenitor 
antigens tested for at 33°C. 
The cell line neither slows down nor stops proliferating at the non-permissive 
temperature (39°C). 
The cell line does not show any immunological or morphological evidence of 
differentiation at 39°. 
The lack of differentiation and the failure to stop proliferating could not be 
attributed to unsustained temperatures alone. 
There is no evidence to support the hypothesis that a subpopulation of these cells 
behaves as originally described. 
There is no evidence to suggest that a significant proportion of these cells is 
undergoing apoptosis at 39°. 
This left two likely explanations for the observed results; either the cell line had 
changed since it was first described, or that the cells under investigation were not 
HWI. 
The cellular and antigenic phenotype is dependent both on the pattern of gene 
expression within the cell, which in tum is controlled by transcription factors within 
the nucleus, and the genome itself. It is reasonable to speculate that changes in gene 
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expression occurring over a limited number of generations, might be restricted enough 
for the cell to retain some demonstrable antigenic similarities to the parent cell. Thus 
the absence of any such marker, while not excluding a change merely in gene 
expression, might suggest a more fundamental change. 
As previously discussed, many SV 40 immortalised cell lines experience a period of 
crisis - where the majority of cells senesce, and a small population, presumably with 
further somatic mutations, continue growing and eventually overrun the original cells. 
There was no description of a period of crisis occurring to this cell line, which was 
investigated while still in its infancy. The poor survival from the defrosting process is 
not likely to have been due to a crisis phenomenon, in that sub-culturing well beyond 
this passage number had occurred in Cambridge without evidence of this. However, 
selection out of cells containing mutations conferring a degree of resilience to the 
process of defrosting, could provide a mechanism for a fundamental change in 
genotype. 
The acquisition of further copies of tsTag may be responsible for altered behaviour of 
cell lines immortalised in this manner. The use of a replication defective virus as a 
vector, the original determination of a single integration site and the magnitude of the 
difference in phenotype of this cell from that described mitigates against this 
explanation. 
Large T antigen is known to be both clastogenic and aneuploidogenic (Ray et al. 
1992), and this action may be exacerbated by its alteration of apoptotic mechanisms. 
The high frequency of chromosomal abnormalities in certain SV 40 induced cell lines 
suggests that it may playa role in the immortalisation process in these cases. In 
addition, there is some evidence that cryopreserving cells in liquid nitrogen may also 
lead to chromosomal breakage - although it appears that affected cells often do not 
survIve. 
It was thus decided to proceed to formal karyotype analysis. This was perfonned by 
the regional cytogenetics laboratory at Southmead hospital on a live culture of passage 
5 cells. 
Karyotype Analysis of HW J 
The report returned as follows:-
"Metaphases obtained from cell culture were apparently of rodent origin. No evidence of 
human metaphases seen." [Dr T Davies BSc PhD FRCPalh Cert MHS] 
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After further questioning the suggestion was made that they were most likely of rat 
origin, although the exact species was not determined with security (Figure 2-11). 
Contamination between mammalian cell lines is a well-recognised hazard of cell 
culture experiments, particularly when different cell lines are being used in the same 
laminar flow cabinet. The uniform behaviour of the cell line suggests that the cells 
were contaminated prior to their arrival in Bristol. In addition, no rat cell work was 
proceeding or had been undertaken in this laboratory prior to our arri val, and the 
laboratory had been empty for in excess of a year. The only rodent cells used in the 
laboratory at the time of these experiments were two mouse hybridoma cell lines - and 
they grow in suspension, rather than as an adherent monolayer. 
Attempts were made to source cells prior to the contamination. Thus cells as early as 
passage three were retrieved from Cambridge and analysed further. Attempts were 
also made to grow these in limiting dilutions and with mitotic agents, but all cells 
retained the characteristics described. A further passage 3 vial was defrosted and 
immediately sent for karyotyping - all cells were of rodent origin. 
Interestingly, one other cell line, named HW2, had been produced in Cambridge. This 
had been less promising as glial antigens, though apparently present, were less 
consistently identifiable. The earliest passage of these cells were karyotyped as well 
and identified as of rodent origin also. It seems likely therefore that the cells were 
contaminated either at the time of transfection, or shortly afterwards. The most likely 
contenders were the RAT 1 cells used to assess infectivity prior to infection of the 
glial prep. P A317 cells, a mouse embryo line with herpes, were used as packaging 
cells and would be another contender. Although it should be possible to identify 
whether the cell behaved like either of these two, this was considered marginal to the 
aims of the thesis, and resources were limited. 
The rationale for using transformed cell lines remains sound, but as has been 
demonstrated, this approach has not so far been fruitful. The facilities for transfomling 
cells are not currently available in the Glial Cell Laboratory here in Bristol and so no 
further attempts were made in this direction. While this approach may again gain 
credence, recent ad\'aIlCeS in stem cell biology and methodological improvcmcnts in 
primary oligodendrocyte culture may reduce the need for such lines in the particular 
realm of human oligodendrocyte biology. 
Rem yel ination Biology 
Illustrations 
Figure 2-1 HW 1 Growing at 33°C 
Figure 2-2 HWl Growing at 39°C 
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Figure 2-3 HWI as Originally Reported 
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Figure 2-4 Apoptosis of HW 1 Under Different Growing Conditions 
o 1 Oug/ml AraC 
o Normal 
• Necrotic 
~ Late Apoptotic 
~ Early Apoptotic 
Figure 2-5 HW 1 Growing at 39°C Incorporates BrDU after a 36 hour pulse 
(Combined BrDU-FITC and phase contrast x200) 
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Figure 2-8 Growth Curves for HWI for a Range of Seeding Densitie at 39 C 
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Figure 2-11 Metaphases from HWI sho typical rodent chromosome 
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Illustrations 
Figure 3-1 CG4 cells growing in B 1 04 condi tioned medium 200 
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Figure 3-2 After four days in PDGF AA alone, CG4 cell s sho signs of 
differentiation. (x 400) 
Figure 3-3 When cells grown in PDGF AA are pl aced in 150/0 FCS they fl atten and 
adhere, and start to express the astrocytic marker GF AP (not shown). (x 200) 
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Figure 3-4 The changes seen in Fig. 3 are re ersed b the remo al of FB an 
addition of FGF (x 200) 
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Figure 3-5 Cells grown in FGF alone adhere poorl y to wlcoated tis u cultur 
plastic and form clumps, but further cell division is limited and true sphere fOimati n 
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Figure 3-6 Summary of protocol and results published b Kondo d R ff. 
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Remyelination Biology 
Chapter 4. Identification, Isolation and Mitogenic Expansion of 
Human Oligodendrocyte Progenitors from Adult Human Brain 
Introduction 
Part 1 Identification of Human Oligodendrocyte Progenitors 
Regardless of the source of progenitors that might be used in any putative 
remyelination therapy, adult CNS tissue, fetal tissue, mesenchymal cells etc, robust 
and reliable means of identifying progenitors must be available. Likewise, a 
prerequisite to the study of progenitor biology in MS lesions and nonnal tissue is the 
ability to identify these cells. 
The rodent oligodendrocyte progenitor was first identified in vitro in perinatal rat optic 
nerve cultures (Raff et a1. 1983) and subsequently in the adult rat CNS (Ffrench-
Constant & Raff 1986) using the monoclonal antibody A2B5 (Raff et a1. 1983). A2B5 
was subsequently shown similarly to act as a specific label for oligodendrocyte 
progenitors cultured from other parts of the developing rodent CNS (Bottenstein et a1. 
1988), from the adult rodent CNS (Baas & Barnstable 1998;Wolswijk & Noble 1989), 
and from the developing human optic nerve (Kennedy & Fok-Seang 1986) and adult 
human brain (Scolding et a1. 1995). The other cell type that expresses A2B5 antigens 
in both rodent and human mixed glial cultures, the so-called type 2 astrocyte, can be 
clearly discriminated both by its characteristic morphology and its co-expression of 
GFAP (Raffet a1. 1983). 
The oligodendrocyte progenitor has, however, proved very difficult to study in vivo. 
The A2B5 antibody (which is directed against specific tetragangliosides) also stains 
neurones in tissue sections (Fredman et a1. 1984;Majocha et al. 1989) and cannot be 
used to identify progenitors. Another anti-ganglioside monoclonal antibody thought to 
be specific for the oligodendrocyte progenitor, LB 1 (specific for G03), also binds to 
microglia (Wolswijk 1994;Wolswijk 1995), while a third marker, the PDGF-a 
receptor (Hart et a1. 1989;Pringle et a1. 1992), has been shown also to be expressed by 
neuronal sub-populations (Vignais et a1. 1995). 
Antibodies directed against a chondroitin sulphate proteoglycan, the NG2-antigen, 
have been shown to label neonatal and developing rat oligodendrocyte progenitors in 
vitro and in tissue sections (Nishiyama et a1. 1996a;Ong & Levine 1999;Pekny et a1. 
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1995). Recently investigators have used this antibody to identify adult human 
oligodendrocyte progenitors in tissue sections (Chang et a1. 2000a;Chang et al. 2002). 
Furthermore, their results suggest that cells bearing this antigen are very numerous, an 
observation in conflict with some earlier estimates of human oligodendrocyte 
progenitor populations (Maeda et a1. 2001 ;Scolding et a1. 1998)and estimates of adult 
rodent progenitor numbers. 
The adult rodent "02A" progenitor has a number of morphological, 
immunocytochemical and behavioural differences from its neonatal counterpart 
(Ffrench-Constant & Raff 1986; W olswijk et a1. 1991 a; Wolswijk & Noble 1989), 
while the immunocytochemical (and proliferative) characteristics of the adult human 
oligodendrocyte progenitor also differ from rodent cells (Armstrong et a1. 
1992;Ffrench-Constant & Raff 1986;Scolding et a1. 1995;Wolswijk & Noble 1989). 
Therefore, extrapolating the finding that NG2 is a marker of the developing rodent 
oligodendrocyte progenitor to adult human glia must depend on direct experimental 
support. 
It was decided to address the labelling characteristics of NG2 in adult human glia in 
vitro, where individual cells can be separately identified. To do this requires a "gold 
standard" with which NG2 can be compared. A2BS, a monoclonal antibody directed 
predominantly against epitopes on the ganglioside GQ (Eisenbarth et al. 1979), is an 
appealing candidate. There is considerable experience in its use in vitro, indeed it was 
used in the earliest descriptions of the oligodendrocyte progenitor (Raff et a1. 1983). 
Cells labelling with this antigen in mixed human glial preparations have similar 
phenotype and differentiation potential to rodent cells (Scolding 1998;Scolding et al. 
1995). Cells isolated from adult humans on the basis of early activity of 
oligodendrocyte-specific promoter activity express A2BS (Roy et a1. 1999) 
Furthermore, cells sorted on the basis of this antigen from adult human white matter 
develop into oligodendrocytes following transplantation (Windrem et al. 2002). The 
considerable problems associated with its use in tissue sections, caused by cross-
reactivity with a neuronal population, are not relevant to unexpanded mixed glial 
cultures from adults - neurons do not survive the dissociation protocol (AnteI2003). 
The development of the type 2 astrocyte phenotype in culture necessitates co-staining 
with both A2BS and GFAP to differentiate these with security from the 
undifferentiated oligodendrocyte progenitors. This limits the number of other antigens 
that can be interrogated on a single slide, but does not detract from its specificity when 
Page 81 
Remyelination Biology 
this factor is taken into consideration. The identification of a new marker for 
oligodendrocyte progenitors that avoids the need for this second antigen would be a 
significant advance. 
Preliminary findings (made by previous researchers in this group) suggested that two 
separate NG2 antibodies reliably label adult human oligodendrocyte progenitors in cell 
cultures, but also bind to GF AP-positive astrocytes and possibly microglia. The 
hypothesis that NG2 is a specific and sensitive marker of adult human oligodendrocyte 
progenitors in vitro was tested against A2B5 as an established standard. Quantitative 
assessment was performed in primary cultures obtained from adult human surgical 
specimens. The sensitivity and specificity of this antigen as a marker of these cells was 
determined, and other popUlations that can express the NG2 antigen in these 
circumstances were identified. 
Part 2 Isolation and Expansion of Human Oligodendrocyte Progenitors 
Closely related to issues of identification is the problem of isolating substantial 
numbers of progenitors from the mixed glial preparations. A major impediment to the 
study of the human oligodendrocyte lineage has been the difficulty of obtaining 
sufficient numbers of purified cells for experimentation. 
In rodents this problem was solved some time ago. Neonatal rodent progenitors are 
highly proliferative cells and can be induced to undergo substantial expansion in vitro 
using FGF2 and PDGF AA in combination (Louis et al. 1992;McKinnon et al. 
1990;Noble et al. 1988;Raff et al. 1988). Thus a purification process that yields only 
small numbers of cells can be combined with a simple but effective amplification step 
to yield a substantial population for further study. Furthermore, there are few 
limitations in the provision of source tissue - if necessary, tissue from several 
genetically related age-matched animals can be combined. 
However, sources of human tissue are scarce and often erratic. While human 
progenitors have been shown to undergo DNA synthesis on an astrocyte monolayer, 
this was not reproducible using defined media and recombinant mitogens (Scolding et 
al. 1995). Furthennore, the astrocyte monolayer, while able to support limited 
division, failed to produce substantial numbers of these cells, as would be required for 
a thorough investigation of their biology. Any purification step would need to be 
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highly efficient to provide a reasonable yield from this method, and substantial 
improvements to the amplification steps are urgently required. 
Various approaches to the purification problem have been tried. Rodent populations 
can be purified by means of differential adhesion to various substrates - and by 
shaking loosely adherent cells off a mixed monolayer (McCarthy & de Vellis 1980). 
However, this is inefficient, relies on a large population of starting cells and further 
substantial proliferation in mixed culture, and one might anticipate the need for several 
experiments to optimise this in a new species. This lUXury is not available with such 
limited human material. A second option that has the added benefit of improved 
popUlation purity is to use sequential immuno-panning (Stallcup & Beasley 1987) 
using the A2B5 antibody, but this too needs large volumes of starting material. 
Flow activated cell sorting is in widespread use in haematology laboratories and two 
approaches have been used to purify human glial preparation with it. The simplest 
option is to label cells with a directly conjugated fluorescent antibody as a marker -
although for most glial antigens these may not be commercially available and a 
secondary antibody would probably be required. The second option is to transfect the 
gene for green (or blue (Martinez-Serrano et a1. 2000» fluorescent protein into target 
cells under control of a cell-type specific promoter, as has successfully been performed 
by Roy et a1. (Roy et a1. 1999). How the basic biology of the cell might change as a 
result of this genetic manipUlation is unclear. 
One elegant option that avoids the need for genetic manipUlation is to use 
immunomagnetic separation (Wright et a1. 1997). This simple method, which relies on 
magnetic beads coated with antibody to bind to, and pull out, specific cell types based 
on surface antigen expression, is both efficient and versatile. Two kits, which differ in 
the bead size and separation method, are available commercially. These techniques are 
gaining credence both in experimental paradigms, and for clinical purposes. 
Furthermore, in the final months of experimentation, a protocol for selection of adult 
human oligodendrocyte progenitors on the basis of A2B5 antigen expression was 
published. The benefits of this technique were reported by the same authors who had 
previously used the more complex promoter-defined separation method (Roy et al. 
1999; Windrem et al. 2002). 
This method was tested as a viable means of purifying progenitors and the cellular 
yield was assessed antigenically. The purity achieved with this method provided 
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important insights into antigenic expression that are not easily demonstrated using 
mixed glial preparations alone. 
Part 3 The Proliferative Requirements Of Human Oligodendrocyte 
Progenitors 
The third component of these experiments was that of optimising the growth 
conditions for human oligodendrocyte progenitors. Some of this work was done in 
parallel with the above studies to maximise the use of available tissue. Substantial, but 
controlled, proliferation and in vitro expansion of adult human progenitors remains an 
important goal of remyelination biology and is as yet unrealised. However, these cells 
have been isolated, grown in vitro for prolonged periods and even shown to undergo 
limited proliferation (Scolding et al. 1995), so many of the basic requirements for their 
growth are already known. There have been important advances in the media 
requirements of closely related cells, which might reasonably be extrapolated to adult 
human oligodendrocyte progenitors (Arsenijevic et a1. 2001;Carpenter et a1. 
1999;Pagano et al. 2000;Zhang et a1. 2000). These include the use of high glucose 
media and ofDMEMlF12 based recipes rather than N2B3 (used in earlier attempts), 
which has subtly different hormonal and micronutrient concentrations. Preliminary 
experiments demonstrated improved yields with these changes but no evidence of cell 
division in the progenitor population (data not shown). 
The working hypothesis remains that human progenitors will divide in vitro in 
response to mitogens identified from rodent work, and as such can provide a source of 
human progenitors for experimental and therapeutic purposes. Earlier failures to 
stimulate adult human oligodendrocyte progenitors using FGF2 and PDGF AA do not 
disprove this hypothesis. The absence of demonstrable proliferation with these two 
may be attributable to reasons other than the differing mitogen requirement of human 
cells. Classical tissue culture teaching suggests that sufficient surface density can be 
critical to in vitro growth (Antel 2003). Furthermore, the contributions, both positive 
and negative, from other cell types in mixed cultures are hard to quantify, and the 
presence of anti-proliferative signals might explain their reluctance to divide. Thus 
attempting to grow purified progenitors at high density was an important priority of 
these experiments. 
Our understanding of mitogen requirements, summarised in the general introduction, 
suggests that PDGFAA. FGF2, NT-3 and stimulation of the IGF receptor with high 
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insulin concentrations are likely contenders for any recipe (Baron et al. 2000;Engel & 
Wolswijk 1996;McKinnon et al. 1990;McKinnon et al. 1993;Wolswijk & Noble 
1992). The appreciation of the role that extracellular matrix ligands have to play in this 
process suggests that vitronectin may be important, at least with more physiological 
concentrations of these mitogens (Baron et al. 2002). These conditions were therefore 
explored alongside the experiments to determine cell identity. They provide important 
evidence that adult human progenitors can be grown in vitro in defined media, and 




Materials and Methods 
Adult human glial cultures 
Cells of the human oligodendrocyte lineage were cultured using modifications of a 
protocol described elsewhere (Scolding et al. 1995)from normal-appearing white 
matter removed at the time of anterior temporal lobe resection for intractable epilepsy. 
(Previous studies confirmed that comparable tissue, dissected from sites distant from 
the epileptic focus, was histologically normal (Scolding et al. 1995». On one occasion 
cerebellar tissue resected during the removal of a benign acoustic neuroma was used, 
as indicated in the text. 
All patients gave their consent for resected tissue to be used for research purposes, and 
ethics approval was obtained from both local and regional ethics committees. Tissue 
was transported to the laboratory at 4°C in Hibernation medium (Hibernate TM A, 
BrainBits, Southern Illinois University) supplemented with penicillin / streptomycin / 
fungizone 1 % (Invitrogen). Tissue was processed between 1 and 12 hours post 
resection. 
Dissociation 
Tissue was placed under a tissue culture hood, and meninges and large blood vessels 
were dissected off. The tissue was then minced with a scalpel and digested. Tissue was 
incubated at 37°C for 20 minutes in S ml Enzyme solution 1 (containing MEM (Sigma 
M7278), 0.116mg/ml trypsin (Sigma T4424), 0.1 84mg/ml collagenase III (Lome LS 
4208) & 18.4J.1g/ml DNAseIIV (Sigma DS02S». The mixture was then centrifuged at 
200g for S minutes, the supernatant replaced with a further Sml enzyme solution 1 and 
incubated for a further 20minutes. Following centrifugation the supernatant was then 
replaced with Sml enzyme solution 2 (containing MEM, trypsin-EDTA (Sigma 
T3924) 23 & 9.2J.1g/ml respectively, 0.184mg/ml collagenase III & 18.4J.1g/ml 
DNAseIlv) for IS minutes at 37°C and centrifuged. Finally the supernatant was 
replaced with Iml of enzyme solution 3 (containing MEM, 2.4mglml trypsin inhibitor 
(Sigma T6S22), 1.9 J.1g/ml DNAseIlv, 1.6mg/ml bovine serum albumin (Sigma A4919) 
and 5% heat inactivated fetal bovine serum (Sigma F413S» and triturated three times 
through 21 gauge and 23 gauge needles. 
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All preparations used the same initial protocol as described above. Some modifications 
to the subsequent steps were made as conditions were optimised. These variations are 
indicated in the pertinent "results" sections. 
Purification 
The cell suspension produced from the trituration step also contained cellular and 
myelin debris, together with a few small undissociated tissue particles. This was then 
filtered through a Nalgene filter containing a 40)lm steel mesh backing a 20J.Ull nylon 
mesh, and flushed with 10% FCS in DMEM. 
Myelin debris was then removed by centrifugation at 2200rpm for 20minutes through 
a 9% Optiprep solution in DMEM. The cellular pellet and bottom 1 ml of supernatant 
were resuspended with a 1 ml Gilson. This was then washed through the final culture 
medium once and resuspended in this medium. The early NG2 identification 
experiments used 10% FCS in DMEM. Later experiments, including all quantitative 
work, were performed using NSATM (Euroclone - a high glucose DMEMlF12 based 
medium) with 2mM L-glutamine, N2 supplements, FGF (1 Onglml), PDGF AA 
(20nglml) and NT-3 (2nglml) further supplemented with insulin (final concentration 
2SJ..Lglml). Cells were plated onto poly-o-Iysine (PDL) coated covers lips and incubated 
at 37°C in 7% CO2• 
Magnetic Selection and Mitogen Expansion 
The protocols used for magnetic selection varied as improvements were incorporated, 
but were based around pre-existing protocols (kindly provided by Dr J Crang, 
University of Cambridge) and product data sheets. Initially, the cell suspension 
obtained following trituration was washed by centrifugation through 10% FCS and 
then through an OptiprepTM density gradient to remove myelin debris. Cells were then 
incubated for 30 minutes in filtered A2BS antibody solution (1 :3) at 4°C on a rotating 
mixer. The cells were then washed and incubated with prewashed anti-mouse IgM 
coated magnetic beads for a further 30 minutes at 4°C. A2BS positive cells were 
removed by repeated selection using a Dynal™ magnet and the beads then digested otT 
the cells with a brief incubation in trypsin, followed by neutralisation with 1 0% FCS 
and centrifugation over concentrated OptiprepTM to remove the high density magnetic 
beads. The cells were then plated onto 4 polylysine coated coverslips, one of which 
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was also coated with vitronectin, and incubated in NSA-N2 with FGF, PDGF and 1 % 
FBS. (Results Figure 4-16 & Figure 4-17) 
The second preparation reintroduced the filtration step through the 20J.lm filter 
immediately after trituration, but was otherwise identical. However following 
magnetic separation the beads were left in situ and all cells were grown on poly-lysine 
coated coverslips in NSA-N2 with FGF2 and PDGFAA without FBS. Wells were 
flooded with fresh medium 12 hours later, and fresh growth factors were added three 
times a week by replacing 1I10th of their volume with a lOx solution of growth 
factors. Every week, old medium was removed sparing a 0.25ml residual and fresh 
medium replaced. This incubation was continued for 18 days prior to staining. (Results 
Figure 4-18 to Figure 4-21) 
The final protocol was modified in accordance with a published protocol (Windrem et 
a1. 2002). Following both the filtration step and density centrifugation to remove 
myelin debris, freshly dissociated cells were incubated for 48 hours in an uncoated 
flask. The medium used was NSA-N2 with FGF2 and PDGF as previously, but with 
the addition ofNT-3. Loosely adherent and non-adherent cells were then washed off 
with Hanks' balanced salt solution without calcium and magnesium and these cells 
used in the subsequent separation step. Magnetic separation was performed as above 
and A2B5+ve cells placed on vitronectin and poly lysine coated coverslips and fresh 
medium added. Growth factors were replaced as described above. 
Fluorescence Immunocytochemistry 
Adherent cells growing on poly-lysine coated covers lips were removed from their 
wells and placed on a humidified platform. Surface antigens were stained on living 
cells by incubation at 37°C for 20 minutes with antibodies diluted in medium 
containing either 10% serum or 1 % bovine serum albumin (A2B5 1:2 dilution, mNG2 
1 :50, pNG2 1: 100) before washing and fixing with 4% PFA. Internal antigens were 
exposed by penneabilising with absolute methanol at -20°C and then blocked with 5% 
nonnal goat serum in phosphate buffered saline at 37°C for 30 minutes. Intracellular 
antigens were stained overnight at 4°C in phosphate buffered saline (PBS) containing 
50/0 nonnal goat serum (NGS). Fluorescein isothiocyanate (FITC), tetramethyl 
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rhodamine isothiocyanate (TRITC), or 7-amino-4-methyl-coumaric acid (AMCA) 
conjugated class and species specific secondary antibodies diluted in 50/0 NGS were 
applied for 1 hour at room temperature. Various controls included the omission of 
individual primary antibodies (of particular pertinence to multiple staining) and the 
use of irrelevant antibodies of the same isotype and derived from the same source (eg 
anti BrDU antibodies in the absence of BrDU incubation). Internal controls were 
provided by other cellular phenotypes within the mixed cultures. After the last 
washing step, coverslips were mounted in Vectashield™ (Vector Labs) and sealed 
with clear nail varnish. Slides were then viewed under using an Olympus IX70 
inverted fluorescence microscope with appropriate filters, and photographed using a 




Systematic analysis of human mixed glial cultures requires triple staining of mUltiple 
parallel coverslips to identify all phenotypes. Because of the critical limitations of 
tissue volumes from surgical specimens (typically less than 0.5cm3) insufficient 
coverslips were available to stain more than one coverslip with each combination of 
markers per sample, thus sacrificing statistical power. In addition these protocols were 
very vulnerable to the failure of a single stain, as the experimental design required 
simultaneous identification of all major cellular groups to test these hypotheses. 
The following results incorporate observations from such experiments where 
qualitative findings were manifest but where quantification was impossible. In 
addition, very commonly during the course of an experiment very specifically 
designed to answer one question, additional observations pertaining to other 
protperties emerged, but the design of the experiment was such that the secondary 
observations could not be quantified. Often the same unsought finding was suggested 
from several different primary experiments. However, attempts to confirm or refute 
such unquantified observations were frustrated by the limited and sporadic nature of 
the tissue supply. 
In the following, where quantified, figures refer to a single comprehensive study of 
tissue from one patient and, unless stated otherwise, refer to one coverslip for each 
separate analysis and are thus invariably provisional. 
The Identification and Immunophenotype of the Adult Human 
Oligodendrocyte Progenitor 
Sensitiyityand Specificity ofNG2 as a Marker ofA2B5+ Oligodendrocyte 
Progenitors 
A2B5 positive cells could be readily identified in these cultures in line with previous 
observations (Figure 4-1) (Scolding et al. 1995). These were not rare (e.g. at 8 days 
10.40/0 (±1 0/0) of total cells in these cultures stained for A2B5) and these cells had both 
rounded and extended morphologies, the latter predominantly uni- or bipolar. The 
rounded cell population would be expected to include processed cells that had lost 
processes during dissociation. With time in culture there was a progressive loss of the 
A2BS+GFAP- progenitor phenotype and a corresponding rise in A2B5+GFAP+ "type 
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2" astrocytes (Figure 4-2). This was quantitatively demonstrated between 5 and 8 DIV 
(Figure 4-3 & Figure 4-4). One explanation for this was that a significant proportion of 
progenitors might be differentiating into "type 2" astrocytes even in serum free 
conditions. 
NG2 is trypsin sensitive (Nishiyama et al. 1991), and no NG2 staining was seen within 
the first 24-48 hours after enzymatic dissociation. Furthermore cellular identification 
became easier with time in vitro, as cellular adhesion, morphology and staining clarity 
improved. Thus time-points of 5 days in vitro (DIY) and 8 DIY were used for 
quantitative analysis. 
NG2 staining was evident in 6.9% (±0.8%) of total cell numbers. However almost all 
NG2+ cells had an extended morphology and they made up a correspondingly greater 
proportion of the non-rounded cell popUlation. 
When the A2B5 +ve GF AP -ve progenitor popUlation was examined, only 31.3% 
(±8.2%) of cells also stained with NG2 (the sensitivity ofNG2 as a marker of 
oligodendrocyte progenitor cells). 
Of the popUlation ofNG2 +ve cells present at 5 DIY, 38.20/0 (±4.8%) were A2B5 +ve. 
However half of these A2B5+NG2+ cells were co-positive for GF AP - ie only 17.6% 
(± 3.8%) of the total NG2 +ve cells had the traditional immunophenotype ofOPCs 
(A2B5+ GF AP-) (Figure 4-3). By 8 DIY this figure had fallen to 9.80/0 (±2.9%) (the 
specificity ofNG2 as a marker ofOPCs) while the proportion of the total NG2+ 
population staining for A2B5 remained broadly the same, due to a corresponding rise 
in the number ofNG2+ "type 2" astrocytes (Figure 4-4). 
PDGFaR expression in primary glial cultures 
The low figures for both sensitivity and specificity prompted further inquiry. Another 
antigen that has been used as a marker for identifying oligodendrocyte progenitors in 
tissue sections is the PDGF a-receptor (PDGFaR) (Hart et al. 1989;Pringle et al. 
1992). Rodent studies have suggested that this antigen expressed in cells at both the 
pre-progenitor and progenitor stage (Ben Hur et al. 1998) and thus overlaps with 
A2B5, but is expressed and lost first. This stage of oligodendrocyte development is 
strongly influenced by exogenous PDGF-AA, which is a potent mitogen (reviewed in 
(Casaccia-Bonnefil & Liu 2003». There are some reports that it may be expressed by 
certain neurons (Vignais et al. 1995), but as discussed earlier, this is not directly 
relevant to primary glial cultures from adult brain as neurons do not survive the 
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dissociation protocol. The use ofPDGFaR as a marker of the human OPC in vitro has 
yet to be established. However, ifNG2 antigen was expressed earlier than A2B5 then 
it might be expected to correlate better with PDGFaR, which has an earlier expression 
profile in the oligodendrocyte lineage (Ben Hur et al. 1998). Interestingly, there is also 
evidence that PDGFaR co-localises with NG2 and may have some role in PDGF 
signalling (Nishiyama et al. 1996a;Nishiyama et al. 1996b). 
It was decided to investigate the possibility that NG2 and PDGFaR were labelling the 
same population of cells. When counted independently, PDGFaR was expressed by 
29% (±1.9%) of the total cell popUlation, most of which were rounded adherent cells. 
This compared with 10% (±1.0%) of cells staining with A2B5 and 6.9% (±O.8%) with 
NG2 in parallel slides. The latter marker stained cells with an almost exclusively 
extended morphology. Differentiation between the traditional OPC phenotype and the 
"type 2" astrocyte was not possible in this analysis. 
When the staining profiles of all three were compared on cells with an extended 
morphology (excluding cells that were unequivocally microglia on morphological 
grounds) a complex overlap between the popUlations was observed (Figure 4-6). This 
did not support the hypothesis that NG2 was labelling an identical population to that of 
PDGFaR. Notwithstanding the reports suggesting a particular association between 
NG2 and PDGFaR, one might expect some variation in the timing of different antigen 
expression as cells progressed through the lineage. The data presented to this point 
could be reconciled with the original hypothesis that NG2 staining, along with A2B5 
and PDGFaR, are specific markers of the early oligodendrocyte lineage in vitro, if 
their expression is broadly sequential, but with a degree of variation between 
individual cells. The previous Venn diagram has been modified to illustrate this idea in 
cartoon form, using normal curves to demonstrate variable expression (Figure 4-7). 
NG2 staining of the oligodendrocyte lineage - comoarison with momhology 
The oligodendrocyte lineage in rodents is traditionally renowned for the reproducible 
and strictly ordered sequence of lineage markers that appear, and in some cases 
disappear during maturation. This is mirrored by increasing morphological 
complexity; pre-progenitors are often unipolar, progenitors typically bipolar and later 
precursors develop increasing numbers of simple and then progressively ramified 
processes (Figure 4-8). We decided to use this to investigate the possibility that NG2 
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was marking a stage of oligodendrocyte development either before or beyond that of 
A2BS. 
We hypothesised that an expression earlier or later in the lineage would be manifest by 
an NG2 expression pattern that was skewed in relation to morphological complexity. 
This could only be directly addressed in relation to number of processes manifested by 
the sub-population of cells that had identifiable (and hence countable) processes. For 
this purpose processes were defined as narrow extensions clearly demarcated from the 
soma which extended for> 1 nuclear diameter beyond the point of demarcation. 
Processes were classed as branched (and hence counted as one) if the division was 
located distal to the demarcation point, but counted separately if the division was 
proximal. 
The number of processes of each NG2+ oligodendrocyte progenitor, NG2-ve 
oligodendrocyte progenitor and the A2BS-ve NG2+ cell was recorded. As previously, 
the oligodendrocyte progenitors were defined by the expression of A2BS and the 
absence ofGFAP staining: When the morphology of these populations were 
compared, we did not see a more primitive phenotype (fewer processes) in any of the 
populations to support this hypothesis. Clearly this result needs repetition before this 
conclusion can be claimed. (Figure 4-9). 
Those cells that could not be included in the above analysis nevertheless gave 
important clues as to the expression patterns ofNG2. Two particular morphologies of 
NG2 positive, A2BS negative cells were highlighted by this. There was a 
preponderance of this antigenic phenotype in those cells classified as growing in 
clumps. These cells were assigned a discrete class irrespective of process number both 
because it was felt they might have a unique origin and because morphological 
definition was prevented by the proximity of neighbouring cells. Stem cells and early 
progenitors appear to grow as aggregates in tissue culture, but may later adhere and 
disperse on permissive substrates (Ben Hur et al. 1998). Clumped cells may therefore 
represent such cells that have recently started to adhere. Although this preponderance 
would not support the expression ofNG2 later in the lineage than A2BS, it might be 
explained by an earlier pattern of NG2 expression. 
The second group ofNG2+A2BS- cells comprised a readily distinguishable population 
of flattened cells with elongated, curved (reverse scalloped) or clawed morphology 
(Figure 4-12). These cells could not be classified as processed as defined earlier 
because the flattened extensions of the soma were noticeably broader and were not 
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clearly demarcated from the soma (occasional cells could, and were classified as 
processed, while still possessing some of these characteristic features - Figure 4-12). 
With occasional exceptions, this morphology was unlike that of previous descriptions 
of oligodendrocyte lineage cells growing in vitro and did not readily support the 
hypothesis that NG2 was a selective marker of this lineage. 
NG2 staining of the oligodendrocyte lineage by iromunophenotyoe 
An alternative approach to address the possibility that NG2 labels oligodendrocyte 
lineage cells, but at a slightly different stage to AlB5, is to look at earlier and later 
antigenic markers. In rodents, neural stem cells and oligodendrocyte pre-progenitors 
label with the intermediate filament protein nestin but this is lost at or around the 
progenitor stage after the acquisition of AlB5 (Ben Hur et a1. 1998). Nestin is not 
considered specific to the oligodendrocyte lineage; indeed many regard its expression 
as an indicator of pluripotentiality (Reynolds et a1. 1992). A homologue of rodent 
Nestin is expressed in human cells and reports of the staining characteristics of stem 
like cells from human source tissue suggests that it too is expressed by immature cells 
(Johansson et a1. 1999), although may be lost at an earlier stage in humans (Scolding 
et a1. 1995). The 04 antibody on the other hand is regarded as a specific 
oligodendrocyte lineage marker both in rodents and humans. It predominantly labels 
sulfatide, an antigen first expressed during the later progenitor stage and one that 
continues to be expressed right through to the mature myelinating oligodendrocyte 
(Zhang et a1. 2000). Thus the combination of these markers might, according to 
traditional dogma, be expected to label all potential and actual oligodendrocyte lineage 
cells. If the proposed hypothesis is correct, all NG2+ cells would be expected to co-
express one of the other three antigens (Nestin, AlB5 or 04) (Figure 4-8). 
This was investigated in a series of triple labelling experiments. Nestin positive cells 
were numerous compared with other phenotypes, and made up 15.50/0 of total cell 
numbers (Figure 4-10). The majority of these cells were rounded and had little 
evidence of protoplasmic extensions or processes. There was an identifiable overlap 
between nestin and A2B5; consistent with previous observations in rodents that nestin 
is lost after A2B5 is acquired (Ben Hur et al. 1998). Furthermore there was a 
proportion of cells that labelled for NG2 and nestin that did not label for A2B5, 
suggesting that NG2 may be expressed earlier in the lineage than A2B5 (Figure 4-11 ). 
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However, this proportion made up only 8.3% of the total NG2 staining population-
leaving a large proportion ofNG2 positive cells without positive identification. 
04 stained 12% (±3%) of adherent cells, and a similar proportion of total cell numbers 
(11 %). A small proportion of these cells co-labelled for NG2 but this made up only 
some 5% of total NG2+ numbers. Again, no 04 staining was seen on the 
morphologically distinct, NG2+ clawed cells. 
These studies suggest that NG2 may start being expressed earlier than A2Bs in the 
oligodendrocyte lineage but may, like A2Bs, extend into the period of 04 expression. 
However it fails to explain all the observed discrepancies between NG2 and putative 
human oligodendrocyte markers, and as such, conclusions about relative timing should 
be interpreted with caution. 
Taken together, these findings suggest that NG2 expression may not be restricted to 
the oligodendrocyte lineage, as defined by established (rodent) oligodendrocyte 
markers. We attempted to identify other cell popUlations that might be expressing 
NG2. 
The identity ofA2Bs- NG2+ cells in primary glial cultures 
The value ofNG2 as a specific marker of oligodendrocyte progenitors is not 
universally supported. Previous reports have identified NG2 staining on a number of 
other cell populations that would be expected to contribute to a mixed glial culture. 
The most consistent report is of co-staining ofNG2 with endothelial cells (Pouly et al. 
2001). Some other observers have suggested that microglia also express this antigen -
although this study rested heavily on F ACS analysis, and the images published of 
immunostained cells showed rounded cells with little or no detail of antigen 
distribution or morphology. These findings have been refuted - at least as far as they 
pertain to microglia in vivo (Chang et al. 2000a;Nishiyama et al. 1999) by those who 
maintain that NG2 is a useful oligodendrocyte progenitor marker. The observation of 
NG2 expression only on a subgroup of activated macrophages may go some way 
towards resolving this discrepancy (Bu et al. 2001). 
To test the hypothesis that NG2 is a specific marker of oligodendrocyte progenitors in 
vitro, it was necessary to use multi-labelling techniques. Only three antigens at one 
time could be identified with any security, so careful analysis of identical, parallel 
samples of mixed glia from the same preparation was necessary. 
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NG2 stains type 2 astrocytes. fibroblasts and endothelial cells 
As previously mentioned, NG2 stains a proportion of type 2 astrocytes in cell culture 
in common with A2B5 (Figure 4-2). The role of these cells in vivo has been much 
debated. However it seems increasingly likely that oligodendrocyte progenitors 
develop exclusively into oligodendrocytes in physiological situations (Groves et al. 
1993), although type 2 astrocytes may occur in some pathological situations (Franklin 
& Blakemore 1997). We found that 50% (±0.9%) of type 2 astrocytes seen in vitro 
labelled with NG2, a proportion that accounted for 11 % (±2%) oftota1 NG2+ cell 
numbers at S DIY (Figure 4-4). Very occasionally, cells with the immunophenotype of 
type 1 astrocytes labelled with NG2, but these cells did not have typical type 1 
astrocyte morphology. Most type 1 astrocytes were negative, and the question ofNG2 
labelling of these cells requires further study. 
Fibroblasts occur variably in human glial cultures, and are believed to originate from 
larger blood vessels or contaminating meningeal fragments. Although usually present 
in small numbers, they proliferate rapidly and can quickly overrun the cultures(Figure 
4-13). They are usually identifiable by their distinct flattened morphology, and can be 
stained with antibodies directed against Thy 1, also known as CDw90 (Ante I 2003). 
All of the Thy-l positive cells in these cultures also stained for NG2 (control 
experiments excluded cross-reactivity between the secondary antibodies) (Figure 
4-13). These cells looked very different from the population of clawed or elongated 
NG2+ cells that were described in the last sections, and remain to be positively 
identified. In total Thyl + cells made up 9.1 % (±4.3%) of the total NG2+ popUlation at 
SDIY. 
Endothelial cells, originating from cerebral vasculature grew in small clumps in these 
mixed glial cultures. They were identified by strikingly granular immunofluorescence 
when labelled with antibodies against intracellular von Willebrand's Factor. These 
cells also co-stained for NG2, as previously described (Pouly et a1. 2001). However at 
S DIY only 7.9% of the total NG2+ popUlation were identified as endothelial cells. 
Neurons are not readily grown in primary glial cultures from adult tissue without 
specific growth conditions designed to expand stem cells - and indeed no neuronal 
markers were expressed. However, neurons did appear to arise de novo from aggregate 
cultures as described later. These are believed to represent the products of stem cell 
proliferation and differentiation. Several co-staining experiments were perfonned on 
this culture system (see stem cell chapter), but no co-expression ofNG2 was observed 
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on any cell labelling with I3I11tubuli~ neurofilament or microtubule associated protein 
2 (MAP-2). 
NG2 antibodies bind to a small population of microglia but the staining pattern 
suggests that this is predominantly artefactual 
Microglia are often identifiable in culture on morphological grounds alone. They are 
usually elongatedlbipolar or amoeboid, but have a prominently granular cytoplasm 
which auto fluoresces (AnteI2003). They can also be stained with antibodies directed 
at a number of different surface antigens. These include the common leukocyte antigen 
CD45, CDllb (Akiyama & McGeer 1990) and CDllc (Ante12003;Pouly et al. 1999). 
The latter is present only on activated microglia - but the process of dissociation is 
sufficient to induce this state in previously resting cells. However, live staining 
(required for both CDllb & CDllc, both of which are fonnaldehyde sensitive 
(product data sheet» can be associated with pinocytosis of antibodies - leading to an 
artefactual punctate staining pattern. This can be reduced by incubation at 4°C for 30 
minutes, but small amounts are still sometimes present unless exquisite care is taken in 
cooling both coverslips and antibody solution prior to and during incubation. 
We found this type of punctate, artefactual NG2 staining commonly occurred on 
microglia with less than rigorous adherence to this protocol. However, even when this 
was excluded there was evidence of very weak surface staining, albeit easily 
distinguishable from standard NG2 staining, on a small proportion of cells (Figure 
4-14). Using double labelling, and the most inclusive criteria for detennination of 
positive NG2 staining, microglia made up only 4.90/0 of the total NG2+ population. 
The clawed or elongated population ofNG2 positive cells indicated earlier have a 
bland homogeneous cytoplasm quite unlike those of microglia and never stained for 
microglial markers. 
Does NG2 stain a noyel popUlation of glial cells? 
When the figures discussed above are combined, there is a significant proportion 
(27%) ofNG2+ cells that remain unaccounted for (Figure 4-15). Simultaneous triple 
staining of identical, parallel covers lips enables multiple separate popUlations in a 
mixed culture to be individually assessed, but makes rigorous assessment of an 
unstained population difficult. However, there is much to support the assertion that a 
distinct population ofNG2+ cells falls outside the other known phenotypes. Firstly, 
while unstained, these cells are identifiable on all slides by means of a characteristic 
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morphology. They are flattened, with two or more elongated, process-like extensions 
to their cell bodies. These extensions are unlike the processes of other cells - they are 
wide and flattened, and often have one or more border with a high contrast, arcuate 
edge, which suggests bowing of the membrane between two points of attachment. In 
fact these cells can be easily identified on phase contrast alone, and their 
immunoreactivity to NG2 antibodies (and unreactivity to other antibodies) predicted 
and confinned under fluorescent microscopy. These observations predate the 
systematic assessment by several months, and were confinned (but not quantified) 
several times with all antigens tested. 
Although the expression ofNG2 by several other phenotypes in glial cultures 
undennines the use of this antibody to identify OPC's in vitro, only the weak staining 
of microglia and the staining of a tiny subpopulation of type 1 astrocytes would be 
expected to contribute to the popUlation of cells identified by NG2 in vivo. Endothelial 
cells and fibroblasts are either clearly identifiable in the vessels themselves, or absent 
from the brain parenchyma, so are unlikely to be confused. In addition, the authors of 
the report detailing unexpectedly large numbers ofNG2+ putative oligodendrocyte 
progenitors (Chang et a1. 2000a) assert that they had excluded microglia as a source of 
the NG2 staining. However the contribution made by the, as yet unidentified, clawed 
or elongated cells described above, is of some significance. The authors assert that 
these are oligodendrocyte progenitors. Our findings using a number of 
oligodendrocyte or oligodendrocyte progenitor specific markers do not allow this to be 
substantiated. However, if confinned, this would suggest a much larger population of 
these cells than had previously been identified. There is a pressing need to characterise 
these cells further. 
Magnetic bead separation of A2B5 positive cells yields a population of bipolar NG2-
positive. A2B5-negative cells which proliferate. 
Having concluded from these experiments that there is a popUlation ofNG2+ cells in 
mixed glial cultures that is not easily defined using traditional immunocytological 
methods, it was decided to pursue the assertion that these are cells of the 
oligodendrocyte lineage using alternative techniques. One possible explanation for the 
difficulties encountered in positively identifying these cells is that the traditional 
antigens used for identification are being lost in culture. This hypothesis is difficult to 
test directly with multiple staining at a single time point (as used above). As most cells 
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were being stained after 5 or 8 days in culture (to overcome the problem ofNG2 loss 
during enzymatic dissociation) there could be a change in antigen expression before 
staining was performed. One such change has already been reported - the acquisition 
of GF AP expression by A2B5 cells. It would be equally plausible for cells, initially 
positive for A2B5, to lose surface antigen expression and thus stain negative for this 
antibody. It was decided to pursue this hypothesis further while simultaneously 
addressing the second major hurdle outlined in the introduction - that of isolation and 
purification of oligodendrocyte progenitors. Cells were therefore isolated on the basis 
of A2B5 expression using immuno-magnetic cell selection. 
A series of methodologies was used as successive technical problems were addressed. 
The first protocol sorted cells directly after dissociation as originally described 
(Wright et al. 1997). This maximised the cell count prior to selection, but involved 
selecting cells that may have had some of the A2B5 antigens stripped offby the 
trypsin. Staining CG4 cells immediately after passaging with trypsin suggested that the 
antigen was significantly down-regulated, but returned over 12-24 hours. Paucity of 
A2B5 staining immediately after dissociation of human cells (data not shown) 
suggested that a similar process was occurring in these cultures. This was surprising in 
that the original reports suggested that A2B5 antigens are resistant to trypsin 
(Eisenbarth et al. 1979). In the first protocol, the 20 .... m filter step used for other work 
was omitted because of concerns about cell loss in the apparatus. However this might 
have allowed small, undissociated clumps to pass through into the final suspension. 
The yield was good and the selected cells grew well in the medium, which also 
contained a low concentration of serum (l % FBS) to improve viability. Furthermore 
the cells proliferate under the influence ofFGF2 and PDGFAA. Interestingly, the cells 
adhere better to themselves than to the poly-lysine substrate, so forming small loosely 
attached aggregates. 
At this point two populations could be discriminated on the basis of morphology and 
immunophenotype. One population was made up of large cells with thick long 
processes that formed a complex network. These stained strongly for A2B5 and 
GF AP, and fulfilled traditional morphological descriptions of type 2 astrocytes (RafT 
et al. 1983;Scolding et al. 1995). The second population was made up of small, 
predominantly bipolar cells that dispersed across the surface. Notably these latter cells 
made up the major proportion of the aggregate population. These cells were unifonnly 
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NG2 positive, but, somewhat surprisingly, considering the selection process, they were 
predominantly A2BS negative (Figure 4-16 & Figure 4-17). 
The success of this experiment was encouraging, but the result needed confinnation, 
and two potential loopholes were apparent. The first related to the medium - these cells 
were growing in an environment containing serum, albeit at a low concentration. It 
was decided to try to eliminate this and so remove the uncertainties associated with 
undefined media. In addition, the assertion that aggregates were forming de novo in 
this culture system could be challenged by the absence of adequate initial filtration. 
The second modification, incorporating these two changes, confirmed that A2BS-
selected cells produce two popUlations when grown under the influence of FGF and 
PDGF, even in the absence of serum. These cells showed similar characteristics to 
those grown in the presence of serum, although the yield was substantially smaller. 
Again small aggregates were formed and there was evidence of proliferation in vitro 
from serial observation. The cells forming the aggregates here were convincingly NG2 
positive (Figure 4-18 & Figure 4-19) and the dispersed cells assumed a variety of 
morphologies. 
Of considerable interest was the morphology of the NG2 cells produced in this way. 
Many of these cells were elongated with broad processes, others were flattened with 
multiple clawed, process like extensions. Most of these cells had the characteristic 
arcuate, phase-bright edges that resembled the unidentified NG2+ cells from the 
previous experiments. Furthermore, these cells grew in colonies containing both 
elongated and clawed cells, which suggested that they might be variations of a 
common phenotype, rather than distinct cells. 
This combination of morphology, immunophenotype and presumptive previous 
immunopositivity for A2BS suggests that cells of the population in question had either 
lost A2BS staining, or were progeny of the A2BS positive popUlation. Both 
interpretations indicate that they belong to the oligodendrocyte lineage. Furthermore 
their growth in colonies suggested that these cells might be proliferating in these 
conditions, a provocative observation if it could be proven. 
Cells purified On the basis of A2BS expressioQ incomorate BrDU with appropriate 
mitogens 
During this work, several variants of the basic media, growth factors, and substratum 
were tried in parallel with the above experiments. The attempts to expand primary, 
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unsorted human oligodendrocyte progenitors in defined media with other cells of a 
mixed glial preparation were broadly unfruitful. There were occasional clusters of 3-4 
A2B5+GFAP- cells in the mixed cell cultures, but little else to suggest in vitro 
proliferation. However oligodendrocyte progenitors are inherently motile, so the 
possibility of rapid dispersal of newly formed progenitors was considered. Attempts 
were made to label with BrDU and identify dividing cells, but no convincing evidence 
of cell division was observed. 
However, when the A2B5 positive cell popUlation was magnetically selected out and 
grown at high density, these cells did show signs of proliferation and formed 
aggregates. However this preliminary work had been performed without the filtration 
step and in medium containing small amounts of serum (see above). Furthermore, 
unlike the other cultures which were from temporal lobe samples, these cells were 
derived from cerebellar tissue and this work therefore carried certain caveats as 
outlined above. In addition, these cells were selected immediately following enzymatic 
dissociation when antigen expression would be expected to be low, and to combat this, 
selected cells from the entire sample of brain tissue ( ..... 0.6 ml yielding approximately 
3.6xl06 cells prior to selection) were concentrated onto 4 coverslips. 
Despite the presence of poly-lysine to promote adherence, these cells were observed to 
form partially adherent aggregates with an interconnecting network of elongated 
processes. Subsequent staining demonstrated a mixture of A2B5+GF AP+ cells and a 
large population of bipolar NG2+ cells that did not appear to stain for A2B5. 
However, the latter appeared to be the major components of the aggregates, and when 
dispersed often formed colonies of similar cells, suggesting recent division. 
Serum is known to contain a number of different growth factors, some of which 
remain undefined. Thus any demonstrable proliferation cannot be safely attributed to 
the recombinant growth factors alone. These experiments were confirmed with a 
second sample using both a filtration step, to ensure all aggregates were newly formed, 
and medium free of all traces of serum. Again significant proliferation was seen, and 
similar populations ofNG2+A2B5- cells were identified growing in colonies. 
Unfortunately, attempts to stain for BrDU and NG2 were unsuccessful, so cell 
proliferation could be inferred but not proven. 
Notwithstanding the caveats expressed in the former paragraph, the growth of this 
population of purified cells into aggregates (and adherent colonies) was indicative of 
significant proliferation under these conditions. However cellular yield remained low 
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making analysis problematic, and a final modification to the protocol was introduced 
to address this. A2B5 antigens are known to be lost during enzymatic dissociation - so 
a higher yield might be expected if the selection process was delayed to allow the 
reacquisition of antigens, as proposed by Windrem et al (Windrem et al. 2002). The 
details of this latter protocol also vary slightly from that used in earlier attempts (see 
methods section). 
Rather surprisingly this yielded substantially fewer cells than before. This could not be 
easily attributed to poor survival during the initial dissociation, as the cell yield after 
dissociation was roughly comparable. Furthermore those cells that survi\"ed had a 
rather different morphology to the cells grown after immediate dissociation. These 
cells were much closer to the traditional description of oligodendrocyte progenitors 
growing in vitro - they had mostly one to three narrow processes (often quite long) 
and a rounded soma. Interestingly, the presence of magnetic beads, while obscuring 
the view under phase contrast, did suggest considerable motility of some of these cells 
- many of which had cleared a bead-free halo off their neighbourhood. In addition 
some pairs of cells became evident, which was suggestive of cell division. 
To confirm proliferation the cells were incubated with bromodeoxyuridine (BrDU) for 
24hours. Technical difficulties with the use of certain surface stains and BrDU 
prevented adequate demonstration ofNG2 co-staining with BrDU, but PDGFaR 
staining was reliable in this situation. PDGFaR+ cells could be demonstrated to 




The presence of oligodendrocyte progenitors in the adult human brain has been well 
demonstrated (Roy et a1. 1999;Scolding et a1. 1995;Windrem et a1. 2002), but the 
range of different putative markers to identify these has lead to discrepancies in these 
findings. Are these different markers equally valid? Issues of antigen sensitivity and 
specificity have implications for cellular identity that are of more than just academic 
interest. Are oligodendrocyte progenitors rare, as originally suggested (Scolding et al. 
1998), or one of the more abundant cells of the adult nervous system (Chang et al. 
2000b)? The answer to these questions will have important implications for 
therapeutic remyelination strategies. This work helps to clarify certain points and 
identifies questions for future studies. 
From this work, NG2 appears neither to be a sensitive marker, nor a specific marker 
for oligodendrocyte progenitors growing in vitro. Provisional results suggest it labels 
under a third of these cells, as defined by traditional markers, while also staining 
astrocytes (both "type 2" and possibly occasional "type 1 "), endothelial cells and 
fibroblasts. It stains microglia only very weakly, but with less than rigorous 
methodology, can identify large numbers of these phagocytes. Furthermore, there is 
evidence ofNG2 expression earlier in the oligodendrocyte lineage than A2B5, 
although this, and the relationship between PDGFaR and NG2, requires further work. 
In addition, NG2 appears to identify a novel population of cells in these cultures that 
are also prevalent in a population magnetically selected for A2B5 expression. The 
identity of these cells warrants further discussion. Finally there is evidence that 
purified A2B5+ cells do proliferate in serum-free medium under the influence of 
mitogens predicted by rodent work. 
In vitro work has contributed a wealth of data towards our understanding of the 
biology of neural and glial lineages, but in vivo confirmation of these findings and 
further exploration of progenitor biology in situ has been complicated by the difficulty 
of reliably identifying precursors. NG2 proteoglycan has previously been shown to be 
a useful marker for oligodendrocyte progenitors in the developing rat in vitro (Stallcup 
& Beasley 1987) and ex vivo (Nishiyama et a1. 1996a;Ong & Levine 1999). However, 
the staining characteristics of adult rodent oligodendrocyte progenitors differ from 
those of neonatal progenitors (Ffrench-Constant & Raff 1986;Wolswijk et al. 
1991a;Wolswijk & Noble 1989). In addition, adult human oligodendrocyte progenitors 
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have been reported as differing from their adult rodent counterparts, particularly in 
their absence of nestin or vimentin expression (Armstrong et al. 1992;Ffrench-
Constant & Raff 1986;Scolding et al. 1995;Wolswijk & Noble 1989) and their failure 
to divide with mitogens which would cause significant expansion of their rodent 
counterparts (Scolding et al. 1995). Despite these differences, we show here that the 
NG2 proteoglycan is expressed by some cultured cells of the adult human 
oligodendrocyte lineage, including a proportion of both A2B5+ve precursors and 
A2B5/GF AP co-positive ("type 2") astrocytes. 
The finding that some adult human oligodendrocyte progenitors exhibit cell surface 
expression of the chondroitin sulphate proteoglycan NG2 provides further illustration 
of the important biological similarities between these cells and their neonatal rodent 
counterparts (Figure 1-5). They also share a common bipolar morphology, A2B5+ve 
GF AP-/GaIC- immunophenotype, capacity for differentiation in vitro into either 
oligodendrocytes or A2B5/GF AP copositive (or "type 2") astrocytes, and proliferative 
activity stimulated by syngeneic astrocytes (Scolding et al. 1995). However the 
significant lack of specificity, and the limitations of sensitivity evident from our 
observations concerning NG2 challenges the exploitation ofNG2 expression as a 
marker of adult human oligodendrocyte progenitor cells in tissue sections. It should be 
emphasised that considerable caution must be exercised in this respect. 
Initial studies ofNG2 showed expression not only by cultured rat oligodendrocyte 
progenitors but, significantly, also by A2B5/GF AP copositive type 2 astrocytes 
(Stallcup & Beasley 1987), so that the similar positive staining of human A2B5/GFAP 
copositive astrocytes by anti-NG2 antibodies is not unexpected. It is therefore apparent 
that NG2+ve cells in tissue sections of rat or human origin must be clearly shown not 
to be astrocytes before it can be concluded that they are indeed oligodendrocyte 
progenitors. This is particularly true when the injured CNS is studied, since it is in 
response to injury that the type 2 astrocyte is proposed to arise (Franklin & Blakemore 
1997); other researchers have also demonstrated the presence of A2B5/GF AP co-
positive astrocytes (using tissue print preparations) in the human eNS (Scolding et al. 
1999). 
Generally, studies using anti-NG2 antibodies to identify progenitors have addressed 
this difficulty using GF AP antibodies to exclude an astrocyte identity of NG2 positive 
cells (Keirstead et al. 1998). It is important to recall, however, that, with 
immunocytochemical techniques, the majority of astrocytes in the nonnal rodent and 
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the normal human CNS are GFAP-negative (Eddleston & Mucke 1993). Therefore, 
ultrastructural investigation might helpfully supplement the use of anti-NG2-based 
immunocytochemistry as a tool for identifying progenitors in studies of normal CNS 
tissue. Furthermore, since GF AP-reactivity has not been confirmed as an inevitable 
consequence of astrocyte reactivity (Eddleston & Mucke 1993) - reactive gliosis can 
occur in the absence of GF AP (Pekny et al. 1995), and GF AP expression can acutely 
diminish during, for example, viral infection (Kennedy & Fok-Seang 1986) - caution 
might also be advisable when using NG2 as a progenitor marker in the injured or 
inflamed CNS. 
This work also confirms the previous observations that cerebral endothelial cells 
express NG2. These too need to be excluded from any analysis of progenitors in tissue 
slices although their very characteristic location is unlikely to cause confusion for the 
careful observer. 
The current observations on microglia may go some way to explaining the discrepancy 
between various reports ofNG2 expression in this cell type (Chang et al. 2000a;Pouly 
et al. 1999). The pino/phagocytotic properties of these cells are well known, but it is 
widely assumed that this can be adequately inhibited by temperature alone. As 
demonstrated, this may not be as secure as is often believed, causing particular 
problems when cells are analysed electronically rather than visually. (NB this artefact 
is caused by viable cells and so will not confound fixed tissue section work). 
Furthermore the diffuse, low intensity NG2 staining seen on a small proportion of 
these cells may not be explained on this basis alone. It should be re-emphasised that 
this staining is of a magnitude unlikely to cause confusion when compared directly 
with the expression seen on oligodendrocyte progenitors. 
An important observation from this work is the presence of significant numbers of 
NG2 positive cells that have defied traditional immunocytochemical identification. 
Various hypotheses as to their identity were proposed and have, in part, been tested. 
Firstly, the population does appear to be identifiable, consistent and real. Fluorescent 
immunocytochemistry may limit the number of antigens identified on one coverslip, 
but it has a number of significant advantages over other techniques. Most prominent 
among these are the ability to scrutinise each cell for structure and morphology, 
expression of three separate antigens independently and the distribution of these 
antigens (and hence fluorescence) on the cells. These attributes allow this population 
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to be identified purely on the basis of morphology and NG2 staining pattern - it seems 
unlikely therefore that they are a phantom population resulting from cumulative 
random error during popUlation analysis [Figure 4-15]. (However these considerations 
must be taken into account before attempting to estimate the size of the novel NG2 
popUlation, and the experiment needs repeating). It has been provisionally concluded 
that these cells are not microglia, endothelial cells, astrocytes or fibroblasts, but rather 
a novel popUlation expressing none of the markers of the above cells. 
Secondly it was hypothesised that they belonged to the oligodendrocyte lineage - but 
at a different stage in development to the A2B5 positive cells. When a single 
quantitative analysis of morphology was performed, it suggested that the A2B5+ cells 
and the NG2+ A2B5- cells were morphologically dissimilar and the latter group not 
easily classified because of their flattened, broad-based processes. Might this 
difference be a manifestation of the physiological role ofNG2? The NG2 molecule is 
known to be involved with cell motility (Diers-Fenger et a1. 2001;Niehaus et al. 1999), 
playing a central role in the processes of adhesion and release (Stallcup & Dahlin-
Huppe 2001). The characteristic morphology may be more than just an unrelated 
characteristic ofNG2+ cells -NG2 expression may itself be influencing the 
morphology in vitro. 
However, the central question of identity remains. Is NG2 staining cells at a different 
stage of the oligodendrocyte lineage? The lack of A2B5, nestin or 04 staining for 
most of this population does appear to refute this suggestion, but the presumption on 
which this argument is based is not watertight. All these antigens were originally 
characterised in the rodent (Raff et a1. 1983 ;Reynolds & Weiss 1992; Warrington et a1. 
1992), and although they have since been demonstrated in adult human work 
(Armstrong et a1. 1992;Johansson et a1. 1999;Scolding et a1. 1995), the assumption that 
human cells have the same highly reproducible and strictly regulated pattern of 
expression has not been unequivocally demonstrated. There may therefore exist stages 
between Nestin, A2B5 or 04 where human oligodendrocyte lineage cells express none 
of these antigens. Having said this, both the demonstration of A2B5+Nestin+ cells 
described here, and A2B5+GalC+ cells described previously (Scolding et a1. 1995) 
limit potential gaps to a subpopulation of cells, and depend on a degree of variation 
between cells, which while credible, has not been demonstrated. Alternatively, these 
antigens may be lost in culture. Cells can lose antigens from their surface when they 
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become cross-linked or clustered. Might this process occur in these cultures - often 
containing traces of debris from the original dissociation? 
Addressing this question by the use of immuno-magnetic selection immediately 
following dissociation may go some way to answering this. It appears likely from 
these experiments that the morphologically distinct NG2+ A2BS- cells are abundant in 
a popUlation that originally expressed A2BS antigens. If so, several possibilities 
remain. It seems unlikely that they were a contaminant of the immuno-magnetic 
sorting process as few other cell types were seen in these cultures. They may express 
these antigens but at a level too low to be identified by fluorescent 
immunocytochemistry but one sufficient to be selected by immuno-magnetic methods. 
As mentioned, few cells were unequivocally A2BS+ by immunocytochemistry 
immediately after enzymatic treatment, yet magnetic separation was effective at 
isolating cells at this stage into a population that contained only two types of cell- the 
"type 2" astrocyte and the NG2+ A2BS- cells, so this hypothesis is plausible. The latter 
cells may have lost A2BS antigens by endocytosis of aggregated surface molecules, 
perhaps as a consequence of cross-linkage by free antibody in the magnetic selection 
process. Alternatively, free A2BS antibody may be released from the beads in a form 
not recognised by the anti-mouse IgM- fluorescent marker and so block ganglioside 
epitopes. These might explain the paucity of A2BS+GF AP- cells in these cultures 
(observed but not quantified), yet the "type 2" astrocytes retain strong surface staining 
in the same milieu. If these NG2+A2BS- cells are oligodendrocyte progenitors that 
have lost their A2BS staining because of the selection process, do they retain the other 
properties of oligodendrocyte progenitors? Why do these cells not re-express these 
antigens while A2BS+GF AP+ cells in mixed culture do after enzymatic loss? If the 
NG2+/-A2BS+ and NG2+A2BS- populations are otherwise identical, why are the 
latter cells so flattened when compared to putative progenitors in unselected cultures 
(Figure 4-19)? 
An intriguing possibility is that these two cell types may represent different pathways 
within the oligodendrocyte lineage (Spassky et aI. 2000). There is some evidence that 
separate populations of putative oligodendrocyte progenitors exist in the developing 
chick, rodent (Fu et aI. 2002) and human (Rakic & Zecevic 2003). It is not clear 
however whether these are alternative stages within the lineage, or represent an 
entirely separate differentiation pathway. This might help to square the discrepancies 
between various reports of the percentage of oligodendrocyte progenitors in adult 
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human brain depending on the marker used. NG2 may be labelling a separate or 
additional population of oligodendrocyte lineage cells not identified by other antigens. 
The caveat pertaining to its use as a marker of oligodendrocyte progenitors in tissue 
sections remains. 
None of these questions can be answered without further study. However the 
observation that this cell type appears to proliferate under these conditions suggests a 
final, plausible explanation. Antigen loss in a dividing population is a well-recognised 
in vitro phenomenon (Louis et a1. 1992). It may become apparent that dividing human 
progenitors in vitro do lose A2B5 reactivity while maintaining NG2 expression, a 
hypothesis that would have far-reaching consequences if proved. Furthermore, the 
presence of cell division in these cultures itselfhas enormous implications. If this 
expansion can be extended, and there is much to suggest that it could (eg presence of 
aggregates), then the foremost problem outlined in the introduction would have been 
solved. Isolation of human progenitors from adult human brain could then be followed 
by immuno-magnetic selection and in vitro expansion as described. Cell numbers from 
the partial aggregate cultures already approach those required for systematic 
assessment of cellular biology (proliferation, differentiation & migration) and may in 
time yield a source sufficient for therapeutic purposes. 
Future work 
The above studies are ongoing and this work needs confirming by repetition. Antigen 
expression and cellular morphology are important means with which cells can be 
identified and followed, but they remain surrogates. A cell is ultimately defined by its 
physiological role, and for oligodendrocytes this means the demonstration of compact, 
functional myelin formation and axonal support. However, many experiments are 
anticipated prior to this. Rodent and human oligodendrocytes express a sequence of 
myelin proteins during development, and the demonstration of some of these together 
with the expected morphological changes will support their claimed identity. Co-
culture experiments in the presence of human neuronal cell lines could be used for 
myelination studies, which would likely culminate in transplantation studies. 
The hypotheses proposed above to explain the observed behaviour require testing, and 
the more significant results need repeating. Furthermore, it might prove important to 
ascertain whether these cells can be obtained from other parts of the brain, and 
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whether origin affects behaviour in vitro. The progeny and differentiation capacity of 
dividing NG2 cells and traditionally defined A2B5+GF AP- progenitors needs 
clarifying as does the role of the persistently enigmatic A2B5+GF AP+ "type 2" 
astrocyte. The results of these experiments are eagerly anticipated. 
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Illustrations 
Figure 4-1 Some bipolar cells growing in culture stained for both A2B5 red and G2 
(green) (bar = lO)lm) 
Figure 4-2 Two astrocytic cells can be identified in culture. Type 1 astrocyte (hollow 
arrow) , which have a fibroblast-like morphology and express GF AP (blue), and type 2 
astrocytes (solid arrow), which are often large cells with long processes, and express both 
GF AP and A2B5 antigens (red) (Scale bar = 20)lm) 
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F igure 4-3 Proportion of G2 cell ta ining for OP fa trocyte anti n of a In I 
representative experiment at 5 DIY . [102 G2 cell identified from a population of > 1 
cell s on one coverslip] 
• GFAP A2BS-
o GFAP+ A2BS+ 
• GFAP- A2BS+ 
o GFAP- A2BS-
Figure 4-4 Proportion ofNG2+ ce ll taining for OP fa trocyte anti g n ofa in I 
representative xpeli ment at 8 DIY [102 NG2+ cell s identi fi ed from a popu lation of > 1 000 
ce ll s on one cover lip] 
.A2B5- GFAP+ I 
DA2B5+ GFAP-
1. A2B5+ GFAP+ 
DA2B5- GFAP-
'e I II 
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Figure 4-5 Paired comparison bet een A2B5 2 and PDGFa R pIon In t 
morphology suggest a di screet populatIOn of adherent G2 cell ith elon at d r r \' r" -
scalloped/clawed morphology [ omprehen i e analysi of all antigen i ph notyp xpr 
on a single coverslip : 989 cells analy ed immunophenotype and morphology of 106 lab II d 
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Figure 4-6 PDGFaR, G2 and A2BS antigen are expre ed on an overlappin 
population of cells [Repre entative analy i of a ingle co er lip - lmmunoph no 'P f I 
cells out of a population of 989 recorded] 
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Figure 4-8 Acquisition of antigen marker and morphological omple It)' 










Figure 4-9 Morphology of various immunophenotypes of putati e OPCs 
[lmmunophenotype of245 cell s recorded from a single representati e co erslip of 
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Figure 4-10 Proportion of total cell numbers staining" ith earl glial mark r [1 19 
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Figure 4-11 Proportion ofNG2+ cells staining for nestin and A2B5 on a single 
representative sample at 5 DIY [72 NG2+ cells counted from one coverslip of 1819 
cells] 
A2BS+ Nestin -
A2BS+ Nestin + 
• A2BS - Nestin+ 
o A2BS- Nestin -
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Figure 4-12 A number of G2+ cells had a distincti e flattened appearan e "th", "den 
processes, and did not stain for other glial antigens" G2 - FITC (green) Bar = 1 O~m)" om 
of these had fairly complex morphology that resemble oligodendrocyte lineage ell but 
retained characteristics features such as flattened, closely adherent processes and arcuate 
borders (lower images) 
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Figure 4-13 Fibroblasts in an adheren t monolayer stain strongly with G2 green but 
overlying microglia, identified by CD 11 b (red), show only yellow autofluore cen e (Bar 
=20Ilm). 
Figure 4-14 Microglia, stained with CDl1 b (red) occasionally stain very weakly for NG2 
(green) digitally enhanced image (Bar = IOllm) 
U l II 
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Figure 4-1 5 Identi ty of the 2 po iti e population in mixed glial pr pIon 
[Composite graph showing cumulati e percentage from multiple anal e on 
coverslips) of a single human primary gl ial preparation] 
10% 
OA2BS+ OPCs 
.. Type 1 Astrocytes 
• Type 2 Astrocytes 
• Nestin+ A2BS- "Stem Cells" 
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Figure 4-16 Cells separated by their expression of A2BS antigen ing magn n b 
develop into A2BS+(red) GFAP+(blue) type 2 astrocytes and a number of mall bipolar 
NG2+(green) cells (solid arrows) which appear to gro in clump and ha e mo tl 10 t 
antigens. A few magnetic beads remain attached to the astrocytic cell bodie holl m arrow 
but not to the bipolar cell s. (Scale bar = 20)lm) 
Figure 4-17 The same population of cells (A2BS , red & GF AP, blue) do not xpre 
neuronal antigens (tJllltubulin, green) (Scale bar = 20)lm) 
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Figure 4-18 Cells selected for A2B5 using magnetic beads and expanded with 
mitogens. NG2 staining bipolar and clawed cells are isible, but oni type 2 tro 
retain A2B5 expression in this culture system 
Pu Ie.: 1_ ) 
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Figure 4-19 These cells stained with G2 green are morpho logi all div r ,an r 
from elongated unipolar and bipolar cells with wide flattened pro e e to mor ompl x 
morphologies with the characteristic feature of flattened adherent pro e e and ar 
phase bright edges (bar = 1 0 ~m) 
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Figure 4-20 Dissociated cells selected for A2B5 expression and grown in FGF, 
PDGF and NT-3 express the PDGFuReceptor (green) and incorporate BrDU (red). 
(scale bar = 10~m) 
Figure 4-21 A2B5 positive cells selected out by magnetic beads, grow on poly-D-lysine 
and vitronectin, and develop 1-3 thin processes. They express both the PDGFuReceptor 
(green) and Vimentin (red). 
Page 122 
Remyelination Biology 
Chapter 5. Neural Stem Cells as a Source of Human Glial 
Progenitors 
Introduction 
Attempts to immortalise human progenitor cells artificially were discussed in Chapter 
2. The possibilities of expanding committed progenitors to provide large numbers of 
these cells, or inducing dedifferentiation to produce less committed (and hence more 
proliferative) cells was described in Chapters 3 and 4. Here the tactic of obtaining 
neural stem cells directly from adult CNS tissue is explored. 
Stem cells possess an intrinsic ability to produce a huge number of daughter cells, and 
as such hold significant promise as a solution to the problem of obtaining sufficient 
cell numbers for systematic experimentation and ultimately therapeutic remyelination. 
They do this, at least in part, by dividing asymmetrically, so producing both an 
identical copy of themselves and a more committed progenitor. Their other properties 
are also of great interest to the neuroscientist. They are by definition pluripotential, 
and can act as a source of any cell intrinsic to (or required for) the mature organ from 
which they were derived (in the case of neural stem cells; astrocytes, oligodendrocytes 
and neurons). Furthermore, the property of asymmetrical division offers the potential 
for maintaining a stock of precursor cells with essentially the same pedigree - of great 
value in research paradigms. 
In addition, stem cells have great therapeutic potential. Rodent embryonic stem cells 
possess significant remyelinating potential (Brustle et al. 1999), but their equivalent 
human sources - aborted foetuses or embryos surplus to IVF requirements - are not 
easy to access. It is commonly suggested that stem cells from embryos cloned for the 
purpose (by cell nuclear transfer) from the patient needing an implant, as recently 
legalised uniquely in the UK, would have the huge advantage of avoiding rejection. 
However, the proposal that every patient requiring a transplant would first have to be 
cloned seems quite unrealistic, and the serious ethical and practical difficulties 
pertaining to all sources of human embryonic stem cells have stimulated the largely 
successful search for alternative sources (Scolding 2001). It is now clear that neural 
stem cells are also present in the adult rodent brain (Weiss et al. 1996) and large 
numbers of rodent oligodendrocyte lineage cells can be generated using 
neurosphereloligosphere techniques (Avellana-Adalid et al. 1996;Rogister et al. 
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1999;Vitry et a1. 1999;Zhang et a1. 1998b;Zhang et al. 1998a;Zhang et a1. 2000), and 
these, upon transplantation, successfully remyelinate axons (Zhang et at. 1999). It has 
been reported that neural stem cells are also present in the adult human brain 
(Johansson et a1. 1999;Kukekov et a1. 1999) and cells with many of these properties 
(albeit derived from tumour surgery specimens) produce peripheral myelin following 
transplantation (Akiyama et at. 2001a). This is in contrast to reports from other 
mammalian systems where prior commitment to the oligodendrocyte lineage was a 
prerequisite of successful myelin fannatian (Smith & Blakemore 2000). 
We hypothesised that the adult human brain does indeed contain neural stem cells. 
Secondly, we proposed that stem cells from adult human brain, mitogenically 
expanded in vitro, could differentiate into oligodendrocyte lineage cells, and could 
ultimately be used as a source of cells for remyelination therapies. 
In testing these hypotheses we anticipated that the first evidence of adult neural stem 
cells might be the appearance of free-floating spherical bodies in these cultures. Most 
reports of mammalian neural stem cells growing in culture describe the formation of 
enlarging aggregates, sometimes termed neurospheres (Chiang et a1. 1996;Milward et 
at. 1997;Mokry et at. 1996;Weiss et al. 1996). While not exclusively seen with stem 
cells (primitive oligodendrocyte progenitors have been reported as growing in 
"oIigospheres" (AveIIana-Adalid et a!. 1996;Decker et al. 2000;Vitry et at. 
1999;Zhang et at. 1998b;Zhang et at. 1998a» the demonstration of aggregate 
formation would be suggestive of their presence. 
If sphere formation could be demonstrated, the next aim would be the demonstration 
of continued propagation in culture driven by mitogens reported to be pertinent to 
stem cell growth, such as EGF (Reynolds & Weiss 1996) and FGF2 (Kalyani et al. 
1999). Stem ceIIs have a notable replicative potential, not least by reason of their 
asymmetric division. Thus they would be expected to continue to expand under the 
influence of appropriate mitogens, and the production of appreciable numbers of cells 
from a limited source should be demonstrable. 
Thirdly, mitogen-expanded adult human neural stem cells growing in spheres would 
be expected to stain for primitive neural antigens. Vimentin, an intermediate filament 
protein, is expressed by a number of primitive neural lineages, and distinguishes 
neonatal from adult rodent oligodendrocyte progenitors (it is only expressed by the 
fonner) (Wolswijk & Noble 1989). S100, a protein associated with intennediate 
filaments, appears to be expressed by immature astrocytes as well as labelling 
Page 124 
Rcmyelination Biology 
Schwann cells. These antigens are expressed widely amongst primitive cells of various 
lineages (Richter-Landsberg & Heinrich 1995). Another intermediate filament protein 
of great interest is nestin, which is expressed in neuro-epithelial stem cells (Re)l1olds 
et al. 1992;Tohyama et al. 1992). This protein was also expressed in some of the 
earliest descriptions of stem cells derived from embryonic rodents and grown in 
culture (Reynolds et al. 1992). Furthermore, cells selected for high expression of this 
protein appear to be multipotent and sphere forming (Kawaguchi et al. 2001). \\Thile 
not all authorities agree as to immunophenotype of the resting, and hence possibly 
rather rare, adult neural stem cell (Doetsch et al. 1999;Morshead et al. 1994) reports of 
neural stem cells growing as spheres usually report nestin expression (Johansson et al. 
1999;Reynolds et al. 1992), with occasional exceptions (Kukekov et al. 1997). 
Fourthly, individual spheres formed by true neural stem cells would be expected to 
give rise to cells of all three neural lineages. In particular, the demonstration of cells 
bearing neuronal antigens would have particular significance, as adult neurones are not 
expected to survive the dissociation procedure. 
Unequivocal demonstration of neural stem cells requires rigorous clonal analysis. 
While this is undoubtedly desirable, it is time consuming and is not a direct 
prerequisite of a potential cell source for therapeutic remyelination. Of considerably 
more pertinence to this cause is the demonstration of successful commitment to the 
oligodendrocyte lineage. The demonstration of functional remyelination following 
transplantation would be a long-tenn goal. 
Remyelination Biology 
Methods 
Adult human stem cell cultures 
Several methods were employed for dissociating stem cells from surgical specimens. 
Many of these were based on the protocol used for human oligodendrocyte precursor 
culture (Armstrong et a1. 1992) with certain modifications (vide infra). However other 
protocols were used in the early stages of this work, including that used by Kukekov et 
al in their work on human and murine stem cells (Kukekov et a1. 1997;Kukekov et al. 
1999). The latter will be described briefly, but the yield was so poor that it was not 
pursued further. 
Most human tissue was provided from temporal lobe resections for intractable 
epilepsy. (It is worth re ... emphasising that comparable tissue, dissected from sites 
distant from the epileptic focus, was histologically nonna! (Scolding et a1. 1995». 
Occasional samples from frontal lobe tissue were made available during the early 
stages, while significant changes to the methodology were underway. The yield from 
these was poor - although it is unclear whether this was due to methodological 
variations in the dissociation protocols, surgical factors or due to intrinsic differences 
in the tissue itself. 
All patients gave their consent for resected tissue to be used for research purposes, and 
ethics approval was obtained from both local and regional ethics committees. Tissue 
was transported to the laboratory at 4°C in Hibernation medium (Hibemate™ A, 
BrainBits, Southern Illinois University) supplemented with penicillin / streptomycin / 
fungi zone 1 % (Invitrogen). Tissue was processed between I and 12 hours post 
resection. 
Dissociation 
Tissue was placed under a tissue culture hood, and meninges and large blood vessels 
were resected. The tissue was then minced with a scalpel and digested. Tissue was 
incubated at 37°C for 20 minutes in 5 ml Enzyme solution 1 (containing MEM (Sigma 
M7278), O.116mg/ml trypsin (Sigma T4424), O.I84mg/ml collagenase III (Lome LS 
4208) & 18.4Jlglml DNAsellv (Sigma D5025». The mixture was then centrifuged at 
200g for 5 minutes, the supernatant replaced with a further 5ml enz}me solution I and 
incubated for a further 20minutes. Following centrifugation the supernatant was then 
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replaced with Sml enzyme solution 2 (containing MEM, trypsin-EDT A (Sigma 
T3924) 23 & 9.2~glml respectively, 0.184mg/ml collagenase III & 18.4Jlglml 
DNAseIIV) for 15 minutes at 37°C and centrifuged. Finally the supernatant was 
replaced with 1m! of enzyme solution 3 (containing MEM, 2.4mglml trypsin inhibitor 
(Sigma T6522), 1.9 J.lg/ml DNAseIlv, 1.6mglml bovine serum albumin (Sigma A4919) 
and 5% heat inactivated fetal bovine serum (Sigma F4135» and triturated three times 
through 21 gauge and 23 gauge needles. 
Trituration and Filtration 
The original protocol favoured the use of three needles, 21, 23 and 25 gauge 
respectively and three triturations through each needle. Careful assessment of cell 
numbers and viability using differential nuclear staining with Hoechst and propidium 
iodide dyes (see below) showed that the increase in total cell numbers released by the 
final 25 gauge trituration was accompanied by a net fall in the viable cell yield. Again 
this was omitted from the later preparations. 
To identify free-floating aggregates required the certain removal of clumps of 
undissociated brain tissue. This required a filtration step. Two filters were used, a 
40Jlm stainless steel mesh and a 20Jlm nylon mesh, both housed in a Natgene filter 
(Millipore, UK). During the early demonstration of aggregate culture, both were used 
sequentially. However, once confirmed that these cells were reliably growing from 
fully dissociated cultures, the 20~m mesh was omitted, as this resulted in a significant 
drop in cell yield. Following trituration, the mixture containing cells, debris and 
enzyme solution 3 was passed through the filter and flushed with 20mllO% Fes in 
DMEM. 
Gradient Centrifugation for Myelin Removal 
Various options were tried for removal of myelin debris. This included the sucrose 
gradient centrifugation step used by Johansson et al in their early demonstration of 
adult human neural stem cells (Johansson et al. 1999), which was partly successful, 
although a large number of cells were lost. OptiprepTM was found to be more 
successful and a final concentration of 9% was detennined as optimal. This was used 
for all the later preparations. 
The (filtered) cell mixture was spun down and the supernatant aspirated to near 
dryness. The cells were then resuspended with 9%Optiprep in DMEM and spun at 
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2200rpm for 20 minutes. This fonned a surface layer of myelin debris, which was 
easily aspirated off, a supernatant containing mostly cell debris and few viable cells, 
which was also removed, and a bottom pellet of cells and red blood corpuscles. The 
latter rarely interfered with the cultures or cell identification so no further methods for 
their removal were applied. 
Alternative Dissociation Protocol (Kukekov et al. 1999) 
Prepared and minced tissue (vide supra) was washed by adding 10 ml medium 
(DMEM with 1 % PSF) and spinning down at 800 rpm for 5 minutes. Tissue fragments 
were resuspended and 5 ml 0.25% trypsin solution with EDT A was added. This was 
warmed in the hand, while gently aspirating and expelling through a 5 ml plastic 
pipette, to avoid the exuded DNA sticking the cells together. This process was 
continued until the supernatant was cloudy with cells, and the majority of the clumps 
were dispersed. The solution was then filtered through sterile gauze, prepared in a 
glass funnel. Viable cells were counted by Trypan blue exclusion in a 
haemocytometer. The remaining cells were centrifuged at 1000 rpm for 5 minutes and 
resuspended in DMEMlF12 with N2 supplements, FGF2 and EGF at double strength, 
with a final cell concentration not exceeding 100,000 cells per ml (minimum 6ml). 
This was then added to a 2% solution ofmethy1cellulose (Sigma) in DMEMlF12 
prepared beforehand, and mixed by adding to the top, and sucking from the bottom. 
2ml of the resulting viscous solution was plated out into each well of a 6-well plate 
pre-coated with Poly HEMA anti-adhesive (see below) and incubated at 37°C in 7%, 
C02. 
In this protocol, 50 ).11 of a 40x solution of growth factors were added twice a week to 
each well. 
Performing a Cell Count 
Two methods were used. Trypan blue exclusion, using a 1: 10 dilution of cell 
suspension in the dye was ideal for counting cells where there was little debris and few 
red cells. Dead cells and debris clumps are unable to exclude the dye and become 
stained dark blue, enabling them to be distinguished from the phase bright viable cell 
population. Hoechst and propidium iodide, both used at a final concentration of 
10).1g1ml, enabled both dead cells and viable cells to be independently counted despite 
considerable debris. Hoechst 33258 is permeant, so both viable and dead cells 
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fluoresce blue under UV light. Propidium iodide, which is impenneant, only labels 
cells with disrupted membranes, which fluoresce pink, a colour which overrides that of 
hoechst when visualised on the IX-70 immunofluorescent microscope. Glasstic™ 
counting chambers were used during cell dissociations as they facilitated the rapid 
assessment of sequential samples. 
Coating Covers lips with Polylysine and Vitroneetin 
13mm diameter glass coverslips were added to 100% Methanol in a 50 ml Falcon 
tube, mixed thoroughly and left to stand overnight. The coverslips were then removed 
and layered between filter paper in a glass Petri dish, autoclaved and dried. They were 
then tipped into a O.1mg/ml solution ofpolY-D-lysine, made freshly with sterile 
ddH20, in a Petri dish, mixed and left to stand for 1 hour. The coverslips were then 
removed individually, washed twice in sterilised ddH20, and then leaned up against 
the side of each well in a 24-well plate. Any extra water was aspirated using a Pasteur 
pipette and a fine Gilson tip. The plates were then left overnight to dry. 
Coverslips were either used with polylysine alone, or with another biologically active 
substrate in addition. 200J,l1 of 1 J.lglml vitronectin solution in ddH20 was added to the 
centre of each polylysine coated coverslip and allowed to dry in situ. 
Coating Flasks with Poly-HEMATM 
Stem/progenitor cells are anchorage independent, and growing these cells in 
suspension selects them out from more differentiated cells. This can be achieved by 
using an anti-adhesive substrate such as Poly(2-hydroxyethyl methacrylate) ... poly-
HEMA TM(Sigma, UK). 
A stock solution of Poly HEMATM was prepared by dissolving the product in 95% 
ethanol at 120mglml with vigorous shaking and overnight incubation at 37°C. 
Undissolved product was removed by centrifugation at 2500rpm for 30 minutes. 
Further dilutions of stock solution with 95% ethanol were occasionally used to 
produce coatings of various thickness - the greater the thickness, the greater the 
inhibition of attachment. Flasks were coated with 0.1 mllcm2 of surface, and allow to 
air dry in a sterile environment for several days. 
B 104 Conditioned Medium for Human Stem Cells 
BI04 cells were grown on uncoated tissue culture plastic in 10% FCS in DMEM (vide 
infra), and passaged 1: 1 0 approximately every 4 days. When approximately 70% 
Page 129 
Remyelination Biology 
confluent, the medium was aspirated to dryness and cells were washed twice in Hank's 
balanced salt solution. This was then replaced with NSA-N2 with insulin and 2mM 
glutamine, and the incubation was continued for 3 days. The supernatant was then 
harvested, spun at 5500rpm for 1 hour, passed through a O.4f.1m filter and frozen at -
20°C until required. 
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The optimised solutions used in the final preparations were as follows:-
NSA-N2 based "stem cell mix" to make 50ml 
NS-A medium [Euroclone] 
N2 supplement [Gibco] 
L-Glutamine (200mM stock) 
Insulin (10mg/ml) 
EGF (200!J.g/ml stock) 
FGF2 (lOO!J.g/ml stock) 
LIF (lO!J.g/ml) 
NSA-N2 based "OPC mix" 
NS-A medium [Euroclone] 
N2 supplement [Gibco] 
L-Glutamine (200mM stock) 
Insulin (lOmg/ml) 
PDGFAA (lOO!J.g/ml) 
FGF2 (1 OO!J.g/ml stock) 















10% FCS in Sigma DMEM to make 200ml:-
DMEM (Sigma 6546) 
L-Glutamine (final conc. 2mM) 






2x stock solution of Propidium Iodide and Hoechst 
Hoechst 33258 (1 OOmg/ml) 
Propidium Iodide (lmg/ml) 








2 mM (292mg ml) 
20 (total 25pg ml) 




(DMEM F 12+6%g1uc) 
1 % 
2 mM (292mg; ml) 






Dissociated cells from adult human brain can grow as aggregates in culture. 
The aim of the initial stage of this study was to confirm whether aggregate cultures 
could be grown from adult human neural cells. The starting points for this 
investigation were the reports of neural stem cells in cultures from the adult human 
brain (Johansson et al. 1999;Kukekov et al. 1999). The conditions used in these studies 
were reproduced as far as possible, building on the experience of mixed glial 
preparations used in this laboratory. erude cell preparations were then grown in the 
presence ofEGF, FGF2 and high insulin concentrations (Mozell & McMorris 1991) in 
uncoated tissue culture flasks. 
This technique did produce small aggregates of cells that appeared to grow slowly 
over the course of several weeks. First visible as small irregular groups of 4-8 cells, 
these grew to form a spherical body with a phase dark centre after about 1 month in 
vitro. These features distinguished them from the irregular clumps of homogeneous 
debris also present in these cultures. After a few weeks in culture some spheres started 
adhering to the tissue culture plastic and cells started migrating in a radial fashion to 
form a small corona of adherent cells. However the large amount of myelin and 
cellular debris present in these cultures made further identification difficult. 
To characterise these cells, the medium containing the suspended cells and aggregates 
was removed, the cells (and debris) separated by centrifugation, resuspended in fresh 
medium and plated onto poly-lysine for 1 week. Following this a larger number of 
cells started to adhere, not only from the visible clumps but also from individual cells 
either surviving in suspension, or released from the spheres when resuspended. These 
quickly formed a network of processes of predominantly astrocytic origin (as 
determined by GFAP staining), with evidence of both oligodendrocyte lineage cells 
(Gale) and bipolar cells with the immunophenotype of oligodendrocyte progenitors 
(A2B5+ GF AP-)(Figure 5-1). Most cells had an immunophenotype and morphology 
consistent with, if not always typical of, eNS glia (Figure 5-2). However, occasional 
cells were seen that stained for both Gale and GF AP antigens (Figure 5-3). These two 
antigens are widely used as markers for oligodendrocytes and astrocytes respectively. 
However RafT et al reported cells with both Gale and GF AP staining in 1983 in their 
seminal paper on the 0-2A progenitor (RafT et al. 1983), which are also seen in adult 
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human progenitors (Scolding et al 1995). Raff et al. 's hypothesis of aberrant 
differentiation induced by the culture conditions seems equally plausible here, 
although the significant possibility of occasional Schwann cell contamination could 
also explain this observation. 
Aggregate cultures from adult human brain continue to grow as spheres in 
EGF and FGF2, and express immature neural antigens 
To confirm that these cultures contained sphere-forming cells, a further glial 
preparation was established using the standard dissociation protocol. These cells were 
placed immediately into a DMEM:FI2 medium with a high insulin concentration 
(sufficient to activate the Insulin-like Growth Factor (IGF) receptor), EGF and FGF2 
and placed in an uncoated tissue culture flask. Growth factors were replaced 3xJweek, 
and the medium changed 50:50 every week, ensuring that no cells in suspension were 
lost. The change to the base medium, and the replacement regime for growth factors 
were based on recommendations made by Dr V.Kukekov (personal communication) at 
around this time. A number of cells with a flattened, fibroblast-like morphology 
adhered to the tissue culture flask within days of plating and eventually formed a 
monolayer. However, after 7-10 days a few small aggregates appeared, and these 
developed into floating spherical bodies that continued to grow until the largest of 
these was approximately 200J.1m in diameter (Figure 5-4). This growth then gradually 
slowed despite continued growth factor replacement, until little change was seen after 
3 months in vitro. Some of the supernatant and floating cells were removed at 12 
weeks, concentrated and plated onto poly-lysine coverslips. These were left for a 
further week in the same medium to adhere before being stained for a number of 
immature and mature neural antigens. 
Many of the cells that subsequently adhered to poly-lysine stained with vimentin or 
S 1 00, but in view of their morphological similarities with "type 1" astrocytes the lack 
of widespread GF AP staining was surprising (Figure 5-5, Figure 5-6 & Figure 5-7). 
(Antibodies to human nestin were not available at this stage of the research.) 
Vimentin, an intermediate filament protein, is expressed by a number of primitive 
neural lineages, and distinguishes neonatal from adult rodent oligodendrocyte 
progenitors (it is only expressed by the former.) S 1 00, a protein associated with 
intennediate filaments, appears to be expressed by immature astrocytes as well as 
labelling Schwann cells, but widespread expression amongst primitive cells means 
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neither of these antigens is regarded as being lineage specific (Richter-Landsberg & 
Heinrich 1995). However they provide suggestive evidence that these spherical 
aggregates contained a primitive popUlation of cells. 
To provide further evidence it was necessary to demonstrate the presence of all three 
lineages in these cultures. This was attempted using antibodies against neurofilament, 
GFAP, GalC and A2B5. The result of this experiment was unfortunately inconclusive. 
While there was a suggestion of fluorescent staining of the spheres with both A2B5 
and GalC (Figure 5-6), the number of spheres grown in these cultures limited the 
staining protocol to 4 coverslips (3 triple immunofluorescent stains and 1 control), 
which was insufficient to rigorously exclude non-specific binding. Furthermore, 
although there was some staining of cells with the neurofilament antibody, these cells 
were morphologically unlike neurons, and the staining pattern was not indicative of 
cytoskeletal binding (Figure 5-6 and inset). Subsequent experiments demonstrated that 
more discriminatory immunofluorescence could be achieved with a lower 
concentration of anti-NF200kD antibody. 
Cell proliferation and commitment to the oligodendrocyte lineage can be 
influenced by altering the culture conditions 
In spite of the undoubted importance of determining the presence or absence of stem 
cells in these cultures, this was subordinate to the requirement of finding a source of 
oligodendrocyte progenitors. At this stage in the research there was a hiatus due to 
severely limited tissue supplies (only one sample became available between November 
2000 and November 2001 due to medico-political fallout from the Alder-Hey 
Scandal). By the time this work resumed, several groups had published different 
protocols using different media combinations and it was unclear which would provide 
the largest yield of oligodendrocyte progenitors from our specimens. It was therefore 
decided to address this question directly by systematically investigating different 
culture conditions to optimise the yield of oligodendrocyte lineage cells from the 
aggregates. 
Several reports had suggested that a high glucose concentration (6g1L) favoured stem 
cell growth over traditional DMEM:FI2 formulations (3g1L) used in the earlier reports 
of stem cell culture (Carpenter et al. 1999). Most investigators had reported protocols 
including EGF and FGF2 as encouraging stem cell proliferation (Johansson et al. 
1999) (although some suggest that the EGF-responsive and FGF-responsive 
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populations were separate (Martens et a1. 2000», but it was not clear to what extent 
these conditions had been obtained by systematic assessment. The hypothesis here was 
that the more primitive, putatively EGF- (& FGF-) responsive cells would proliferate 
best in these circumstances, giving high total cell numbers, of which a proportion 
would spontaneously commit to the oligodendrocyte lineage. However reports were 
emerging of EGF encouraging astrocytic differentiation at the expense of other 
lineages [8 Goldman - personal communication]. Certain groups were using FGF2 in 
isolation to expand oligodendroglial precursors with some success (Grever et a1. 
1999). FGF2 appears to have mitogenic properties both in the stem cell popUlation 
(Johansson et a1. 1999;Kukekov et a1. 1999) and in more committed progenitors 
(McKinnon et a1. 1990) and it was hypothesised that this could be sufficient to expand 
stem cells without biasing their commitment away from oligodendrocyte development. 
Thirdly, the traditional combination of FGF and PDGF was selected because of its 
attested growth promoting properties on rodent oligodendrocyte progenitors. It was 
hypothesised that these mitogens would promote proliferation of oligodendrocyte 
progenitors as they differentiated from more primitive cells. The previous observations 
of oligospheres (free floating aggregates of proliferating oligodendroglial cells at the 
pre-progenitor and progenitor stage) had been reported to form in media known to 
promote the expansion of oligodendrocyte progenitors (Avellana-Adalid et a1. 
1996; Vitry et a1. 1999;Zhang et a1. 1998a). It was therefore possible that human 
progenitors might grow as free floating aggregates under these conditions, and to 
address this question it was decided to compare the cellular yield from both the 
adherent and floating populations. 
To identify the optimum growth conditions, the next glial preparation was processed 
in 6 different ways (3 growth factor combinations by 2 glucose concentrations), and 
the yield from both the adherent and free-floating populations were assessed by 
immunocytochemical means. 
The small number of cells available from a single brain specimen limited the statistical 
power of this experiment, and so comparisons between the groups were not 
significant. However, there was a trend towards an optimum yield with EGF and FGF 
in a high glucose medium (N8A - Euroclone™) (Figure 5-8). Roughly one third of 
these cells stained with A2B5, a higher proportion than seen in the other groups (again 
not statistically significant). Interestingly. very few adherent cells grew in these 
conditions, a further pointer to suggest that the final population of cells were 
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anchorage independent for at least some of their growth. These growth conditions 
were reproduced for subsequent experiments. 
Aggregate cultures expand as spheres in stem cell mitogens 
Further steps were taken to optimise the growing conditions and to demonstrate 
continued proliferation in vitro. The next sample was placed under similar growth 
conditions to those determined above, but three notable changes were made to the 
protocol. Firstly, a density centrifugation step was added to the dissociation protocol to 
remove most of the myelin debris. The continued presence of the debris made 
identification of free-floating cells problematic, and the loss of viable cells in this 
process was outweighed by the gains in terms of clarity and staining quality. Secondly, 
following advice from other groups, recombinant growth factors were replaced weekly 
rather than on alternate days. The final point related to the source tissue which was 
obtained from the convexity temporal cortex of a 4 year old boy with post meningitic 
epilepsy, while most previous samples had come from mesial temporal structures of 
young adults. These cells started forming aggregates as before, but the aggregates then 
started adhering spontaneously. As they plated down, they formed small nests of cells 
with a mixture of morphologies and further proliferation was halted (Figure 5-9). The 
immunophenotypes of these cells were not successfully identified, but it was felt that 
the paucity of growth factors might have been responsible for this. 
To prevent this effect growth factors were once again added 3x Iweek during the next 
preparation. In addition, to inhibit premature adhesion and to remove the anchorage-
dependant population, the tissue culture plastic was first coated with the anti-adhesive 
Poly-HEMA ™ on parallel flasks. However the increased frequency of growth factor 
replacement alone appeared sufficient to reduce this effect, and total cell yield was 
notably reduced by the anti-adhesive coating. Spheres formed under these 
circumstances and continued to expand under the influence of EGF and FGF2 to sizes 
between SO-80J.1m in diameter by the third week. 
Cells from these spheres express nestin and poly-sialated NCAM. 
After an initial fortnight growing in suspension cultures and a four-day period on poly-
lysine. to promote adherence and facilitate identification, a thorough delineation of 
cellular constituents was possible, supported by appropriate controls. Cells at this 
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stage adhered to the coated coverslips and migrated short distances from it. Most cells 
in the corona had a flattened or elongated, bipolar morphology. 
Staining with an antibody to human nestin revealed widespread staining both of the 
migrating cells and of those cells still resident in the sphere. The cytoplasm stained in 
a pattern consistent with that expected for a cytoskeletal protein, and delineated 
processes clearly. 
Glial and neural progenitors express the "embryonic" form ofNCAM, which differs 
from the counterpart expressed on the surface of more mature cells by the presence of 
a chain of sialic acid residues. This chain may play an important role in migration by 
limiting cell-cell adhesion by means of its size (Murray & Dubois-Dalcq 1997;Vitry et 
a1. 2001). Antibodies to PSA-NCAM clearly labelled the surface of many cells as they 
migrated out of the spheres onto the substrate(Figure 5-10). 
Neural spheres contain cells from all three neural lineages 
After a further three days on poly-lysine, these preparations were stained with markers 
specific for the separate neural lineages. Neurons were identified with the neuron 
specific ~III isoform of tubulin, astrocytes by glial fibrillary acidic protein and cells 
committed to the oligodendrocyte lineage with 04. Both neuronal cells and astrocytes 
were common in the adhering aggregates. Oligodendrocyte lineage cells were also 
evident at this stage but less prevalent (Figure 5-11 & Figure 5-12). It had previously 
been reported that neurons do not grow in primary cell preparations from adult human 
brain (Ante I 2003). Several attempts using various markers have been made over 3 
years to identify neurons in mixed glial cultures but we confirm that neurons do not 
survive the dissociation process. Thus the identification of cells expressing neuronal 
markers in these cultures after expansion of aggregate cultures in conditions known to 
promote stem cell propagation suggests that multipotent cells are growing in these 
conditions. 
The yield of committed oligodendroglia remained relatively small. There may be 
many explanations for this; no attempt was made to induce di fferentiation in these 
cultures. and the cells may not have had time to differentiate to the 04 positive stage. 
Interestingly, cells detached from the adherent population with trypsin (the free 
floating aggregates were aspirated off without physical or enzymatic assistance first) 
and grown in similar conditions on poly-lysine. possessed more typical 
Page 137 
Remyelination Biology 
oligodendrocyte progenitor morphology. However, while they stained with AlB5, 
they also stained positive for GF AP suggesting a "type 2" astrocyte identity (Figure 
5-11). In fact, few A2B5 positive cells in this preparation were GF AP negative, 
irrespective of morphology. In contrast, cells derived from the suspended cells 
revealed a mixture of oligodendrocyte antigens but without GF AP co-staining (Figure 
5-14). 
Adult human stem cells can give rise to substantial numbers of 
oligodendrocyte lineage cells. 
The demonstration of characteristic stem cell growth characteristics with appropriate 
mitogens, the expression of a mixture of stem and progenitor antigens and the 
differentiation of daughter cells into all three neural lineages all supported the 
hypothesis that stem cells could be grown from the adult human brain. However it 
remained unclear whether the oligodendrocyte yield from these cultures was sufficient 
to provide a viable source for therapeutic transplantation. 
To address this required a further experiment where sphere progeny could be assessed 
quantitatively. It was decided to compare the current protocol with two alternatives 
suggested by contemporary reports that had used the aggregate culture approach. The 
first approach was to induce the formation of "oligo spheres" similar to those reported 
form rat, mouse and canine brain (Avellana-Adalid et al. 1996;Vitry et al. 1999;Zhang 
et al. 1998a) using medium conditioned with the rat neuroblastoma line B 1 04. The 
second was to use the conditions reported by a group, experienced at obtaining high 
oligodendroglial yield from other mammals (Zhang et al. 1998b;Zhang et al. 1998a), 
which had focussed on oligodendroglia formation from fetal human brain at 15-20 
weeks gestation (Zhang et al. 2000). These cells had been expanded first as neural 
spheres using FGF2, EGF and Leukaemia Inhibitory Factor (LIF). The addition of LIF 
was reported as preserving their differentiation potential better than FGF2 and EGF 
alone, particularly with regards to oligodendroglia formation, although the final 
oligodendroglial yield remained below 5%. 
Following dissociation along standard lines, cells were grown initially in EGF and 
FGF for three weeks to form free floating spheres. These cultures were then split 
equally into three different flasks in E&FGF, E&FGF with LIF or E&FGF with B 1 04-
conditioned medium for a further four weeks with regular growth factor replacement. 
Cells were then dissociated from the spheres using trypsin and EDT A and plated onto 
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poly-lysine coverslips in a differentiation medium containing low PDGF( Ingml) 
concentrations and O.s% serum (Zhang et a1. 2000) for a further \\ cck. Cells were then 
immunostained for markers of different neural lineages (04, GFAP). (PlIItubulin 
staining on this occasion was unfortunately unreliable and has been omitted from the 
graph). Other putative markers of more immature oligodendroglia were assessed on 
parallel cultures at 2-4 days post dissociation and are included here (Figure 5-15). 
Observation prior to dissociation suggested some qualitative differences bct\\een 
groups. The cells grown in EGF & FGF alone had formed spheres that were between 
1 00-1S0Jlm in diameter, while those in EGF, FGF & LIF were slightly smaller at 
between SO-1 OOJlm. Interestingly, those grown in B 1 04-conditioned medium \\ere 
very large (>300Jlm), although many of these larger aggregations were now irregular 
and appeared to be composed of several spheres that had adhered to each other. 
When the dissociated cells were identified there was surprisingly little variation in the 
percentage of each cell type found between the different conditions tested (Figure 
S-1S). However there was a notably high yield of oligodendrocyte lineage cells as 
identified by 04 antigen expression amongst cells from all conditions. This yield or 
around 60% contrasts starkly with that obtained from fetal human cells in similar 




The presence of neural stem cells in the adult brain is gaining credence. First 
hypothesised from developmental observations, neural stem cells have been identified. 
isolated and grown in vitro (Reynolds & Weiss 1996). Many of the properties of 
embryonic neural stem cells have been seen in cells dissociated from the mature 
mammalian brain, and these cells now appear to be present in the adult human 
(Akiyama et al. 2001a;Arsenijevic et al. 2001;Johansson et al. 1999;Kukekov et al. 
1999). However, it should be noted that in none of these reports are all attributes of 
stem cells unequivocally demonstrated. One report does demonstrate clonality of 
many individual spheres by means of retroviral insertion analysis, and separately 
demonstrates mUltipotency by antigenic means, but these spheres failed to propagate 
beyond four passages - true assymmetric division would predict unlimited division. 
Others fail to demonstrate clonality with absolute security or use tissue sources that 
could contain transformed cells (Akiyama et al. 2001a). 
The experiments described here broadly support the hypothesis that adult human brain 
contains stem cells. However, in view of the strict requirements for proving clonality, 
asymmetric division and true, functional multipotency it would be more accurate to 
conclude that sphere-forming cells are present in adult human brain, and that these 
cells proliferate to form multipotent spheres, staining widely for immature antigens, 
and demonstrating differentiation markers of all three neural lineages. 
While this in itself is notable, it is not entirely new. However, the high proportion of 
04 staining cells from these cultures is of great significance. Several reports suggest 
that oligodendroglia are a minority popUlation from differentiating neurospheres. 1-5% 
is a common yield (Palm et al. 2000;Zhang et al. 2000). Other reports do not quantify 
the oligodendroglial yield. If adult human neural stem cells are to be a viable source of 
remyelinating cells for therapeutic purposes then prior commitment to the 
oligodendrocyte lineage may be an important first step (Smith & Blakemore 2000). 
Certainly, widespread differentiation of transplanted cells into unwanted neurons 
(which could be epileptogenic) or astrocytes (which could impede remyelinating cells 
(Fawcett & Asher 1999» may be highly detrimental. Interestingly, when transplanted, 
putative neural stem cells (albeit tumour-derived), produced peripheral, not central 
myelin following transplantation. Tissue specific cues for lineage determination 
remain poorly understood. Peripheral myelin may be sufficient to provide short-term 
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functional benefit, but the requirement for axonal trophic support may mitigate against 
such a therapeutic strategy. The demonstration of a viable source of oligodendrocyte 
lineage cells expanded ex vivo from adult human brain is therefor encouraging. 
Future work 
Two important elements remain unaddressed. Firstly the phenomenal replicative 
potential remains to be fully realised. To some extent this may be amenable to 
relatively minor changes in technique. There were considerable difficulties in 
adequately dissociating spheres using purely mechanical means, despite trying fire-
polished Pasteur pipettes, Gilson™ Pipettes and other means. In fact, high 
concentrations of both the chelating agent EDT A and trypsin were required to 
dissociate these cells into individual cells, a process that has been reported to be 
associated with a significant reduction in subsequent proliferation and sphere 
formation (Zhang et al. 2000). Furthermore, the importance of sphere-conditioned 
medium - that is undefined soluble factors secreted by proliferating spheres that 
encourage sphere formation and cell division in other cells with a similar potential, 
may have been underestimated (Zhang et al. 2000). It is clear also that there are cell-
cell interactions within spheres that facilitate both proliferation and self renewal. The 
requirements for both a cell of stem potential, and a stem cell "niche" created by 
surrounding cells and the extracellular matrix are conjectured, but remain to be 
elucidated. 
Secondly the progeny of these spheres need further assessment. As has been 
underlined in other chapters, we believe that identification by immunophenotype and 
morphology, while reproducible, convenient and generally reliable, is most robustly 
supported by functional analysis. In the oligodendrocyte lineage this means the 
sequential expression of differentiation antigens, contact with axons, ensheathment 
and maturation of the myelin sheath, and finally both restoration of saltatory 
conduction and axonal trophic support. These will require both co-culture experiments 
and transplantation studies to ascertain. 
Transplantation studies require an adequate means of identifying transplanted from 
host cells. While various options are available at differing levels of technical 
complexity, the use of ret rovira I vectors allows both labelling, and, crucially, the most 
robust form of clonal analysis. While no sine qua non of a transplantation strategy, 
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rigorous confinnation of the presence of neural stem cells in the adult human brain 




Figure 5-1 Free floating , unpurified cells grown first in 10% F 
form aggregates on uncoated plastic . When transferred to a permi i e ub tr t 
adhere and develop a network of interlocking processes . Some bipolar ell with th 
immunophenotype of oligodendrocyte progenitors areisible stained \ ith A2 B r 
more mature putative oligodendrocytes stain with GaIC(green) (arrO\ ). F AP blu 
identifies a network of interconnecting astrocytic processes . Melin debri al t in with 
oligodendrocyte antigens. Nuclei are identified by Hoechst(blue) (x I 00 Bar = 40)lm . 
Figure 5-2 The same cell preparation as figure 1 under high power ( 400 . ~r 
a tJ'ocyte with bundles of cytoskeletal GF AP (blue), and a separate flatten dell \ \th 
like exten ion taining trongly with the oligodendrocyte marker Gal (gr n ar 
A2B5 taining wa negati e (not hown). 
d 
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Figure 5-3 Occasional cells stained for both oligodendrocyte and tro m 
(GF AP-blue, Gale-green, A2B5-red x400). 
Figure 5-4 Some cells cultured ab initio in DMEM :FI2 medium with FG and 
grow into spheres on uncoated tissue culture plastic, but other ce ll adhere , om of whi h 
appear to migrate out from the sphere (Phase contrast x I 00) 
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Figure 5-5 Cellular migration from E&FGF expanded sphere i enhan e b ' pi In 
onto poly-lysine (phase contrast xl 00). orne of the e cell tain \ ea or \ 1m n In r 
Staining for neurofilament (NF200kD green & below x600 hO\ an atyp1 I p n m n 
consistent with a cytoskeletal protein. 
Figure 5-6 A separate sphere grown under the same condition a Figur ph 
contrast x200) shows a mi xture of normal and pyknotic nuclei lab II d v ith H h t, an 
emerging astrocytes labelled with GF AP (blue) . There i e id n 28 (r d) and 
(green) staining of the sphere, but not o f the adherent cell population . 
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Figure 5-7 SI OO staining was al so evident in a subgroup of adh rent II 
Figure 5-8 The Effect of Di fferent Growth ondition on the ol igod ndr yt and 
astrocyte lineages (Adh = adherent condi tion Float = free -floatin g Hi . lu = 6% glu 
Lo.Gluc = 3% glucose) [Analys is of 12 parall el co er li p incl ud d h r for illu tra ti 
purposes only - see text] 
r. GFAP+ Cells 
• GaIC+ Cells 
I_A2B5+ Cells 
o Unstained Cells 
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E&FGF E&FGF FGF FGF PO&FGF PO&FGF E&FGF E&FGF FGF FGF PO FGF PO FGF 
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Figure 5-9 Spheres grown in EGF and FGF top left and right - al b = 
down spontaneously if growth factors are not regularly repleni h d and m TIll' t \ n 
morphologies (bottom left and right; scale bar = 20~m)_ 
Figure 5-10 Free-floating aggregate adhere to pol -Iy in ub trat and pr 
of early progenitors; Nestin (Red) and P A-N AM (green) cal Bar = 20llm ) 
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Figure 5-11 After a week on poly-lysine, markers of neuron ,BII/ tubulin - gr n 
astrocytes (GF AP - blue) are expressed by different subpopulation . ale Bar = 
Figure 5-12 Parallel cultures demonstrate that oligodendro yte lin ag ell id ntifi b 
the 04 antibody (red) are also present in these adhering aggregate ( al bar = 20 !lm 
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Figure 5-13 Bipolar cells, which appear to originate from a 100 el adh r nt p P n 
growing alongside the aggregate cultures, can be dislodged with trypsin r - dh r p I -
lysine and stain variously for A2B5 (red), Gale (green) and GFAP (blue . al B = 
20~m) . 
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Figure 5-14 . A~ter aggregate cultures are transferred to adhesi e ub trat 
express putatIve olIgodendrocyte markers; A2B5 (green) and 2 a homolo ' om 
II 
(red) but not GFAP (blue). (Scale Bar = 20)lm) 
Figure 5-15 Different growth factor mak little appar nt dif~ r n t th 
immunophenotype of the di ociated ell population . [parall I analy ,ingl hum n am lc.:, 
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Chapter 6. Oligodendrocyte Progenitors (CG-4) Are Resistant to the 
Effects of Immune-Modifying Agents In VlIro 
Introduction 
An example of one of many questions that requires a source of human oligodendrocyte 
progenitors to answer definitively, is whether anti-inflammatory drugs used to 
suppress disease activity in mUltiple sclerosis may impair the myelin repair process. 
The absence of such a source means alternative models have to be used, in this case, 
the rodent oligodendrocyte progenitor cell line CG4. These studies exemplify the 
numbers of cells required to answer these crucial questions of cell biology, and the 
way in which such important questions can be addressed. 
The pathology of Multiple Sclerosis (MS) is dominated by oligodendrocyte damage 
and myelin loss. Intrinsic repair in the form of remyelination occurs in MS (Perier & 
Gregoire 1965), but is limited and ultimately fails to prevent the progression of 
disability. Quiescent oligodendrocyte progenitor cells residing in normal adult brain 
divide and migrate into demyelinated lesions, and are thought to be largely responsible 
for new myelin formation (Blakemore & Keirstead 1999;Carroll & Jennings 
1994;Scolding & Franklin 1997). In MS, this is seen as areas with unusually thin 
myelin sheaths predominantly distributed towards the edge of lesions. Experimental 
remyelination suggests that this repair restores robust saltatory axonal conduction with 
demonstrable functional benefits (Jeffery et al. 1999;Utzschneider et al. 1994). 
Furthermore it may protect axons from subsequent degeneration (Halfpenny et al. 
2002;Kornek et al. 2000;Scolding & Franklin 1998). Consequently therapeutic 
remyelination strategies are being actively pursued with considerable enthusiasm and 
optimism; indeed early clinical studies implanting myelinating cells into patients are 
already underway (http://www.myelin.orglschwannupdate.htm). 
Immune mediated myelin and oligodendrocyte destruction appears to be predominant 
in MS, and many immunomodulatory drugs have been assessed in clinical practice. Of 
these, corticosteroids and interferon-beta (IFN-fl), and to a lesser extent azathioprine, 
are widely used and are efficacious in relapsing-remitting disease (Milligan et aI. 
1987;Sellebjerg et al. 1998;The IFNB MS Study Group 1993;The OWIMS study 
group 1999;Yudkin et al. 1991). Despite the increasingly recognised importance of 
remyelination in MS, there is little understanding of whether or how these drugs may 
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affect myelin repair, either spontaneous or putative therapeutl'c ap h S' h proac es. mce suc 
reparative strategies are already now being implemented~ it is timely to explore the 
possibility that these drugs might significantly affect remyelinating cell function. 
It is well established that two basic biological characteristics; migratory capacity and 
mitotic potential, are important determinants of myelinating cell efficacy (Blakemore 
& Keirstead 1999;Franklin & Blakemore 1997). There is limited evidence that steroids 
inhibit oligodendrocyte proliferation (Alonso 2000); type I interferons (a&~) have an 
anti-proliferative effect on some cell types (Lin et al. 1986;Moore et al. 1984), and 
azathioprine is a more potent anti-mitotic agent: these effects could have a significant 
impact on the behaviour of oligodendrocyte progenitors in acute demyelinating 
lesions. 
Here we use an in vitro approach to assess firstly potential direct cytotoxic effects of 
these drugs, and secondly to explore both proliferation and migration of 
oligodendrocyte progenitors under the influence of three immunomodulatory agents 
used widely in multiple sclerosis: corticosteroids, IFN-~ and azathioprine. 
Materials and Method 
Determining Drug Concentrations 
Pharmacological studies vary in their pertinence to drug regimes used in MS, making 
direct extrapolation of drug concentrations for use in vitro problematic. Thus wide 
ranges of concentrations were used aiming to investigate drug concentrations 
approximately 2 orders of magnitude above and below those thought to be clinically 
relevant, as guided by available in vivo studies. Peak levels of methylprednisolone 
reach 0.5 Jlg/ml in the cerebrospinal fluid of MS patients after a 1.5 g infusion (Defer et 
al. 1995), and levels of IFN-~ peaked at approximately 4 IU/ml4 hours after a single 
60Jlg injection of IFN ~la (Munafo et al. 1998). Levels of azathioprine have to be 
extrapolated from non-MS patients and studies have shown significant differences in 
steady state levels between extensive metabolisers, whose steady state remains below 
27nglml irrespective of oral dose, and a small proportion (-300/0) of poor metabolisers 
whose levels may reach 600nglml (el Yazigi & Wahab I 993).Although some of 
azathioprine's biological activity resides in the parent compound (el Yazigi & Wahab 
1993), its principle metabolite 6-mercaptopurine may be responsible for much of its 
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clinical effect, and levels of this compound appear to be more predictable, with levels 
of ISng/ml being recorded (Weller et al. 1995). 
Anti-Inflammatory Drugs 
Stock solutions were made by dissolving reagents (all obtained from Sigma, Poole UK. 
unless otherwise specified) in methanol (methylprednisolone) or 1M NaOH 
(azathioprine & 6-mercaptopurine ). IFN-~ was available in solution. All further 
dilutions were made into Sato medium containing BSA and pH corrected where 
required. Vehicle controls were used where appropriate. In particular, the experimental 
protocol required the presence of a significant quantity of met hanoi (final 
concentration 1 %) in the highest concentrations of methylprednisolone. 
CG-4 Cell Culture 
CG4 cells were grown as previously described. Briefly, the cells were grown on poly-
o-lysine (PDL) coated flasks in Sato medium (containing OMEM, 2mM L-glutamine, 
5 J.1g/ml insulin, 50J.1g/ml holo-transferrin, 100 J.1g/ml bovine serum albumin, 16 J.1g1ml 
putrescine, 60 ng/ml progesterone, 5 ng/ml sodium selenite and 400 ng/ml each of 
thyroxine (T 4) and tri-iodothyronine (T 3», supplemented with 30% B 1 04 conditioned 
medium. Cells were passaged 1:3 every 3-4 days. For the migration assay, cells were 
harvested from flasks with trypsin when about 800/0 confluent. 
MTT Assay 
CG4 cells in the logarithmic phase of growth were plated uniformly into POL-coated 
96 well plates (Nunc) and incubated for 24 hours in FGF2 (I Ong/ml) alone or FGF2 
and PDGF AA (1 Ong/ml) (Peprotech). Serial dilutions of test reagents were added across 
the plate, with both positive and negative controls in parallel, and the incubation was 
continued for a further 90 minutes (to assess cytotoxicity) or 24 hours (to assess 
proliferation) (Mosmann 1983). Cytosine arabinoside was used as one of these 
controls for its toxic effect on dividing cells. MTT was added to a final concentration 
of Imglml for I hour at 37°C. The supernatant was then aspirated ofT, the formazan 
product dissolved in isopropanol and the reading measured with a Multiskan Ascent 
spectrophotometer. All assays were repeated with di fTerent passage numbers and using 
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different layouts to avoid systematic variations across the plates. Results shown are of 
a representative experiment. 
BrDU Incorporation Assay 
CG4 cells were plated on PDL-coated 13mm glass covers lips in multi-well plates and 
allowed to adhere overnight. Each well was then flooded with Sato medium 
supplemented with FGF2 and PDGF AA and different test reagents. Incubation was then 
continued for a further 24 hours. Bromodeoxyuridine was added to each well for the 
last four hours of this, to a final concentration of 1 o J.lM , before fixing in 4% 
paraformaldehyde for 5 minutes. The cells were then permeabilised for 10 minutes in 
ice-cold methanol and DNA was partially denatured in 2N HCI for 30 minutes at 
37°C. Following a neutralisation step in borate buffer pH 8.5 they were labelled with 
anti-BrDU antibodies (Roche), washed and revealed with anti mouse IgG,-FITC 
secondary antibodies. BrDU positive cells and total cell numbers were identified in at 
least 10 high power visual fields taken at random using an Olympus IX70 inverted 
immunofluorescence microscope with a x40 objective lens, counting a minimum of 
200 cells per coverslip. 
Agarose Drop Migration Assay 
CG-4 cells growing exponentially were harvested with trypsin, washed through Sato 
medium, suspended in 40J.lI of Sa to with 10% fetal bovine serum and kept at 37°C in a 
water-bath. To this was added 20J.lI 1 % agarose in phosphate buffered saline and 
mixed thoroughly. The agarose drops were formed by seeding 1.5J.lI of this solution 
onto PDL coated multi-well plates and allowing the agarose to set for 10 minutes at 
4°C. Sato medium, together with the test reagents were added gently so as to avoid 
disturbing the droplet. B 1 04 conditioned medium was omitted from the migration 
experiments, but FGF2 was added to the test wells and controls to prevent the CG-4 
cells differentiating. Limited migration occurred in the absence of growth factors - but 
this was terminated by the acquisition of a more ramified, immotile morphology (Fig. 
3). Migration was measured at 40 hours using an Olympus IX-l 0 inverted microscope 
with a xl 0 objective lens and a graticule in the eyepiece. Measurements were taken by 
recording the distance travelled by the furthest cell from the edge of the agarose 
droplet in each of four quadrants (0, 90, 180 and 270°). Occasionally. agarose drops 
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became dislodged from the substrate, but this was easily detected and these results 
were discounted from the final analysis. Because proliferation of cells in the halo can 
contribute to the measured migration distance, certain experiments used aphidicolin 
(20 J.1g/ml), a mitotic inhibitor, to block this effect (Frost et al. 2000). 
Statistical Analysis 
All experiments were repeated at least three times on separate occassions with 
consistent results. Migration distances from the droplets were normally distributed 
within each experimental group. To correct for systematic differences between 
experiments, migration distances were converted to a migration index. This was 
calculated by dividing the distance migrated in the test wells by the mean distance 
migrated in the control wells and expressing this as a percentage. 
All results were processed using Microsoft Excel and SPSS version 10 software. 
Migration and MTT results were analysed using a one-way ANOV A and where 





We looked first to see whether any of the drugs had a cytotoxic effect on CG4 cells. 
Methylthiazoletetrazolium (MIT) is reduced to a fonnazan dye b . bl II b Y via e ce s ut not 
by dead cells, and can be used as an assay for cellular injury (Mosmann 1983). CG4 
cells incubated for 90 minutes in the presence of pharmacological levels of these 
reagents showed no fall in MTT value compared with untreated controls. However 
very high dose methylprednisolone (lOOflglml) did show a fall in viability (33%), 
although this did not reach statistical significance (p=0.066). 
Proliferation 
We used both the MTT assay and BrDU incorporation to assess proliferative activity. 
When incubated for 24 hours in the presence of the growth factors FGF and PDGF. 
CG4 cells proliferate, an effect that can be measured by a corresponding rise in their 
ability to reduce MTT (Mosmann 1983). We looked to see whether any of these drugs 
might affect this proliferative response (Figure 6-1). Again, only supra-
pharmacological doses of methylprednisolone impeded this response (p<O.OO 1), 
leading to a 71 % reduction in MTT signal (and by inference, cell numbers). This effect 
exceeded that of cytosine arabinoside (AraC) (p=O.044), a selective inhibitor of DNA 
synthesis used as a control, suggesting that non-dividing cells might also be damaged 
by this dose. 
Bromodeoxyuridine (BrDU) is incorporated into cellular DNA during the S-phase of 
the cell cycle, thus labelling actively dividing cells. Measuring the proportion of cells 
incorporating BrDU in a defined period enables a more direct measure of cellular 
proliferation (Figure 6-2). This confinned earlier findings that these drugs have no 
direct effect at more pharmacologically pertinent doses. No effect on proliferation was 
observed with any of the drugs and doses examined. 
Migration 
Migration was assessed using the agarose drop assay as modified by Frost (Frost et at. 
2000). FGF2 was used to maintain CG4 cells in an undifferentiated phenotype for the 
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duration of the migration assay, without which cells started to migrate nonnally. but 
quickly became multipolar and sessile (Figure 6-3). 
Neither preliminary dose-ranging experiments, nor more statistica))y powerful studies 
disclosed any significant effects on migration mediated by the drugs tested (Figure 
6-4a-d). Several different time periods were also investigated but no consistent effects 
were observed. A modest reduction in migration was seen with methylprednisolone at 
the highest dose investigated - 10Jlglml (Figure 6-4a), but on this occasion a similar 
reduction was seen with an equivalent methanol concentration used as the vehicle 
control. Neither of these approached statistical significance. 
In the first series of experiments PDGF AA was used as a positive control. This 
consistently and significantly (p<O.OOl) promoted migration (Figure 6-4a-d). FGF2 
and PDGFAA are established mitogens for CG4 (Louis et al. 1992), and the agarose 
drop assay may be confounded by alterations in cellular proliferation. The addition of 
aphidicolin, an inhibitor of mitosis, reduced the number of cells seen in the halo, and 
had a modest effect on the maximum migration distance as measured. However this 
protocol did not reveal any hitherto unobserved drug effects, while PDGFAA continued 
to stimulate migration in this situation. This supports previous reports that PDGF AA 
stimulates progenitor migration in rodent OPCs independently of proliferation) 
(Decker et al. 2000;Noble et al. 1988;Simpson & Annstrong 1999). 
Remyelination is thought to occur under the influence of astrocyte-derived growth 
factors, such as PDGFAA. We investigated the possibility that these agents might act 
by inhibiting PDGF-stimulated migration. We therefore repeated the experiments 
using both FGF2 and PDGFAA in all wells, together with the test reagents. Again, 





The reasons for remyelination failure in MS remain to be fully defined. Progenitor 
numbers in lesions may become depleted, the milieu within lesions may become 
unfavourable over time (Fawcett & Asher 1999) and/or persistently demyelinated 
axons may lose their potential to be remyelinated (Charles et al. 2002). Limitations of 
proliferative or migratory capacity are implicated either as key causes of, or 
contributors to this failure (Franklin 2002) . 
IFN-iS, high-dose corticosteroids and, to a lesser extent, azathioprine have a proven, if 
limited efficacy in suppressing immune activity and relieving clinical symptoms in 
relapsing-remitting MS (The IFNB MS Study Group 1993;Yudkin et al. 1991). 
However, their impact on progressive disability has been disappointing (Kappos et aI. 
2001;The IFNB MS Study Group 1993;The PRISMS Study Group 2001). This may 
reflect important differences in the mechanisms underlying acute and chronic disease. 
Immune processes are relatively quiescent in chronic progressive disease, but it 
remains surprising that the beneficial effect of reducing immune mediated damage is 
not reflected in greater long-tenn functional gains. This raises the possibility that 
treatment may have other less beneficial effects. Remyelination contributes to 
recovery from acute relapse and this process starts during the acute inflammatory 
phase (Smith & McDonald 1999), thus even steroids, given solely during the acute 
attack, may have the opportunity to interfere with remyelinating oligodendroglia. 
The evidence concerning the effects of immunomodulatory agents on remyelination is 
at present conflicting. In vivo studies have explored spontaneous remyelination 
following toxic demyelination in rodents. In mice methylprednisolone (4Smglkg) 
accelerated remyelination (Pavelko et al. 1998) while in rats dexamethasone 
(3mglkglday) reversibly delayed remyelination. Azathioprine ( 1Smglkglday) 
accelerated remyelination and increased myelin thickness (Herndon 1987). However 
these drugs produced profound variations both in the degree of demyelination and of 
the inflammatory infiltrate (Herndon 1987), making interpretation of the mechanisms 
for these effects problematic. Others have shown some promotion of remyelination in 
a virus induced demyelinating mouse model by type I interferons (Njenga ct al. 2000). 
In more recent studies a clear inhibitory effect of immunosuppressive drugs on 
remyelination was demonstrated (Smith & Franklin 2(01) 
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We attempted to circumvent these problems by taking a reductionist approach. Having 
shown no direct cytotoxicity, we looked specifically at direct drug effects on two 
biological properties of oligodendrocyte progenitors, proliferation and migration. 
Experimental work has repeatedly identified these as necessary and important for 
efficient remyelination (Blakemore et al. 2000;Crang et al. 1998), and stimulating both 
these properties, by the infusion of PDGF, yields a corresponding increase in 
myelinating cell efficacy (Allamargot et al. 2001). 
Of these agents, only the effects of corticosteroids on basic oligodendrocyte biology 
have been investigated in any detail, and their role in proliferation and differentiation 
is complex. Exogenous corticosteroids appear to delay the onset of developmental 
myelination in vivo but normal myelin formation follows its withdrawal (Huang et aI. 
2001). Other studies have demonstrated a reduction in BrDU uptake by parenchymal 
NG2+ve cells (putative oligodendrocyte progenitors) in adult rats treated with 
corticosterone. These cells did not stain for the glucocorticoid receptor, prompting the 
authors to propose that indirect mechanisms might be involved (Alonso 2000), 
although in vitro all stages of the oligodendrocyte lineage from progenitors to 
oligodendrocytes appear to express mRNA for the glucocorticoid receptor 
constituitively (Chan et al. 1998). Barres et al. implicated corticosteroids, along with 
thyroid hormone and retinoic acid, as alternatives necessary for the effecter 
mechanism of a cell clock, although the evidence is slightly in favour of thyroid 
hormone playing this role in physiological conditions (Barres et al. 1994). Later in 
cellular maturation glucocorticoids appear to playa role in the initiation of 
myelination (Chan et al. 1998) and promote myelin formation by controlling the 
translation of myelin basic protein and proteolipid protein, as well as stimulating 
myelin lipid production (Kumar et al. 1989). 
Our results help to clarify this picture. We did not see a reduction in proliferation in 
vitro to mirror that reported by Alonso (Alonso 2000) except at doses that are unlikely 
to be clinically relevant. In addition, both azathioprine and IFN-,g had no demonstrable 
effect on proliferation, and no agent directly affected migration. The assays used were 
sensitive to the effects of the control agents, so the absence of any positive or ncgativc 
effects on the drugs tested thus appears more robust. 
We conclude that direct inhibition ofremyelinating cells by these drugs is unlikely. 
This would suggest that the effects on remyelination previously observed in \';\'0 
(Herndon 1987;Njenga et al. 2000;Pavelko et al. I 998;Triarhou & Herndon 1986) 
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were caused indirectly. There is some evidence to support this. The role of the 
inflammatory response in promoting remyelination has been explored in animaJ 
models of de- and remyelination. These have suggested that macrophages can have 
important trophic effects (Kotter et a1. 2001), perhaps through secreted inflammatory 
mediators such as IL1(j (Mason et a1. 2001) or TNFa (Arnett et al. 2(01). previously 
thought to fulfil a more malign role in the pathogenesis of MS and oligodendrocyte 
biology (Andrews et a1. 1998;Cammer 2000;Cammer & Zhang 1999). This may help 
to explain why potent immunosuppression appears to be associated with a reduction of 
remyelination in some of these models (Smith & Franklin 2001 ;Triarhou & Herndon 
1986). The possibility of indirect effects on migration also exists; migration and 
adhesion of OPCs on astrocyte monolayers can be modulated by cytokines that act 
primarily on the astrocytes (Fok-Seang et al. 1995). 
Questions of basic oligodendrocyte biology assume new relevance if oligodendrocyte 
progenitor transplantation for MS becomes a clinical reality. Clinical experiments 
wherein autologous remyelinating glia are implanted into brain lesions in patients with 
MS have commenced and more are expected. Notwithstanding the limitations of in 
vitro studies, our findings imply that any future relapsing disease activity in these 
patients can be treated in conventional ways with a little more confidence that the 
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Chapter 7. Conclusion 
The burden of disability caused by multiple sclerosis remains huge, and effective 
treatments elusive. In addition to the need for therapies that prevent myelin damage. 
there is a pressing need for repair strategies to alleviate existing neurological deficits. 
The underlying aetiology is poorly understood and the relationship between the 
different pathological components of the disease, myelin destruction. inflammation 
and progressive axon loss is complex. However, myelin damage dominates both the 
pathology and the pathophysiology of early disease, and we have argued that a second. 
important component of chronic disease, axonal damage, may be most convincingly 
attributed to persistent demyelination. 
Remyelination is a striking example of regeneration in the brain, an organ otherwise 
notable for its failure to repair damage. However, while apparently effective both at 
restoring conduction (Smith et. al. 1979) and in preventing subsequent axonal 
degeneration (Komek et al. 2000), intrinsic remyelination is limited, and ultimately 
fails to prevent the relentless progression of the disease. The cause of this failure 
remains a crucial question in designing treatment strategies, a question that depends 
for its solution on an understanding of the biology of the cell responsible; the adult 
human oligodendrocyte progenitor. 
Much has been learnt about oligodendrocyte progenitors from studying experimental 
animals. An enormous amount is known about rodent oligodendrocyte progenitors, but 
there are sufficient differences between rodent and human cells to make the study of 
adult human oligodendrocyte progenitors essential. However, sources of these cells are 
scarce and, unlike rodent progenitors, it has not been possible to expand them in \·;tro. 
an uncomfortably pertinent example of the differences between the species. This 
problem of cell number has, par excellence, hampered the study of these important 
cells. 
Notwithstanding these difficulties, some studies have succeeded in studying the adult 
human oligodendrocyte lineage. It is these very studies that have discerned their 
failure to proliferate in mitogens that expand rodent cells. However, they have also 
underlined the important similarities between the rodent and human oligodendrocyte 
progenitor, such as ganglioside expression and lineage potential ;n \';Iro. These 
. '1 't' h d 'nned the a priori hypothesis on which this work was based simi an les ave un erpl 
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namely that rodent and human cells are, despite some evidence to the contrary. 
biologically similar. It is this hypothesis which has informed our attempts to solve the 
problem of obtaining sufficient numbers of adult human oligodendrocyte progenitors 
to allow their study. 
Chapter 2 described the result of one such attempt to use retroviral vectors carrying 
conditional oncogenes to transform primary adult human progenitors. Unfortunately. 
HWI instead provides a salutary lesson about the risks of cross-contamination in cell 
culture. 
Despite this particular example, the use of cell lines can and has provided dramatic 
insights into lineage biology. They can provide large numbers of cells in absolute 
homogeneity, and the judicious use of conditional oncogenes is a powerful tool in 
returning cells to an untransformed state. They can yield important insights into the 
biology of the parent cell, and properly manipulated cells can approximate more 
closely to the original than cells of a related species. Furthermore, they are frequently 
more faithful than cell lines arising stochastically in primary cultures, or grown from 
tumour tissue. However, all such studies require confirmatory experiments with 
primary cells, although it would be expected that these latter experiments could be 
perfonned with much smaller numbers. 
In that the original reports were promising, it was eagerly anticipated that systematic 
assessment of HW 1 would discern the crucial mitogen and media requirements that 
would then allow primary adult human oligodendrocyte progenitors to be expanded in 
vitro. The fact that the cells were overrun by a contaminating population does not 
negate this approach, which remains sound. However, it would always be a "stepping 
stone" to primary cell work for the reasons given. As such. the results of later chapters 
may render this approach, and the considerable time and resources required to repeat 
it, unnecessary. 
Chapter 3 tested a different approach. Traditional assumptions of lineage potential are 
being increasingly challenged, and the idea of "reprogramming" cells to adopt a more 
primitive, and thus more proliferative, phenotype has some attractions. Ultimately. this 
type of approach suffers from a fundamental concern. To what extent do the 
observations of Kondo and Raff represent a tissue culture artefact? Do glia really 
reverse their differentiation pathway in \'ivo? This reversal of the developmental 
pathway in the laboratory may be retrograde in more than one sense if it affects the 
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phenotype of the progeny, and hence the conclusions of any experiment that uses 
them. 
There are more provocative questions that arise from the discrepancies between the 
original work and the results of Chapter 3, despite the caveats discussed. If as we 
suggested, these discrepancies could be explained on the basis of different 
subpopulations of bipolar "O-2A" progenitors, then could some of these behave as a 
stem cell in their own right? The possibility that adult oligodendrocyte progenitors 
were in fact more akin to stem cell has been raised before (Noble et al. 1992) and their 
existence as a subpopulation of postnatal optic nerve "O-2A" progenitors is thus not 
inconceivable. If so, are adult human oligodendrocyte progenitors also stem cells? The 
results from Chapters 4 & 5 may help to answer these questions. 
In Chapter 4 we returned to the traditional approach of addressing questions of cell 
biology to primary cells derived from the tissue of interest. While facing the 
substantial problem of limited cell numbers, this approach minimises the effects of 
manipUlation ex vivo, and thus maximises the relevance of any findings. In addition, 
recent pUblications had provided useful suggestions for optimising the growth and 
isolation of these cells which fuelled optimism about the potential for their subsequent 
expansion in vitro. 
An interesting early observation from these studies was the relative prevalence. in 
percentage terms, of the A2B5+GF AP- population in these cultures compared to 
previous observations (Roy et al. 1999;Scolding et al. 1995). This may reflect 
differential loss of other phenotypes, but growth factors were present in the culture 
media, so a more provocative possibility might be that these cells are proliferating 
prior to assessment. Evidence of cell proliferation was forthcoming during these 
experiments and we were able to demonstrate this by labelling PDGFaR+ cells in the 
final stages, so, once repeated, a major aim of this work will have been achieved. This 
will confirm that PDGF AA and FGF2, and in the last experiment NT -3. in combination 
with sufficient insulin to activate the IGF-receptor. are mitogenic for adult human 
oligodendrocyte progenitors. Nevertheless, the substantial expansion seen with rodent 
progenitors. while now eagerly anticipated, has yet to be demonstrated. 
Secondly, we aimed to clarify the immunophenotype of these cells. Firstly, despite 
., arker of oligodendrocyte progenitors in adult humans. the NG1 
mcreasmg use as a m 
proteoglycan is also expressed by endothelial cells. fibroblasts. "type 2" and 
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occasional "type 1" astrocytes, as well as being expressed at low levels on some 
microglia. Secondly, provisional figures suggest NG2 antI'bod' C:'I 'd 'fy 
les lat to I enn 68% 
of A2B5+/GF AP- cells in primary cultures. Both of these cast significant doubt on the 
rationale for using it as a marker of oligodendrocyte progenitors in adult humans. 
However, NG2 antibodies have identified a novel population of morphologically 
distinct, flattened cells with wide, clawed processes, which we have argued may be 
related to the oligodendrocyte progenitor despite a lack of AlB5 staining or later 
oligodendrocyte markers. Similar cells arise from an AlB5+ population and grow as 
clumps and colonies in FGF2 and PDGFAA, implying significant proliferation. They 
are associated with, but distinct from AlB5+GF AP+ '~ype 2" astrocytes that also 
grow in these cultures and a major aim of future work is to identify the progeny of 
these intriguing NG2+ cells. 
To do this requires a separation step, and the use of magnetic beads to this end was 
highly successful. The development of such a protocol allows some important 
questions to be addressed that cannot be asked of mixed cell cultures. The questions of 
NG2+ A2B5-cell origin answered above exemplify the power of this approach. 
However it also provides a technique with which cells might be purified prior to 
transplantation, and its simplicity and efficacy could (and in certain haematologica) 
examples, has) been exploited in a clinical therapeutic setting. 
Chapter 5 described the approach of harnessing the replicative potential of stem cells 
to overcome the problem of cell numbers. However, in contrast to Chapter 3, this 
approach made no attempt to divert cells from their normal maturation pathway. The 
first aim, to confirm the existence of stem cells in the adult human brain was broadly 
successful. Cells were noted to grow in suspension, expand under the influences of 
mitogens predicted to target stem cells, enlarge in vitro into spherical bodies with the 
appearance of neurospheres, and finally differentiate into cells of all three neural 
lineages. A particularly notable result was the demonstration of large numbers of cells 
bearing antigens specific for the oligodendrocyte lineage, substantial support for the 
assertion that this strategy could provide large numbers of mitogen-expanded 
oligodendrocyte lineage cells for research, and perhaps therapeutic purposes. 
The neurosphere strategy produces colonies containing large numbers of cells that arc 
best described as "expanded neural progenitors". This begs the question; can the 
oligodendrocyte progenitors be selected out and puri fied from these'? A few smaJl 
hurdles remain before the potential is fully realised. As discussed. the diSSOCiation of 
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individual spheres requires some fine tuning to optimise the growth potential of the 
spheres. Progeny from these would then need to be sorted Th . f . 
. e expenence 0 magnetIc 
bead separation, based on immunophenotypic insights also described in Chapter 4. 
provides an ideal method for this. 
Two strategies in particular stand out as viable solutions to the problem of cell 
numbers; purification and direct expansion of adult human oligodendrocyte 
progenitors from primary cultures (Chapter 4) and primary expansion of adult human 
neural stem cells as spheres followed by dissociation and separation of developing 
oligodendrocyte progenitors (Chapter 5). However, does this work shed any light on 
how one might intervene therapeutically to augment remyelination in MS? 
Therapeutic Remyelination in Multiple Sclerosis 
A key question remains the root cause of the failure of intrinsic remyelination in MS. 
As has been discussed, many causes have been proposed for this, and different 
strategies could be devised to ameliorate each. Depletion of remyelinating cells is an 
explanation with considerable (Carroll et al. 1998;Duncan et al. 1997;Keirstead et al. 
1998;Rosenbluth 1996;Scolding & Franklin 1999), but not universal (Penderis et al. 
2003) support and this could be ameliorated by cell replacement strategies, such as 
that of therapeutic transplantation (Halfpenny et al. 2002), and this will be the focus of 
much of the subsequent discussion. However, an alternative approach to this problem, 
of relevance if impaired inward migration or late arrival of progenitors after axonal 
changes and/or glial scar formation was responsible, could be to find ways to 
manipUlate the biology of the oligodendrocyte progenitors. In particular the functions 
of proliferation and migration, which are repeatedly associated with efficient 
remyelination, would be targets for the latter approach. 
The hypothesis of dysregulation might, if correct, be the most complicated cause to 
redress, unless some orchestrating process could be identified that could itselfbe 
manipulated. The process of inflammation is an interesting contender. Long regarded 
as the villain in MS, its beneficial role is being increasingly appreciated. 
Remyelination occurs during the inflammatory phase of lesion fonnation (Smith & 
McDonald 1999;Babinski 1885). Indeed immunosuppressive agents have been 
associated with impaired remyelination (Smith & Franklin 200 I ). but it was not clear 
whether this was due to a direct effect on the remyelinating cells. or because of the 
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absence of stimulatory, chemokinetic or orchestrating signal fro . fl 
s m In ammalory cells. 
The fact that many of these agents are widely used to achieve short term gains in terms 
of resolving or suppressing acute relapses, adds some clinical relevance to these 
concerns. The study in Chapter 6 (also published in 2003 (Halfpenny & Scolding 
2003» goes some way towards focussing on inflammation per se as an important 
component of remyelination. It seems that future therapies may need to be more 
discriminatory about the way they alter the immune processes in MS. 
While our understanding of the causes for failing remyelination progress, there is sti II 
a pressing need to design therapies to benefit those whose suffering will not wait for 
science to catch up. What if any prospect is there for treatment? 
Cell replacement therapies remain a strong contender. A surprising variety of cells 
have been considered (Halfpenny et al. 2002), and it is worth reviewing the rationale 
behind some of these. 
Adult Human Oligodendrocyte Progenitors as Therapeutic Remyelinaling Cells. 
Much experimental work on remyelination has focused on the oligodendrocyte 
lineage. There is an inherent logic in concentrating on these cells. They are the cells 
lost in mUltiple sclerosis; it is their normal function to myelinate the eNS, and 
spontaneous oligodendrocyte remyelination in multiple sclerosis bears witness to their 
substantial inherent capacity for remyelinating damaged areas of the brain. In addition. 
there is a wealth of experimental evidence to demonstrate the production of new 
myelin in experimental animals after transplantation of puri tied oligodendrocyte 
lineage cells (Duncan et al. 1992;Franklin & Blakemore 1997;Groves et al. 
1993;Kocsis 1999;Rosenbluth 1996;Warrington et al. 1993) or cell lines (Barnett et al. 
1993;Groves et al. 1993;Tontsch et al. 1994). There is also evidence to suggest that 
this process is accompanied by both improved conduction (Utzschneider et al. 1994) 
and demonstrable functional recovery (Jeffery et al. 1999). 
The stage within the oligodendrocyte lineage most suitable for transplantation is 
important. Although some studies have suggested that mature di fferentiated 
oligodendrocytes are useful myelinating cells (Duncan et al. 1992), others suggest they 
have only limited capacity (Archer et al. I 997;Keirstead & Blakemore 1997). 
Comparative experiments have shown better myelin formation by implanted immature 
progenitors than mature oligodendrocytes (Warrington et al. 1993). The majority vicw 
is that mitotic potential is an important prerequisite for successful myelin formation 
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(Blakemore & Keirstead 1999), and that post-mitotic oligodendrocytes do not readilv 
recapitulate their development to form mature myelin sheaths again. . 
A further significant advantage of the progenitor phenotype is its demonstrable 
migratory potential (Baron-Van Evercooren et a1. 1996;Kieman & Ffrench-Constant 
1993; Warrington et a1. 1993). Partly assisted by their bipolar morphology. these cells 
appear to migrate better through demyelinated lesions than their mature counterparts. 
which manifest a more complex morphology both in vitro and in vivo. However. 
endogenous progenitors only migrate 1-2mm to repopulate demyelinated areas 
(Franklin et a1. 1997), indicating a very limited migratory potential through nonnal 
brain parenchyma. In vitro, astrocytes significantly impede progenitor migration 
(Duguid et a1. 1985), as do mature oligodendrocytes (Jefferson et a1. 1997). suggesting 
significant inhibition by surface molecules. 
Transplantation studies also show poor survival and migration when progenitors are 
implanted into normal white matter, although they are able to populate and 
remyelinate when injected into, or very close to, lesioned tissue (Franklin et al. 1996). 
By contrast, these cells survive well in X-irradiated tissue, which depletes endogenous 
progenitor numbers (Hinks et a1. 2001). Part of this increased survival may reflect 
competition between endogenous and implanted cells for survival factors, since 
progenitor numbers increase with increased availability of platelet derived growth 
factor (Barres et a1. 1992) or glial growth factor 2 (Noel et a1. 1999). The possibility of 
improving graft survival and proliferation by the use of growth factors has been 
explored in vivo with some success (Milward et a1. 2000). 
Investigations of human eNS glia have consistently demonstrated signi ficant 
biological differences from rodent cells, so that data concerning rodent 
oligodendrocyte progenitors cannot be directly extrapolated to hunlan glia. Early 
studies identified glia similar to the rodent ope's in cultures derived from the fetal 
human eNS (Kennedy & Fok-Seang 1986). These cells can synthesise myelin in the 
dysmyelinated rodent eNS, even after cryopreservation (Seilhean et al. 1996). 
More recently, a progenitor was identified in cultures of adult human brain, and shown 
to possess similar immunophenotype and differentiation potential to its rodent 
counterpart (Scolding et a1. 1995). but the response to growth factors appeared 
different. The work presented in Chapter 4 confinns the existence of this cell. 
However it suggests that the soluble mitogens for this stage of developmcnt may not 
be dissimilar to those of rodent cells under appropriatc culture conditions (FGF2. 
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PDGF AA and IGF-stimulation +1-NT3), but further work is required to define the 
effects of individual mitogens in more detail. When mixed human oligodendrocyte 
lineage cells containing small numbers of progenitors were transplanted into 
demyelinated rat spinal cord, myelin membranes but not compact multi-lamellar 
myelin sheaths were observed (Targett et al. 1996). Methods for selection of these 
cells (for experimental purposes) from samples of human white matter have since been 
perfected (Chapter 4) (Royet al. 1999;Windrem et al. 2(02), but as yet myelin 
antigens but no demonstrable myelin sheath fonnation after transplantation of adult 
human progenitors have been published (Windrem et al. 2002). 
With the demonstration of proliferative signals (Chapter 4), obtaining adequate 
numbers of oligodendrocyte progenitors for therapeutic purposes, whether autologous 
or heterologous becomes rather more feasible. The requirements for microbiological 
safety make the removal of serum from the cell harvesting process a minor obstacle; 
the demonstration of proliferation in serum-free medium has removed a rather more 
substantial barrier. It is anticipated that the adjustments required to transform 
demonstrable cell division to therapeutically viable expansion are now a realistic 
possibility, and are perhaps imminent. Further experiments using these cells are now 
required to determine whether mature, functional compact myelin can be achieved 
following transplantation into animal models of demyelination. 
Adult Human Stem Cells as a Source of Therapeutic Remye/inating Cells 
Stem cells themselves have potential as a source of remyelinating cells for 
transplantation therapies. As we have demonstrated here in Chapter 5, the adult human 
brain does contains neural stem cell and these can be expanded in vitro. Furthermore, 
they can give rise to significant numbers of oligodendrocyte lineage cells. Autologous 
cells could be harvested from the subventricular zone by endoscopic techniques 
through a small ventriculostomy, and re-implanted following ill vitro expansion. 
Myelin formation following transplantation of apparently uncommitted stem cells 
from the adult human subventricular zone (albeit removed during tumour surgery) into 
the demyelinated rat spinal cord has been demonstrated (Akiyama et aJ. 200 I b). 
As our understanding of stem cells grows, and in particular of the cues that induce 
lineage commitment in them, alternative sources of autologous stem cell might 
become feasible. Dramatic recent examples of the generalised commitmcnt of stcm 
cells (Alison et aI. 2000;Rietze et al. 200 1). and in particular of the neural 
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differentiation of non-neural cells gives credence to this approach (Mezey et al. 
2000b). Bone marrow derived cells are a particularly appealing candidate (Brazelton et 
al. 2000; Woodbury et al. 2000) because of their ease of retrieval and the considerable 
clinical experience of their use, and acutely isolated bone marrow fractions have been 
reported to remyelinate rodent spinal cord (Sasaki et a1. 200 1). These experiments also 
emphasise the importance of environmental influences to the process of lineage 
specification, the mechanisms of which remain predominantly conjectural. 
Does this negate the requirement for lineage commitment prior to therapeutic 
transplantation? There are two important reasons why this is unlikely to be true. 
Firstly, while direct stem cell transplantation has been reported to yield myelin 
(Akiyama et al. 2001a;Sasaki et a1. 2001), the myelin so formed was predominantly 
peripheral in type. Others report that commitment to the oligodendrocyte lineage is 
required for effective myelin formation (Smith & Blakemore 2000). While peripheral-
type remyelination has been demonstrated to restore saltatory conduction (Honmou et 
al. 1996) and function (Akiyama et al. 2001 a), there remain questions as to its trophic 
support of central axons. Secondly there is a more specUlative concern. Stem cells are 
rare cells with an extraordinary specialist role. Their scarcity may not be without 
reason; their phenomenal replicative potential may carry an inherent risk of neoplastic 
transformation. Embryonic stem cell transplantation provides dramatic evidence of the 
tumorigenic potential of uncommitted stem cells. Furthennore, there is some 
conjecture that primary cerebral tumours may arise from just such immature cells and 
any increase in the population of these cells, through artificial means or otherwise, 
may lead to an increased risk of one of these cells accruing sufficient mutations for 
malignant transformation. One might propose that prior commitment, with an expected 
diminution of replicative potential, may increase the threshold for transformation and 
thus protect against this event. 
Clinical Aspects of Transplantation Strategies 
When to Intervene in the Disease Process? 
Timing a remyelinating treatment in multiple sclerosis remains problematic. 
Clinically, the unpredictable course increases the temptation to defer a potentially 
hazardous intervention until progressive disability is established, and hope of 
spontaneous recovery extinguished - the first principal in any new therapeutic 
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endeavour must always remain "first, do no harm" Yet from b' I'cal . 
. a 10 081 perspectl ve. 
early intervention may offer significant advantages: as mentioned above. this is when 
spontaneous remyelination occurs, suggesting an optimally propitious environment~ 
and whatever the specific reason(s) for failed endogenous repair, the majority of 
proffered explanations relate to chronicity (Charles et al 2(02). Furthermore. the 
contribution of progressive axonal loss to secondary progressive mUltiple sclerosis 
(Bjartmar et a1. 2000;Bjartmar & Trapp 2001) also mitigates against late intervention: 
little could be expected of repair strategies when the axonal framework for 
remyelination has been lost. In fact, as we have argued. axonal loss itself is a potent 
reason for augmenting remyelination early. Whatever the mechanisms responsible. 
remyelination appears, par excellence, to protect axons against later degeneration 
(Komek et a1. 2000). This may prove one of the most important reasons for therapeutic 
remyelination. 
Thus the earlier the intervention, the greater the potential gain. But the significant 
obstacle to this approach is the risk of losing repaired areas. and carefully prepared and 
implanted remyelinating cells, to ongoing disease activity. Although advances in the 
area ofMS immuno-therapy may give cause for cautious optimism. no current 
therapies are able to suppress myelin destruction completely. Concurrent use of potent 
immuno-suppressive agents, perhaps required in any case to prevent graft rejection. 
might help, yet there is evidence to suggest that some of these agents themselves 
(Smith & Franklin 2001), or suppression of inflammation in general (Edge et al. 
1998;Platt 1996;Rosenbluth et al. 1993), may impair myelin repair. Chapter 6 would 
suggest that the onus of impaired remyelination in these cases may lie at the door of 
impaired inflammation, so considerable caution would be required if 
immunosuppressives were to be considered. 
Where to Implant Cells in Disseminated Disease? 
Most experimental studies have explored the effects of transplantation into a single 
site, but in multiple sclerosis almost innumerable areas of demyelination are 
commonly disseminated through the CNS. Clearly the prospect of multiple 
inoculations into widely disparate lesions is hardly realistic. What should not be 
overlooked, however, is that many plaques are clinically silent. while a 
. . d fd' abl'II'ty frequently emanates from a few critical lesions an dIsproportIonate egree 0 IS 
I Th . lantatl'on into a very small number of carefully selected e oquent areas. us Imp 
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lesions - for example, the optic nerves, the spinal cord, or the superior cerebellar 
peduncle - could yield a useful therapeutic dividend (Compston 1996). Early phase II 
clinical trials are likely to proceed on this basis. 
An appealing solution to the problems of cell dispersal would be to encourage 
transplanted cells to migrate widely, as occurs during development (Komack & Rakic 
2001 ;Thomas et al. 2000; Yamaguchi et al. 2000). Migration through mature brain 
parenchyma is very limited, but pro-migratory agents have been identi fled. and 
supplementing cellular transplantation with growth factor infusions (Fricker-Gates et 
al. 2000), or even co-transplantation with growth factor secreting cells (Milward et al. 
2000) has been tried with limited success. An alternative would be to block or 
suppress the expression or recognition of molecules that inhibit migration. an approach 
already under investigation to overcome inhibitors of axonal sprouting (Shearer & 
Fawcett 2001). Third, studies in neonatal dysmyelinating rodents have demonstrated 
significant cell dissemination after intraventricular transplantation (Learish et al. 1999) 
especially after two implantations separated by a few days (Mitome et al. 200 I). 
Assessing and Monitoring Transplantation Therapies 
Considerable attention needs to be focussed both on clinical management and 
monitoring following transplantation. Three modes of treatment may potentially be 
required: ongoing exogenous trophic support of grafted cells, immune-suppression to 
prevent graft rejection, and adequate control of ongoing disease activity to reduce graft 
loss. These issues cannot be fully addressed prior to the early clinical trials. not least 
because of the substantial differences between animals and human models. 
Regarding the first, little information is available, though the very limited number of 
animal studies do illustrate its potential impact (Milward et al. 2000). The adverse 
influence of anti-mitotic immunosuppressants on remyelination has been mentioned 
already. More positively, in multiple sclerosis, anti-rejection prophylaxis might help 
inhibit disease progression. The anti-leukocyte humanised monoclonal antibody 
Campath-1H, currently under investigation for the treatment of both (solid organ) 
transplant rejection and multiple sclerosis (Hale & Waldmann 1996;Morcau et al. 
1996) is particularly promising in this respect. Nevertheless. if cell implantation is 
adopted, there may be a risk. despite immunosuppression, of inciting new anti· 
oligodendrocyte immune reactions, which not only see otT the graft. but also augment 
underlying disease processes. Autografting might avoid this. 
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Sensitive and precise methods of monitoring graft SUrvI·VaJ . . ffi f 
' mIgratIon. e lC3CY 0 
remyelination and early detection of uncontrolled growth will be essential if~ese 
therapeutic protocols are to be responsibly explored in a clinical setting. Furthermore. 
myelin repair without clinical improvement will be a hollow victory. so robust and 
reproducible methods of clinical assessment would need to be applied ab initio. 
Non-invasive imaging is clearly attractive, most obviously magnetic resonance 
imaging (MRI) since it is widely available, safe and reasonably tolerated. Resolution is 
high, but contrast and specificity are more problematic. Standard protocols are 
unlikely to be sufficient to monitor remyelination, but considerable advances continue 
to offer new techniques, of which magnetisation transfer contrast is the strongest 
candidate for imaging remyelination (Barkhof 1997;Deloire-Grassin et al. 2000). 
Magnetic resonance spectroscopy (MRS) measuring N-acetyl aspartate (NAA) levels 
offer means of assessing any impact on local neuron/axon survival (Davie et al. 
1995;De Stefano et al. 1995). 
Using paramagnetic particles to label cells prior to transplantation, enabling their 
dispersion to be tracked by MRI (Bulte et al. 1999;Franklin et al. 1999;Lewin et al. 
2000) has promise, though from a safety perspective, even the most trivial 
manipulation of cells prior to implantation would be better avoided. Furthermore, graft 
survival cannot be inferred from migration, since dead cells remain visible (Buite et al. 
1999), and this method not only fails to show new myelin formation but may also 
impair the ability of other MR modalities to do so. Positron emission tomography, 
although expensive and of limited availability, can be both sensitive, and specific. but 
no appropriate ligands are yet available for monitoring remyelination. 
Serial neurophysiology may also prove valuable, and by monitoring conduction times 
may provide evidence of returning saltatory conduction in the targeted pathway(s). 
The optic nerve has particular advantages in this respect. 
If the sites mentioned above - the optic nerve, spinal cord, or brainstem - are selected 
for the first experimental trials seeking clinical benefit, then prognunmes for 
rigorously monitoring both the biological and clinical effects of the intervention ne~~ 
to be established, including not only imaging and electrophysiological examination. 
but physical assessment of any clinically relevant effects. Specific clinical outcomes; 
measures of function, disability. and handicap must be adopted and tailored for each 
patient group. Ultimately, success will need to be measured using properly designed 
clinical trials, in which clinical outcomes are likely to wield the greatest weight. 
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Considerable advances in the field of clinical scale design have improved physical and 
functional measurement in multiple sclerosis (Hobart et al. 2000;Hobart et al. 
2001b;Hobart et al. 2001 a), so that the tools for assessing clinical outcome, on which 
remyelination therapies must stand or fall, are becoming available. 
Final Comments 
In conclusion, we have argued that there is a pressing need to augment myelin repair 
in Multiple Sclerosis, and to do so requires an understanding of the biology of the cell 
responsible; the adult human oligodendrocyte progenitor. The major obstacle to its 
study is the limited numbers of cells available, and its failure to proliferate in vitro. 
We have explored four separate approaches to this problem. and we contend that two 
offer a feasible solution. We have confirmed the presence of both stem cells and 
oligodendrocyte progenitors in cultures from adult human brain and have explored 
their immunophenotype and identified conditions for each that stimulate cell division 
in vitro. We have demonstrated how questions of oligodendrocyte biology can be 
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